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Aortic Valve Disease
Aortic valve (AV) disease is relatively common with an estimated prevalence in the United 
States of AV stenosis and regurgitation of o.4% and 0.5%, respectively [1]. Degenerative, 
age-related changes are the major cause of AV disease in developed countries. As such, 
this supports the fi nding that the prevalence of AV disease increases markedly with age 
[1]. Changing demographics and increasing life expectancy will result in an increase in the 
number of patients with AV disease over the coming years.
 The function of the aortic valve is to ensure unidirectional blood fl ow from the left 
ventricle to the systemic circulation. In keeping with its function, AV disease is subdivided 
into two entities based on hemodynamic consequences: aortic valve stenosis (AS) and 
regurgitation (AR). In AS, outfl ow of the systemic ventricle to the aorta is obstructed, 
which in adults is most often the result of aortic valve leafl et thickening and stiffening 
through calcifi cation. Leafl et calcifi cation is an age-related phenomenon, which may be 
accelerated by hemodynamic abnormalities such as exist in congenital bicuspid aortic 
valve disease (BAV). A BAV is the most common congenital cardiac abnormality with an 
estimated prevalence in live births of 1.4% [2]. In addition, BAV disease is associated with 
aortic root dilation and dissection [3, 4]. In AR, closure of valve leafl ets is impaired from a 
decrease in coaptation surface from aortic root dilatation or by leafl et perforation from 
endocarditis. Interestingly, it is not uncommon for AS and AR in adults to be present at the 
same time. Leafl et thickening and stiffening in AS may decrease the ability of valve leafl ets 
to coapt and thereby reduce the coaptation surface. Rheumatic heart disease following 
rheumatic fever, nowadays rare in developed countries but unfortunately still common in 
the developing world, may lead to leafl et destruction resulting in both AS and AR [5].
 Aortic valve disease can be benign when hemodynamic consequences are limited. 
However, moderate to severe AS or AR may result in signifi cantly reduced quality of 
life and life expectancy. Although the pathophysiological mechanisms in AS and AR are 
different, both may result in symptomatic left ventricular dysfunction. This may present as 
dyspnoea on exertion, fatigue, angina pectoris, syncope and / or heart failure. In people 
with symptomatic AS, sudden cardiac death is a relatively rare but real threat. The severity 
of symptoms combined with the relatively high and increasing prevalence underscores the 
worldwide burden of disease associated with AV disease.
Evolution of Aortic Valve Surgery
Medical management of AV disease may result in adequate relief of symptoms. However, 
drug therapy does not lead to regression or halt progression of the disease [6]. Therefore, 
repair or replacement of the valve may become necessary over time. Nowadays, trans 
catheter aortic valve implantation may be performed in selected patients [7]. However, 
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the focus of this thesis concerns the vast majority of patients with AV disease who receive 
surgical treatment.
 Charles Hufnagel was the fi rst to implant a ball-and-cage mechanical valve in the 
descending aorta of a patient with severe AR in 1952 [8, 9]. This landmark achievement 
marks the beginning of surgical treatment in AV disease. Introduction of cardiopulmonary 
bypass in the mid-1950s allowed surgeons to engage with the aortic valve directly [10, 
11]. In the early to mid-1960s, surgeons began to set up aortic valve replacement (AVR) 
programs and developed most types of valve substitutes available today. This era has been 
coined appropriately as the great “valve rush” [12].
 At present, the majority of AVRs are performed with a mechanical or biological valve 
substitute. Mechanical valves have evolved from the early ball-and-cage design to a bileafl et 
valve. The advantage of a mechanical valve substitute is durability, which in most patients is 
lifelong. The disadvantage is the requirement of lifelong oral anticoagulation use to prevent 
thromboembolic complications. Use of oral anticoagulation is associated with signifi cant 
morbidity and mortality due to bleeding complications. Biological valves can be divided 
into two main categories: human tissue valves and bioprostheses made from porcine or 
bovine tissue. The advantage of biological valves is that lifelong oral anticoagulation use is 
not required. The disadvantage is the increased reoperation rate, as durability is limited, 
that is inversely correlated with age at implantation.
 After the pioneering work performed in the 1960s, AVR has evolved from a complex 
procedure with high operative mortality to a routine procedure with limited associated 
morbidity and mortality. However, the search for the ideal aortic valve substitute described 
by Dwight Harken in the early-1960s is still ongoing [13]. Implantation of mechanical 
valves is still associated with bleeding complications and biological valves with the need for 
reoperation. Given the limitations of current AV substitutes, a focus on valve preservation 
in patients with AR has emerged. In isolated AV disease, repair of one or more leafl ets may 
preserve the native aortic valve [14]. In addition, in patients with AR due to aortic root 
dilatation, valve-sparing aortic root replacement may be performed. Although data from 
long term follow-up studies is still pending, selected patients are expected to benefi t from 
these approaches.
Ross procedure
There is another alternative to traditional AV substitutes. In 1967, Donald Ross published 
a seminal paper in The Lancet on AVR with a pulmonary autograft [15]. Struggling with 
the limitations of available AV substitutes at the time, he proposed that the patient’s own 
pulmonary valve would be the ideal candidate for use as an AV substitute in AVR.
 The fi rst step of the procedure published in 1967 is to create a cylindrical graft from 
the pulmonary valve by transecting the pulmonary trunk proximally and distally close 
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to the valve annulus. Second, the diseased aortic valve is excised. Third, the pulmonary 
autograft is transplanted into the aortic position and a human tissue valve (homograft) 
is used to reconstruct the right ventricular outfl ow tract (RVOT). Technical complexity 
of the procedure has led to development of modifi cations to the original “sub-coronary” 
technique. In the “root replacement” technique, distal transection of the pulmonary 
trunk is performed at the level of the sinotubular junction [16]. This technique requires 
reimplantation of the coronary arteries in the pulmonary autograft, but makes preservation 
of the unique and complex three dimensional architecture of the root easier. In the 
“inclusion cylinder” technique, the root replacement technique is modifi ed by placing the 
pulmonary autograft root in the native aortic root for additional support [17]. 
 The procedure as described by Donald Ross, which now bears his name, has several 
advantages. First, use of oral anticoagulation is not required. Second, autograft tissue remains 
viable and can therefore facilitate somatic grow when transplanted into children and young 
adults [18]. Third, hemodynamic performance of pulmonary autografts is assumed to be 
superior to other valve substitutes, which might translate to better recovery of the left 
ventricle and subsequent improved life expectancy after the Ross procedure. Fourth, 
the fi nding that aortic and pulmonary valves are derived from a common embryological 
truncus led researchers to suggest that transplanting a native pulmonary valve into the 
aortic position may result in remodelling towards an aortic phenotype. This supports the 
idea that the pulmonary autograft is an aortic valve substitute for life. However, the Ross 
procedure also carries a number of disadvantages.
Debate
Use of the Ross procedure in adults requiring AVR is not widespread, with only a handful 
of centres worldwide offering this procedure to a select patient population [19]. The 
Ross procedure has been a topic of academic debate for decades and its popularity is 
continuously shifting. Despite the advantages of the Ross procedure, the current debate 
focusses on three major points of criticism: creation of double prosthetic valve disease, 
technical complexity and limited autograft durability.
 In his seminal paper, Dr. Ross stated that “… the problem of the homograft has now been 
transferred to the pulmonary area” [15]. Patients with single valve disease will, in effect, have 
double valve disease after the Ross procedure. The RVOT, nowadays reconstructed using 
a human tissue valve or bioprosthesis, requires reoperation at some point. Evaluation of 
long-term follow-up studies shows that results in single centre studies are consistently 
better than those reported by registries. This fi nding may refl ect technical complexity, 
as low-volume centres contributing to registries will have less experience and expertise 
with the Ross procedure. Young cardiothoracic surgeons nowadays are hesitant to learn 
this complex procedure due to the risk of less favourable early outcomes [20]. This fact 
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is compounded by the lack of consensus on which Ross technique to use. In addition, 
the community of surgeons dedicated to performing the Ross procedure in adults is 
small, which results in few mentors worldwide to enthuse and teach. The major concern 
raised by opponents of the Ross procedure in adult patients is the reported increase 
in pulmonary autograft reoperation rates after the fi rst postoperative decade. Use of 
the root replacement technique is associated with progressive autograft root dilatation 
resulting in valvular regurgitation.
 The 2014 ACC / AHA guidelines on management of valvular heart disease acknowledge 
these points of criticism, with a focus on technical complexity [21]. They recommend that 
the Ross procedure may be considered when performed by experienced surgeons and 
should be limited to use in young adults in whom oral anticoagulation use is not desirable 
(Class IIB, level of evidence C). The 2012 ESC / EACTS guidelines on management of 
valvular heart disease state similar arguments [22]. The authors report that use of the 
Ross procedure in adults is rare; no offi cial recommendation has been included in the 
guidelines.
 Both guidelines refer to the 2010 seminal publication in The Lancet of a single centre 
randomized clinical trial (RCT) in 216 patients comparing the Ross procedure to AVR 
using a human tissue valve [23]. Ten years follow-up in the Ross group shows 95% freedom 
from reoperation on the autograft and RVOT graft combined. Actuarial survival at ten 
years was superior in the Ross group (97%) compared to the donor valve group (83%). 
Strikingly, survival in the Ross group was similar to the age and sex-matched general 
population. When writing the recommendations for the 2014 ACC / AHA guidelines, this 
publication appears to have been disregarded and in the manuscript the committee stated 
that “… these outstanding results have not been generally replicated” [21]. This statement 
is remarkable as this is the only published RCT comparing the Ross procedure to 
conventional AVR. Moreover, a recent publication from the German Ross Registry has 
replicated these results in a prospective, multicentre study with 1779 patients [24]. After 
ten years, freedom from reoperation on the autograft and RVOT graft combined was 
91.1%. Similar to results from the RCT, survival at ten years follow-up was comparable 
with the age and sex-matched general population. Whether the observed survival benefi t 
of the Ross procedure refl ects the superior hemodynamic performance of the pulmonary 
autograft or patient selection bias, remains a topic of a heated debate.
 In contrast to reoperation rates and late mortality, quality of life (QoL) after AVR has 
not been studied extensively. In a Canadian study, QoL was included in a comparison of 
long-term follow-up after AVR with either a mechanical or biological valve substitute [25]. 
The results show superior QoL in patients who received biological valves. These fi ndings 
are corroborated by a more recent study showing superior QoL at mid-term follow-up in 
patients who received aortic valve repair or AVR with a pulmonary autograft compared to 
AVR with a mechanical valve substitute [26].
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Unsolved issues
The choice of valve substitute in AVR should be a shared decision making process involving 
both clinicians and informed patients, especially given the value-sensitive nature of the 
decision [27]. Clinicians have the obligation to support and embrace scientifi c studies and 
interpret the data in order to best inform their patients and engage them in prosthetic 
valve selection. The aim of this thesis is to identify and address key unsolved questions 
regarding the Ross procedure.
 The available literature shows a focus on studies reporting on long-term follow-up 
after the Ross procedure in adults. Published experience in neonates and infants is mostly 
limited to small, single centre studies with short to mid-term follow-up [28-31]. The Ross 
procedure is the treatment of choice for neonates and infants with severe left ventricular 
outfl ow tract obstruction requiring AVR. Therefore, it is important to answer questions 
regarding changes in left ventricular (LV) function in patients with severely impaired pre-
operative LV function, changes in pulmonary autograft dimensions during somatic growth, 
and both long-term function and durability of the pulmonary autograft valve. 
 Aortic valve repair and valve-sparing aortic root replacement techniques have been 
introduced into the armamentarium of surgeons confronted with patients requiring a 
reoperation on the pulmonary autograft after the Ross procedure. Preservation of the 
autograft valve may conserve some of the benefi ts of the original Ross procedure. Moreover, 
several studies have reported favourable short-term outcomes [32-34]. However, possible 
factors associated with failure are not well studied and long-term durability of the autograft 
leafl ets is unknown.
 Fundamental research on the remodelling response of the pulmonary autograft in 
humans is limited. A few studies have shown that autograft tissue displays a remodelling 
response and remains viable [35, 36]. The interesting question that remains unanswered 
is whether the native pulmonary valve can undergo phenotypic transformation upon 
exposure to the systemic circulation to resemble the native aortic valve.
Thesis Outline and Aims 
This thesis aims to improve our understanding of long-term consequences of pulmonary 
autograft exposure to the systemic circulation after the Ross procedure. To this end, I have 
evaluated clinical outcome after the Ross procedure in different patient populations and 
studied remodelling in explanted pulmonary autografts.
In Chapters 2 and 3, clinical outcome following the Ross procedure in neonates and 
infants is presented. In Chapter 2, the focus is on identifying variables associated with 
increased risk of early and/or late death following the Ross procedure. Chapter 3 aims to 
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answer the question how pulmonary autograft function and dimensions change in growing 
patients. Moreover, longitudinal analysis of left ventricular function is presented.
Chapters 4 and 5 focus on valve-sparing reoperations after the Ross procedure. Chapter 
4 aims to identify variables associated with increased risk of reintervention after a valve-
sparing reoperation. Chapter 5 is a case report presenting a young patient who required 
early reintervention after a valve-sparing reoperation.
Histological analysis of explanted pulmonary autograft leafl et is the focus of Chapters 
5 and 6. The focus of Chapter 6 is to examine how pulmonary autograft leafl ets change 
after exposure to the systemic circulation. The central question of the chapter is whether 
native pulmonary leafl ets become identical to native aortic leafl ets. The case report in 
Chapter 5 offers a unique opportunity to study how leafl ets change after autograft root 
dilatation is reversed following valve-sparing autograft root replacement.
In Chapters 7 to 10 a biomechanical analysis of explanted pulmonary autografts is 
presented. Chapter 7 compares wall stiffness of the autograft wall to the native pulmonary 
root at pulmonic pressures. In Chapter 8, a similar study presents a comparison between 
the autograft wall and native aortic root at systemic pressures. The focus of Chapter 9 
is on measuring leafl et stiffness of pulmonary autografts and offering a comparison with 
native aortic and pulmonary leafl ets. Chapter 10 is a case report showing the material 
properties of a dissected autograft wall specimen.
Discussion
In Chapter 11, the fi ndings in this thesis will be discussed with a focus on the (potential) 
impact on clinical practice in aortic valve disease. Future studies will be proposed following 
a discussion of the limitations of the studies presented in this thesis as well as existing 
knowledge gaps.
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Abstract
Background
Infants and neonates with severe left ventricular outfl ow tract obstruction may require 
pulmonary autograft replacement of the aortic root. In this retrospective multicenter 
cohort study, we present our experience with the Ross procedure in neonates and infants 
with a focus on mid-term survival and pulmonary autograft durability.
Methods
Retrospective observational study of 76 infants (age < 1 year) operated on in 6 congenital 
cardiac centers in The Netherlands and Germany between 1990 and 2013.
Results
Patients had a pulmonary autograft replacement of the aortic valve with (68%) or without 
(32%) septal myectomy. Median patient age was 85 days (range 6 – 347 days). Early mortality 
(n=13, 17%) was associated with neonatal age, pre-operative use of intravenous inotropic 
drugs and congenital aortic arch defects. Five patients (9%) died during follow-up. Freedom 
from autograft reintervention was 98% at ten years. Echocardiography demonstrated 
good valve function, with no or trace regurgitation in 73% of patients. Freedom from 
right ventricular outfl ow tract reintervention was 51% at ten years. Univariable analysis 
demonstrated superior freedom from reintervention of pulmonary homografts compared 
to aortic homografts or xenografts.
Conclusions
Pulmonary autograft replacement of the aortic valve in neonates and infants is a high risk 
operation but offers a durable neo-aortic valve. Mid-term durability refl ects successful 
adaptation of the autograft to the systemic circulation. Late mortality associated with 
heart failure was an unexpected fi nding.
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Introduction
Congenital aortic stenosis (AS) is a relatively common type of congenital heart disease 
with an estimated worldwide incidence of 0.22 per 1000 live births.1 Although surgical 
valvotomy or trans-catheter balloon valvuloplasty may be considered as the fi rst choice 
of treatment in neonates and infants with critical AS, replacement of the aortic valve may 
become necessary over time.2 Aortic root replacement using a pulmonary autograft was 
fi rst performed in a neonate in 1989 and has subsequently gained acceptance as a valuable 
and reproducible strategy in young children.3 Attracted by the alleged growth potential 
of the pulmonary autograft, surgeons have reported on this operation in neonates and 
infants with increasing frequency over the past years.4-9 However, reported long-term 
experience with the Ross procedure in neonates and infants is limited to a few small 
single center studies.10,11 Therefore, we present our data from an international multicenter 
experience with the Ross procedure in neonates and infants with a focus on mid-term 
survival and autograft reintervention.
Methods
Institutional review board permission for this study was obtained in each participating 
center. Informed consent was obtained from parents or legal guardians.
Patient inclusion and data collection
Pre-operative patient characteristics, peri-operative surgical details and post-operative 
follow-up data of all patients who had an aortic valve replacement with a pulmonary 
autograft as an infant (age < 1 year) or neonate (age < 30 days) were obtained from the 
German-Dutch Ross Registry (congenital cardiac centers of Rotterdam, München, Berlin 
and Hamburg) and from two additional centers (congenital cardiac centers of Leiden and 
Utrecht). In total, 76 neonates and infants, operated on between 1990 and 2013, were 
included in the study.
Data analysis
Statistical analyses were performed using IBM SPSS version 20.0 (IBM, Somers, NY, USA). 
Normal distribution of data was assessed using the Shapiro-Wilk test. Reported values are 
quoted as mean ± standard deviation or median and interquartile range for continuous 
variables and percentages for discrete variables.
 Overall survival and right ventricular outfl ow tract (RVOT) graft durability, defi ned as 
freedom from any reintervention, were visualized using Kaplan-Meier curves. Curves were 
truncated at the follow-up time when the proportion of patients at risk dropped below 
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10%. 95% confi dence intervals were calculated using log transformation of the cumulative 
hazard function.
 The predictive value of several variables on peri-operative mortality was assessed with 
a univariable analysis based on binary logistic regression. Variables included gender, body 
surface area, number of aortic valve cusps, presence of severe mitral regurgitation and 
yes / no status regarding pre-operative use of intravenous inotropic drugs, age <30 days 
(neonate), emergency surgery (operation before start next working day after decision to 
operate) and congenital aortic arch defects. Multiple imputation with 100 iterations was 
performed to manage missing values in the following parameters: body surface area (18%), 
number of aortic valve cusps (12%), use of inotropes (21%) and circulatory arrest strategy 
(9%). Spearman’s correlation coeffi cient was used to assess correlations between variables 
included in the univariable analyses.
 With Cox regression, a univariable analysis of the predictive value on RVOT graft 
intervention of several variables was assessed. Variables included age <30 days (neonate) 
yes / no, graft type (pulmonary homograft, aortic homograft or xenograft) and graft 
diameter.
Results
Pre-operative patient characteristics are shown in Table 1. Two babies were born 
prematurely (gestational age 33 and 35 weeks) after induction of labor for chronic severe 
left ventricular dysfunction. Both underwent balloon valvuloplasty of the aortic valve 
shortly after birth. On day 97 and 20, respectively, the aortic valve was replaced with a 
pulmonary autograft. Both patients survived and remained in good clinical condition now 
more than six years after the operation.
TABLE 1 Pre-operative patient characteristics
Total patients 76
Sex Male 60 (79%)
Female 16 (21%)
Age at Surgery (in days) * Median 85
Interquartile range 39 - 166
Range 6 - 347
Neonates (<30 days) 17 (22%)
Height (n=62) † 59 ± 9 cm
Weight (n=68) † 5.1 ± 2.0 kg
IV inotropes (n=60) 14 (23%)
Aortic valve Unicuspid 9%
Bicuspid 58%
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TABLE 1 Pre-operative patient characteristics (Continued)
Tricuspid 22%
Unspecifi ed 11%
Indication Stenosis 66%
Regurgitation 16%
Combined 18%
Concomitant CHD ‡ 46 (61%)
PFO 18
Endocardial fi broelastosis 16
VSD 16
ASD 11
IAA 11
Mitral dysplasia 7
Hypoplastic arch 6
Coarctation 5
Shone’s complex 1
HOCM 1
Previous intervention ‡ 58 (76%)
Balloon valvuloplasty 37
Surgical valvotomy 10
Other cardiac surgery ‡ 23
VSD closure 8
ASD closure 7
Aortic arch repair 6
Coarctation repair 5
Rashkind 5
IAA repair 4
Bilateral PA banding 2
Atrial septostomy 1
PFO closure 1
MVP 1
TVP 1
Septal myectomy 1
Enlargement ascending aorta 1
Fetal balloon dilatation 1
Number of patients with available data is indicated by “(n=)” for variables with missing data. * Age at surgery does 
not conform to a normal distribution. † Values represent mean ± standard deviation. ‡ Overlapping categories. IV 
indicates intravenous; CHD, congenital heart disease; PFO, patent foramen ovale; VSD, ventricular septal defect; 
ASD, atrial septal defect; IAA, interrupted aortic arch; HOCM, hypertrophic obstructive cardiomyopathy; MVP, 
mitral valve plasty; TVP, tricuspid valve plasty. 
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Ross procedure
An overview of peri-operative characteristics, including in-hospital complications, is 
provided in Table 2. The aortic root was replaced with the pulmonary autograft root 
in all patients, without use of external support. The left ventricular outfl ow tract was 
enlarged to allow size matching the autograft in 52 patients by septal myectomy (modifi ed 
Konno procedure). The septal incision was closed with autograft muscle in the majority of 
patients according to the operative reports. In six patients, a separate pericardial or Gore-
Tex patch was used to reconstruct the ventricular septum. Circulatory arrest was used 
when concomitant aortic arch repair was necessary (n=10).
TABLE 2 Peri-operative characteristics
Procedure (n=74) Emergency 5 (7%)
Elective 69 (93%)
Septal myectomy 52 (68%)
Perfusion time (n=64) * 204 ± 80 minutes
Cross-clamp time (n=68) * 138 ± 43 minutes
Circulatory arrest (n=69) * 10 (14%)
40 ± 22 minutes
RVOT Pulmonary Homograft 38%
Aortic Homograft 13%
Xenograft 46%
Unknown 3%
Concomitant surgery* 29 (38%)
PFO closure 11
VSD closure 6
Resection endocardial fi broelastosis 6
Arch reconstruction 5
IAA repair 5
Isolated septal myectomy 3
MVP 3
Atrial septostomy 2
MVR 2
TVP 2
Pulmonary artery debanding 2
Ascending aorta repair 2
Hospital stay (n=62) * † 21 ± 14 days
Complications (n=62) † ‡ 29 (46%)
Low cardiac output 10
Total AV-block 9
Tamponade 9
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TABLE 2 Peri-operative characteristics (Continued)
Transient pulmonary hypertension 3
Endocarditis 2
Temporary renal dialysis 2
LCA obstruction 2
Ventricular fi brillation 1
Sternal instability 1
Sternal wound infection 1
Pneumothorax 1
Cerebral parenchymal bleeding 1
Convulsion 1
Capillary leak syndrome 1
Thromboembolism 0
Post-operative interventions † ‡ Resternotomy 14
Temporary pacemaker 7
Resuscitation 6
Permanent pacemaker 3
ECMO 1
Sternal refi xation 1
In-hospital death 13 (17%)
Intra-operative 5
Failure to wean from CPB 4
Uncontrolled hemorrhage 1
Post-operative 8
MOF following ECMO 3
Septic shock 2
LV failure 1
Unknown 2
Number of patients with available data is indicated by “(n=)” for variables with missing data. * Values represent 
mean ± standard deviation. † Excluding 13 in-hospital deaths. ‡ Overlapping categories. RVOT indicates right 
ventricular outfl ow tract; PFO, patent foramen ovale; VSD, ventricular septal defect; IAA, interrupted aortic arch; 
MVP, mitral valve plasty; MVR, mitral valve replacement; TVP, tricuspid valve plasty; ASD, atrial septal defect; 
AV, atrioventricular; LCA, left coronary artery; CPB, cardio-pulmonary bypass; MOF, multiorgan failure; ECMO, 
extracorporeal membrane oxygenation; LV, left ventricle.
Intra-operative course
Obstruction of the left coronary artery was suspected intra-operatively in two patients 
with poor left ventricular function and failure to come off bypass. In one patient, the left 
coronary button was reimplanted, which resulted in improved contractility and allowed 
this patient to be weaned successfully from bypass. In the other patient, the RVOT graft 
was elongated to relieve tension on the left coronary artery and button.
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Early deaths
In-hospital death occurred in 13 patients (17%); 8 in neonates (47% of all neonates) and 
5 in infants (8% of all infants). Autograft failure was not observed in these patients. Rather, 
cause of death was related to low output failure in the majority of these patients. In total, 
7 patients could not be weaned from bypass: 4 patients (1 neonate) died intra-operatively 
and 3 patients (all neonates) received ECMO and died several days later. When ECMO 
was initiated in the operating room, in-hospital mortality was 100%. Limited information in 
surgical notes and absence of performed autopsies prevented a more detailed description 
of early mortality.
 Univariable analysis demonstrated several variables potentially associated with 
increased risk of peri-operative mortality (Table 3). These variables were also correlated 
with each other: being a neonate at the time of the Ross procedure correlated with a 
lower body surface area (Rho -0.521, P<0.001), pre-operative use of inotropes (Rho 0.602, 
P<0.001) and concomitant arch repair (Rho 0.273, P=0.031). With respect to congenital 
aortic arch defects, no hospital mortality occurred in the 4 neonates who had their arch 
repaired during the Ross operation, whereas 4 out of 8 neonates died who had undergone 
aortic arch repair in a previous operation. 
Post-operative course
Total AV-block developed in nine survivors; normal AV conduction returned in seven, two 
patients required a permanent pacemaker, one of whom had a septal myectomy (modifi ed 
Konno procedure).
 Fourteen patients underwent resternotomy for bleeding (N=9) or hemodynamic 
instability and resuscitation (N=5). Visual inspection of coronary buttons did not reveal 
abnormalities. Additional imaging of coronary circulation was not performed. Two patients 
who required resternotomy died during follow-up (patients 2 and 5 in Table 4).
 One patient required reoperation for a residual ventricular septal defect one month 
after the Ross procedure. 
One patient received ECMO treatment for 5 days due to deterioration of left ventricular 
function on the fi rst post-operative day. This patient, operated 16 days after birth, had 
been treated by both fetal and neonatal aortic valve balloon dilatation prior to the Ross 
procedure. At last follow-up, two months after the Ross procedure, the patient was in 
good clinical condition.
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TABLE 3 Univariable analysis of peri-operative mortality
Variable Odds Ratio 95% Conﬁ dence Interval P-value
Neonate 9.6 (2.6 – 35.9) 0.001
Inotropy 16.5 (3.0 – 89.6) 0.001
Emergency 9.2 (1.4 – 61.8) 0.023
Arch repair 5.5 (1.2 – 25.0) 0.026
TABLE 4 Causes of late mortality and characteristics of the initial Ross procedure
Patient 1 2 3 4 5
Cause of death Interventionwat HF Unknown HF HF
Interval Ross (years) 1,0 1,1 1,2 1,8 11,6
Sex Male Male Male Male Male
Age at Ross (days) 174 74 52 104 146
Aortic valve Bicuspid Bicuspid Bicuspid Bicuspid Unicuspid
Concomitant CHD - EFE - ASD EFE + CoA
Septal myectomy No Yes No Yes No
Complications - Tamponade - - Tamponade
Reinterventions - Resuscitation - - Resuscitation
Hospital stay (days) 11 26 10 26 46
HF indicates heart failure; CHD, congenital heart disease; EFE, left ventricular endocardial fi broelastosis; CoA, 
aortic coarctation; ASD, atrial septal defect.
Follow-up
Follow up of patients who survived to discharge after the Ross procedure was 92% 
complete, with a median duration of 3.6 years (range 23 days to 17 years, 44 patients had 
a follow-up of more than 1 year).
Late deaths
Five patients (9%) died during follow-up (Table 4). A Kaplan-Meier curve visualizes overall 
survival (Figure 1). Autograft failure was not observed in any of these fi ve patients. Patient 
1 died upon reintervention for a stenotic Contegra conduit (Medtronic, Minneapolis, 
MN, USA). Balloon dilatation produced a conduit dissection in this patient. Subsequent 
emergency surgery in attempt to replace the conduit caused myocardial damage and 
biventricular failure. The patient died from multiple cerebral infarctions following ECMO 
support. Patient 2 was readmitted to hospital a year after the Ross procedure with 
symptomatic heart failure. Echocardiography demonstrated poor biventricular function 
with pulmonary hypertension. The patient died from sepsis after placement of a central 
venous access device. Patient 3 died of unknown causes three months after RVOT graft 
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replacement. Ventricular function and cardiac rhythm were normal in this patient. In 
patient 4, heart failure was the cause of death. An echocardiogram performed six weeks 
before death demonstrated severe right ventricular dilatation with massive RVOT graft 
regurgitation as well as signs of left ventricle restrictive cardiomyopathy. Patient 5 died 
following an episode of ventricular fi brillation associated with heart failure. This patient was 
known to have left and right ventricular dysfunction with severe pulmonary hypertension.
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FIGURE 1 Kaplan-Meier curve of overall survival
Autograft reinterventions
Only one patient required reintervention on the autograft during follow-up. This patient 
had a Ross-Konno procedure at the age of 13 days for multilevel left-sided outfl ow tract 
obstruction. Reoperation was performed 75 days after the initial Ross procedure for 
autograft regurgitation. Upon reoperation, a leafl et tear was identifi ed and successfully 
repaired. A technical cause of this tear seemed likely. Good autograft valve function was 
maintained at 10 years of follow-up. None of the autografts were explanted and freedom 
from autograft reintervention for the entire cohort was 98% at ten years follow-up.
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RVOT graft reinterventions
During follow-up, 17 patients (30%) underwent a total of 31 interventions on the RVOT 
graft: 18 surgical replacements, 12 balloon dilatations and 1 percutaneous valve implantation. 
The median time to fi rst intervention was 1.3 years, ranging from 279 days to almost 9 
years. Freedom from RVOT reintervention was 51% at ten years follow-up. In the majority 
of cases (87%), graft stenosis was the indication for reintervention. Two patients, who both 
had a xenograft (Contegra 1, Shelhigh 1) implanted, developed endocarditis during follow-
up: one patient was successfully treated with antibiotics, the other underwent surgical 
replacement.
 Univariable analysis demonstrated graft type to be associated with an increased 
hazard of RVOT reintervention. Freedom from reintervention was higher in pulmonary 
homografts compared to aortic homografts (HR=7.633, CI 1.391 - 41.901, P=0.019) 
and xenografts (HR=6.157, CI 1.357 - 27.933, P=0.018). A Kaplan-Meier curve visualizes 
freedom from RVOT graft reintervention (Figure 2).
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FIGURE 2 Kaplan-Meier curve of freedom rom any RVOT graft reintervention
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Other interventions
Three patients underwent other major cardiac interventions during follow-up. One had 
balloon dilatation of the right pulmonary artery due to compression by the autograft 1.2 
years after the Ross procedure. Another patient had mechanical mitral valve replacement 
after 2.8 years together with an RVOT graft replacement. One patient underwent isolated 
resection of discrete subaortic stenosis located at the site of the proximal suture line after 
4.5 years. 
Echocardiographic follow-up
At latest follow-up, 52 patients (74%) were still alive and their latest echocardiographic 
report was reviewed. Left ventricular ejection fraction was normal in 42 patients (95%) 
and reduced in 2 patients (5%) at last follow up.
 Autograft regurgitation in late survivors was absent or minimal in 73% of patients, 
grade I in 18% and grade II in 10%. Regurgitation greater than grade II was not described 
in any patient. Six patients had more than 10 years of follow-up (range 10.8 – 16.9 years). 
In those patients, autograft and left ventricular function were good at last follow-up.
 The RVOT graft had a peak gradient less than 30 mmHg in 25 patients (60%), between 
30 and 60 in 11 patients ( 26%) and more than 60 in 6 patients (14%).
Comment
Replacement of the aortic root with the pulmonary autograft, with or without enlargement 
of the left ventricular outfl ow tract by septal myectomy, has become an important surgical 
treatment modality for infants and neonates with critical aortic stenosis. Our study has 
expanded the clinical knowledge in this complex patient population.
 Early mortality in our cohort was substantial, especially in neonatal patients. Woods 
et al. analyzed the Society of Thoracic Surgeons Congenital Heart Surgery database for 
in-hospital mortality following the Ross procedure in 145 neonates and infants. In-hospital 
mortality for their entire cohort was 16%, with a marked difference between neonates 
(29%) and infants (11%).5 In our cohort, this difference was even more pronounced with 47% 
early mortality in neonates and 8% in infants. The high early mortality in neonates relative 
to results from the STS database should be perceived in the context of time as our series 
includes pioneer cases operated on before the year 2000. Similar to other investigators, 
we have shown that pre-operative use of intravenous inotropic drugs and congenital 
aortic arch defects are correlated with a higher risk of early death. Not surprisingly, these 
variables were correlated with neonatal age at the time of surgery. Interestingly, all neonates 
who underwent concomitant aortic arch repair survived the early post-operative period. 
However, patients who received aortic arch repair prior to the Ross procedure were 
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more likely to die within the fi rst 30 days after the Ross procedure. Congenital aortic 
arch defects and neonatal age at the time of the Ross procedure have also been shown by 
other investigators to be associated with early death.5,6,12 In contrast to the study by Lo 
Rito et al.7, pre-operative severe mitral regurgitation was not recognized as a risk factor 
for early mortality in our cohort. In our study, only a few patients were reported to have 
severe mitral valve regurgitation. In summary, we found that early mortality was higher in 
neonates, who more often had congenital aortic arch defects and were in poor clinical 
condition prior to the Ross procedure evidenced by pre-operative use of inotropes.
 Coronary reimplantation after enlargement of the left ventricular outfl ow tract 
appears a critical issue. It demands accurate surgical assessment to determine the optimal 
position of the button on the much larger neo-aorta. Two of our patients with signs of 
myocardial ischemia needed a second pump run to change the position of the coronary 
button. Post-operative course was uneventful in both patients. Although not confi rmed by 
angiography, we suspect that myocardial ischemia due to compromised coronary fl ow may 
have played a signifi cant role in patients who died of undetermined low cardiac output. 
In the literature, malposition of a coronary button resulting in coronary fl ow obstruction 
following the Ross procedure in neonates and infants has been reported.8,11 In a publication 
by Elder et al., two cases of right coronary artery occlusion were described: one patient 
died following myocardial ischemia, while in the other the lesion was clinically silent and 
apparently compensated for by adequate collateralization.11
 Our study revealed that, in addition to the early mortality risk, there is also a late 
mortality risk. Despite adequate relief of left ventricular outfl ow tract obstruction, low 
output failure due to poor ventricular function may evolve late after the operation and 
result in late mortality.  This happened to three of our patients. .Unfortunately, limited data 
prevented us from analyzing these cases in more detail. Based on the current data, we 
cannot distinguish whether heart failure was related to intra-operative damage or caused 
by inadequacy of left sided structures. .
 Reassuring fi ndings of this study are that young children with complex aortic valve 
disease who are severely symptomatic can be adequately treated by means of the Ross 
operation, survive and that autograft valve function remains excellent with no or only 
trace regurgitation in 73% of patients at 3,6 years mean follow up. No autografts were 
replaced and reoperation on the autograft was necessary in only one patient with an early, 
possibly technical, valve failure requiring repair of a torn leafl et. These results indicate that, 
during somatic growth, the autograft appears to adapt to the demands of the systemic 
circulation. Nevertheless, we recognize that more follow-up is needed to assess long term 
valve durability. Previous reports on autograft durability in neonates and infants are less 
convincing. While Brancaccio et al. found a signifi cant drop in durability at ten years, Elder 
et al. reported results similar to our fi ndings.11,12
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 Reinterventions on the RVOT graft were common and remain a substantial drawback 
of the Ross procedure. Both structural valve deterioration and patient growth play a 
signifi cant role in development of graft stenosis. Reinterventions were not without risk, 
as illustrated by the death of one of our patients following balloon dilatation of the RVOT 
graft Maeda et al. suggested freedom from reintervention of pulmonary homografts might 
be superior to aortic homografts.8 Brancaccio et al. demonstrated superior freedom 
from reintervention of homografts compared to xenografts.12 Interestingly, Poynter et al. 
showed superior freedom from reintervention of xenografts compared to homografts.13 
This is in contrast to our fi nding of superior freedom from reintervention of pulmonary 
homografts compared to both aortic homografts and xenografts..
Limitations
The retrospective nature of this study imposed constraints on data collection. We were 
confronted with missing values and several patients who were lost to follow-up. As 
missing values and lost patients are thought to have arisen (completely) at random, we 
feel confi dent no bias has been introduced. Multiple imputation allowed preservation of 
study power.
 Low absolute number of late deaths and RVOT reoperations precluded use of 
multivariable analyses. To compensate, correlations between variables which were 
signifi cant in univariable analyses were assessed.
 Median follow-up duration in the present study was limited. However, the information 
from the peri-operative and immediate post-operative period collected in the present 
study, has already offered valuable insights and may impact surgical management of future 
patients.
Conclusions
Pulmonary autograft replacement of the aortic valve with or without septal myectomy is 
an adequate surgical treatment for infants and neonates with critical aortic valve stenosis. 
Durability and function of the pulmonary autograft remained good during follow-up. No 
patients required autograft explantation. Similar to other series, early mortality was highest 
in neonates. Late death may occur due to heart failure warranting close surveillance of 
these patients.
14009_AMookhoek_BW.indd   34 20-09-16   10:21
Ross in neonates and infants
35
2
References
1. van der Linde D, Konings EE, Slager MA et al. Birth prevalence of congenital heart disease 
worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241-47.
2. McLean KM, Lorts A, Pearl JM. Current treatments for congenital aortic stenosis. Curr Opin 
Cardiol. 2006;21:200-4.
3. Ziemer G, Beierlein W, Salehi-Gilani S. Aortic root remodeling 13,5 years after neonatal Ross 
operation. Thorac Cardiovasc Surg 2004:52 suppl.1. S46-7.
4. Schoof PH, Cromme-Dijkhuis AH, Bogers JJ et al. Aortic root replacement with pulmonary 
autograft in children. J Thorac Cardiovasc Surg. 1994;107:367-73.
5. Woods RK, Pasquali SK, Jacobs ML et al. Aortic valve replacement in neonates and infants: 
an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac 
Cardiovasc Surg. 2012;144:1084-9.
6. Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG. Intermediate-term results of the Ross 
procedure in neonates and infants. Ann Thorac Surg. 2010;89:1827-32.
7. Lo Rito M, Davies B, Brawn WJ et al. Comparison of the Ross/Ross-Konno aortic root in children 
before and after the age of 18 months. Eur J Cardiothorac Surg. 2014 [Epub ahead of print].
8. Maeda K, Rizal RE, Lavrsen M et al. Midterm results of the modifi ed Ross/Konno procedure in 
neonates and infants. Ann Thorac Surg. 2012;94:156-62.
9. Nelson JS, Pasquali SK, Pratt CN, Yu S, Donohue JE, Loccoh E, Ohye RG, Bove EL, Hirsch-Romano 
JC. Long-Term Survival and Reintervention After the Ross Procedure Across the Pediatric Age 
Spectrum. Ann Thorac Surg. 2015;99:2086-95.
10. Fadel BM, Manlhiot C, Al-Halees Z et al. The fate of the neoaortic valve and root after the 
modifi ed Ross-Konno procedure. J Thorac Cardiovasc Surg. 2013;145:430-7.
11. Elder RW, Quaegebeur JM, Bacha EA, Chen JM, Bourlon F, Williams IA. Outcomes of the infant 
Ross procedure for congenital aortic stenosis followed into adolescence. J Thorac Cardiovasc 
Surg. 2013;145:1504-11.
12. Brancaccio G, Polito A, Hoxha S et al. The Ross procedure in patients aged less than 18 years: The 
midterm results. J Thorac Cardiovasc Surg. 2014;147:383-8.
13. Poynter JA, Eghtesady P, McCrindle BW et al. Association of pulmonary conduit type and size 
with durability in infants and young children. Ann Thorac Surg. 2013;96:1695-702.
14009_AMookhoek_BW.indd   35 20-09-16   10:21
14009_AMookhoek_BW.indd   36 20-09-16   10:21
Chapter 3
Echocardiography Findings after the Ross 
Operation in Neonates and Infants
Aart Mookhoek, Bas R Rebel,  Ad J J C Bogers, Regina Bökenkamp, Mark G Hazekamp, 
Folkert J Meijboom, Paul H Schoof, Eleni-Rosalina Andrinopoulou, Jaroslav Hruda, 
Irene M Kuipers, Luc HPM Filippini, Johanna J M Takkenberg
Submitted
14009_AMookhoek_BW.indd   37 20-09-16   10:21
Chapter 3
38
Abstract
Background
Long-term follow-up after the Ross operation in neonates and infants is still limited. While 
waiting for patients to reach puberty, echocardiography may offer insights into possible 
future events. Therefore, we used advanced statistical methods to study evolution over 
time of left ventricular function, autograft dimensions and valve function.
Methods
In a retrospective multicenter study, echocardiograms of 42 neonates and infants who 
survived a Ross operation between 1990 and 2013 were analyzed. An echocardiography 
protocol was developed for this study to measure ejection fraction, autograft root 
dimensions, severity of valve regurgitation and stenosis and endocardial fi broelastosis. 
Evolution over time of echocardiographic variables was analyzed using mixed-effects 
models.
Results
Median follow-up was 3.2 years (interquartile range 1.0 – 7.2 years). Three patients (7%) 
died during follow-up. No patient required autograft reintervention, 10 patients required 
right-sided reinterventions. Left ventricular function signifi cantly improved over time 
(p<0.001) with an increase in fractional shortening from 26±14% pre-operatively to 
34±2% at last follow-up. Evolution of autograft root diameter showed an increase at the 
sinotubular junction level (p<0.001) with a Z-score increase from 2.6±1.1 to 3.1±1.3. 
No time-related changes were observed in autograft valve regurgitation or stenosis. 
Pulmonary regurgitation and stenosis increased signifi cantly over time (p<0.001 and 
p=0.014, respectively).
Conclusions
The Ross operation offers adequate relief of left ventricular outfl ow tract obstruction 
in neonates and infants. The fi rst decade after the operation is characterized by an 
improvement of left ventricular function. Moreover, autograft root growth is parallel to 
somatic growth with preservation of autograft valve function.
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Introduction
Treatment options for neonates and infants with severe left ventricular outfl ow tract 
obstruction are limited. When biventricular repair is feasible, the Ross operation is 
currently considered the treatment of choice [1]. Additionally, surgical valvotomy and 
balloon valvuloplasty are fi rmly established techniques which may delay the need for aortic 
valve replacement and allow patients to grow [2]. The rationale behind this approach is to 
delay a complex operation with high early mortality, especially in neonates.
 In recent years, several studies have reported clinical experience with the Ross 
operation in neonates and infants [3-6]. Interestingly, several patients who underwent 
the Ross operation as neonate or infant have now reached puberty. However, long-
term follow-up is still limited as the majority of patients have been operated in the last 
decade. While waiting for more patients to reach puberty and beyond, advanced statistical 
methods may aid in prediction of future events based on analysis of echocardiographic 
parameters [7]. For instance, evolution of pulmonary autograft dimensions in the rapidly 
growing child may offer information on whether the expected increase in root dimension 
is parallel to or out of pace with somatic growth. In addition, we are interested in whether 
left ventricular function normalizes after the Ross operation in neonates and infants with 
severely impaired left ventricular function.
 To answer these questions, we performed a retrospective multicenter echocardiography 
study in patients who underwent a Ross operation as neonate or infant in The Netherlands.
Patients and Methods
Institutional review board permission for this retrospective observational study in which 
echocardiograms were re-evaluated was obtained in participating centers (Erasmus MC 
IRB approval THCHOZ 2012-13). Informed consent was obtained from the patient’s 
parents or legal guardians.
Patient inclusion
Neonates (age < 30 days) and infants (age < 1 year) who underwent aortic valve replacement 
with a pulmonary autograft in congenital cardiac centers in Rotterdam, Leiden and Utrecht 
(The Netherlands) between 1990 and 2013 for whom echocardiographic follow-up was 
available were included in the study. As we were interested in the post-operative evolution 
over time of echocardiographic variables, patients who died in-hospital or within 30 days 
after the operation were excluded from the study.
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Data collection
The current study is a satellite project from a large European initiative to study the Ross 
operation in neonates and infants [8]. Data regarding pre-operative patient characteristics, 
surgical details and follow-up data after the operation were collected retrospectively as 
part of this initiative. Echocardiographic exams were collected at several time points for 
each patient: last exam prior to operation, last exam prior to discharge from hospital after 
operation, at 3, 6, 9 and 12 months and annually thereafter. When a patient had a valve-
related reintervention during follow-up, the last exam prior to reintervention and last exam 
prior to discharge were also collected. Because of the retrospective nature of this study, 
there was no uniformity in echocardiographic recording between participating centers.
 To minimize inter-observer variability in reporting, an echocardiography protocol was 
developed for this study (Appendix 1). Measurements of pulmonary autograft annulus, 
sinus and sinotubular junction diameter in systole as well as left ventricular end diastolic 
and systolic dimensions were transformed into Z-scores based on data from Pettersen 
et al. [9], measurements of ascending aorta diameter based on data from Warren et al. 
[10]. To allow Z-score calculation, body surface area was calculated using the Mosteller 
formula [11]. Peak velocity measurements over the semilunar valves were transformed 
into stenosis grades: 0, less than 2m/s, 1, between 2 and 2.9m/s; 2, between 3 and 3.9 m/s; 3, 
more than 4m/s. Fibroelastosis was graded according to its distribution in the left ventricle: 
0, no fi broelastosis; 1, limited to papillary muscles; 2, papillary muscles and less than 50% 
of endocardium involvement; 3, papillary muscles and more than 50% of endocardium 
involvement. Re-evaluation of the echocardiograms using our protocol was performed by 
one experienced pediatric cardiologist from each participating center: Rotterdam (BR), 
Leiden (RB) and Utrecht (FM).
Statistical analysis
Descriptive data analysis was performed using IBM SPSS version 21.0 (IBM, Somers, NY, 
USA). Normal distribution of data was assessed using the Shapiro-Wilk test. Reported 
values are quoted as mean and standard deviation or median and interquartile range for 
continuous variables and percentages for discrete variables. Overall survival and freedom 
from right ventricular outfl ow tract (RVOT) reintervention after the Ross operation 
were analyzed using the Kaplan-Meier method. Paired samples t-tests were performed to 
analyze autograft diameter comparing the fi rst and last exam during follow-up. Ninety-fi ve 
percent confi dence intervals were calculated using log transformation of the cumulative 
hazard function.
 Advanced statistical analyses were performed using R (version 3.1.1, available at 
www.r-project.org). Evolution over time of the echocardiographic variables of interest was 
analyzed accounting for the correlation between repeated measurements in each patient 
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using mixed-effects models [7]. For these analyses, the last echocardiographic exam prior 
to the Ross operation was excluded. Analysis of pulmonary regurgitation and stenosis was 
performed using all data obtained prior to the fi rst reintervention on the right ventricular 
outfl ow tract. For the purpose of mixed-effects modelling of autograft and pulmonary 
stenosis grade, stenosis grade 2 and 3 were combined.
 Mixed-effects models consist of fi xed effects describing the average evolution over 
time of a specifi c variable and random effects describing the evolution over time for each 
patient. We corrected for age at the time of the Ross operation and presence of septal 
myectomy in the fi xed effects component of the model for all variables, except for the 
Z-score of the sinotubular junction diameter due to limited available data. Longitudinal 
analysis of aortic stenosis grade was not possible as in only one patient autograft stenosis 
grade greater than zero was measured during follow-up.
Results
During the inclusion period, 50 neonates and infants underwent the Ross operation in the 
participating centers. There were seven early deaths and in one patient no echocardiographic 
follow-up was available. As a result, 42 patients were included in the study (Table 1). 
TABLE 1 Patient characteristics
Total patients 42
Sex Male 34 (81%)
Female 8 (19%)
Concomitant CHD * 29 (69%)
Aortic arch interruption / hypoplasia 9 (21%)
Aortic coarctation 4 (10%)
Mitral dysplasia 2 (5%)
Age at Ross Neonates 5 (12%)
Infants 37 (88%)
Range 16 – 347 days
Emergency surgery 1 (2%)
Septal myectomy 32 (76%)
RVOT graft Pulmonary homograft 23 (55%)
Aortic homograft 5 (12%)
Xenograft 14 (33%)
* Only major congenital heart disease listed, overlapping categories. CHD indicates congenital heart disease; 
RVOT, right ventricular outfl ow tract.
Median follow-up after the Ross operation was 3.2 years (interquartile range 1.0 – 7.2, 
range 0.1 – 16.9). Three patients died during follow-up: 1 at reintervention on the right 
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ventricular outfl ow tract (RVOT) graft after one year, 1 of cardiogenic shock after two 
years and 1 of sudden cardiac death 12 years after the Ross operation. Estimated survival 
after 5 years was 93.2% (95% CI 84.6 – 100.0%). No patient required reintervention on 
the pulmonary autograft. The RVOT graft required reintervention 17 times in 10 patients. 
Freedom from RVOT reintervention at 5 years was 68.2% (95% CI 51.6 – 90.3%).
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FIGURE 1 Evolution over time of autograft root diameter
Autograft root diameter at the level of the annulus (A), sinus (B) and sinotubular junction (C). 
Continuous line represents mean Z-score, while dashed lines represent the 95% confi dence interval. 
STJ indicates sinotubular junction. 
In total, 306 echocardiographic exams were evaluated (median number per patient 6, 
range 1 to 16). On average, left ventricular systolic function was impaired at the time of 
the last exam prior to discharge from hospital after Ross operation with a mean fractional 
shortening of 26±14%. Mixed-effects models showed an overall improvement over time 
in fractional shortening (34±2%, p<0.001). Individual patient evolution was variable, with 
fi ve patients showing deterioration of left ventricular function with a continuous decrease 
in fractional shortening over time (patients 12, 21, 46, 47 and 48 in Figure 1). In patient 
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46, obstruction of the left coronary artery was suspected intra-operatively upon failure 
to come off bypass. After coronary button reimplantation, contractility improved and the 
patient was successfully weaned from bypass.
Comparing the fi rst and last exam after the operation (median interval 3.7 years, 
interquartile range 1.6 – 7.4), dimensions of the pulmonary autograft increased at each 
level of the root: annulus (12 to 19 mm, p<0.001), sinus (16 to 25 mm, p<0.001) and 
sinotubular junction (14 to 20 mm, p=0.002). The autograft root was dilated directly after 
the Ross operation at the level of the annulus (Z-score 3.2±1.9), sinus (Z-score 2.6±1.1) 
and sinotubular junction (Z-score 2.4±1.7). At the last exam during follow-up, dilatation 
was still present at the level of the annulus (Z-score 3.4±1.6), sinus (Z-score 3.1±1.3) 
and sinotubular junction (Z-score 2.7±1.5). Analysis with mixed-effects models showed 
a signifi cant Z-score increase over time only at the level of the sinotubular junction 
(p<0.001) (Figure 2).
FS
 (
%
)
 
Follow-up (years) 
FIGURE 2 Patient-specifi c evolution over time of fractional shortening
Individual patients are represented by “NEO” followed by a number for each patient. FS indicates 
fractional shortening.
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Prior to the Ross operation, echocardiographic features of endocardial fi broelastosis were 
present in 22 patients: 9 patients with grade 1, 10 with grade 2 and 3 with grade 3. A 
decrease in endocardial fi broelastosis grade was observed in four patients (18%): grade 3 
to 1 in the fi rst post-operative month, grade 2 to 1 in the fi rst post-operative month, grade 
1 to 0 after six months and grade 2 to 0 after three years.
 Autograft valve function was good in the majority of patients at the time of discharge 
after Ross operation with one patient having greater than mild autograft valve regurgitation 
and one patient having greater than grade 1 autograft valve stenosis. Mixed-effects models 
did not show time-related changes in autograft valve regurgitation (p=0.113), which is 
illustrated by our prognostic model (Figure 3A). Since only one patient presented with 
autograft valve stenosis, longitudinal analysis was not possible.
 
B C 
no 
mild  
moderate + severe 
no 
mild  moderate + severe 
A 
B C 
no 
mild  
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no 
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A 
FIGURE 3 Patient-specifi c prediction of valve function evolution over time
Severity of autograft regurgitation (A), pulmonary regurgitation (B) and pulmonary stenosis (C).
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Function of the RVOT graft was good in the majority of patients at the time of discharge 
after Ross operation with fi ve patients having greater than mild pulmonary regurgitation 
and one patient having more than grade 1 pulmonary stenosis. Mixed-effects models 
showed an increase over time in both pulmonary regurgitation (p=0.014) and pulmonary 
stenosis (p<0.001) (Figure 3B and C).
 Regurgitation of the mitral and tricuspid valve at the time of discharge after Ross 
operation was limited to three and two patients, respectively. Mixed-effects modeling did 
not show time-related changes in mitral (p=0.259) or tricuspid regurgitation (p=0.161).
Comment
We have shown an improvement in left ventricular systolic function after the Ross 
operation in neonates and infants. While the majority of patients had (severely) impaired 
left ventricular function at the time of the operation, function at latest follow-up was 
restored to normal in the majority of patients. Our fi ndings closely resemble those from 
Frigiola et al. in pediatric patients, who showed increased left ventricular ejection fraction 
after the Ross operation [12]. Despite improvement in left ventricular systolic function, 
endocardial fi broelastosis persisted in the majority of patients.
 The autograft root was shown to be dilated directly after the Ross operation according 
to aortic Z-scores. One could argue that the Z-scores on which this statement is based, 
were developed for native aortic valves whereas the autograft valve is in fact a native 
pulmonary valve. Consequently, aortic Z-scores in the context of the Ross operation 
should be interpreted with caution. More important is that at the level of the annulus 
and sinus, diameter increase during follow-up was parallel to somatic growth as Z-scores 
remained stable over time. Similarly, Lo Rito et al. showed stable Z-scores during follow-
up in patients who underwent the Ross operation below the age of 18 months [13]. 
Interestingly, we have shown an autograft root diameter increase out of pace with somatic 
growth at the level of the sinotubular junction. In addition, we report a cautious trend 
towards increased Z-scores at all levels of the pulmonary autograft root after the fi rst 
decade.
 Autograft valve function remained good during follow-up. Autograft stenosis was 
present in only one patient and autograft regurgitation did not progress over time in 
any patient. These fi ndings explain the 100% freedom from autograft reoperation in our 
series. Freedom from autograft reoperation was similarly favorable in the series from 
Birmingham [13]. Interestingly, there is a somewhat puzzling discrepancy between the 
Dutch and British series compared to the fi ndings of the Italian Pediatric Ross Registry 
[6]. In the Italian series 6 of 29 infants (20.7%) were reoperated after a mean follow up of 
8.4+/-4.9 years.
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 Progression of both pulmonary regurgitation and stenosis were anticipated and in 
accordance with other studies on the use of these grafts in neonates and infants. The 
relatively low number of reoperations most likely refl ects our short follow-up duration 
and future reinterventions due to progression of pulmonary regurgitation and stenosis 
should be anticipated. RVOT graft dysfunction remains an important draw back of the Ross 
operation when performed at an early age. 
 Application of mixed-effects modelling allows us to make predictions for future 
patients while accounting for the special features of the data, such as the correlation 
between measurements obtained from the same patient. Based on our dataset, we have 
predicted the evolution over time of left ventricular function, as measured by fractional 
shortening, for a patient aged 113 days receiving the Ross operation with septal myectomy 
(Figure 3). Future studies may focus on increasing the power of these predictive models 
and integrating them in decision making in daily clinical practice.
Limitations
To study the evolution over time of the echocardiographic variables of interest, we 
excluded patients who did not survive the early post-operative period as they did not 
contribute to echocardiographic follow-up. The result of this selection is creation of a 
cohort with limited coexisting congenital heart disease compared to previously reported 
cohorts [4,5].
 Retrospective re-evaluation of echocardiographic exams in the setting of a multicenter 
study was associated with several limitations. There were certain differences, both between 
centers and within centers over time, in the quality and range of views and modalities of 
stored images. In addition, early echocardiographic exams were stored on videotapes, 
which made re-evaluation diffi cult. 
 Missing data, data loss and limited follow-up duration prevented more detailed 
data analysis. In the future, we would like to correct for more baseline covariates and 
study the possible interaction between baseline covariates and evolution over time of 
echocardiographic variables of interest. More data and a longer follow-up duration will also 
increase the accuracy of our prediction models, which may allow them to be implemented 
in clinical practice.
Conclusions
The Ross operation offers adequate relief of left ventricular outfl ow tract obstruction in 
neonates and infants. During the fi rst decade after the operation an improvement of left 
ventricular function is observed. Moreover, autograft root growth is parallel to somatic 
growth with preservation of autograft valve function.
14009_AMookhoek_BW.indd   46 20-09-16   10:21
Echocardiography after infant ross
47
3
References
1. Stelzer P. The Ross procedure: state of the art 2011. Semin Thorac Cardiovasc Surg. 2011;23:115-23.
2. Hraška V, Sinzobahamvya N, Haun C, et al. The long-term outcome of open valvotomy for critical 
aortic stenosis in neonates. Ann Thorac Surg. 2012;94:1519-26.
3. Shinkawa T, Bove EL, Hirsch JC, et al. Intermediate-term results of the Ross procedure in 
neonates and infants. Ann Thorac Surg. 2010;89:1827-32.
4. Maeda K, Rizal RE, Lavrsen M, et al. Midterm results of the modifi ed Ross/Konno procedure in 
neonates and infants. Ann Thorac Surg. 2012;94:156-62.
5. Elder RW, Quaegebeur JM, Bacha EA, Chen JM, Bourlon F, Williams IA. Outcomes of the infant 
Ross procedure for congenital aortic stenosis followed into adolescence. J Thorac Cardiovasc Surg. 
2013;145:1504-11.
6. Luciani GB, Lucchese G, Carotti A, et al. Two decades of experience with the Ross operation in 
neonates, infants and children from the Italian Paediatric Ross Registry. Heart. 2014;100:1954-9.
7. Andrinopoulou ER, Rizopoulos D, Jin R, Bogers AJ, Lesaffre E, Takkenberg JJ. An introduction 
to mixed models and joint modeling: analysis of valve function over time. Ann Thorac Surg. 
2012;93:1765-72.
8. Mookhoek A, Charitos EI, Hazekamp MG, et al. Ross Procedure in Neonates and Infants: a 
European Multicenter Experience. Ann Thorac Surg. 2015;100:2278-84.
9. Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z 
scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an 
echocardiographic study. J Am Soc Echocardiogr. 2008;21:922-34.
10. Warren AE, Boyd ML, O’Connell C, Dodds L. Dilatation of the ascending aorta in paediatric 
patients with bicuspid aortic valve: frequency, rate of progression and risk factors. Heart. 
2006;92:1496-500.
11. Mosteller RD. Simplifi ed calculation of body-surface area. N Engl J Med. 1987;317:1098.
12. Frigiola A, Varrica A, Satriano A, et al. Neoaortic valve and root complex evolution after Ross 
operation in infants, children, and adolescents. Ann Thorac Surg. 2010;90(4):1278-85.
13. Lo Rito M, Davies B, Brawn WJ, et al. Comparison of the Ross/Ross-Konno aortic root in children 
before and after the age of 18 months. Eur J Cardiothorac Surg. 2014;46:450-7; discussion 457.
14009_AMookhoek_BW.indd   47 20-09-16   10:21
Chapter 3
48
A
pp
en
di
x 
1 
Ec
ho
ca
rd
io
gr
ap
hi
c 
pr
ot
oc
ol
V
ar
ia
bl
e
M
ea
su
re
m
en
t
V
ie
w
M
od
al
it
y
R
oo
t 
di
am
et
er
A
nn
ul
us
In
 m
m
, i
nn
er
 e
dg
e 
to
 in
ne
r 
ed
ge
 a
t 
90
° 
re
la
tiv
e 
to
 b
lo
od
 fl 
ow
PL
A
X
2D
Si
nu
s
In
 m
m
, i
nn
er
 e
dg
e 
to
 in
ne
r 
ed
ge
 a
t 
90
° 
re
la
tiv
e 
to
 b
lo
od
 fl 
ow
, 
m
ax
im
um
 d
ia
m
et
er
PL
A
X
2D
ST
J
In
 m
m
, i
nn
er
 e
dg
e 
to
 in
ne
r 
ed
ge
 a
t 
90
° 
re
la
tiv
e 
to
 b
lo
od
 fl 
ow
PL
A
X
2D
A
sc
en
di
ng
 a
or
ta
In
 m
m
, i
nn
er
 e
dg
e 
to
 in
ne
r 
ed
ge
 a
t 
90
° 
re
la
tiv
e 
to
 b
lo
od
 fl 
ow
PL
A
X
 / 
su
pr
as
te
rn
al
2D
A
or
tic
 r
eg
ur
gi
ta
tio
n
G
ra
de
G
ra
de
 0
 / 
1 
/ 2
 / 
3,
 e
xp
er
ie
nc
e 
of
 c
ar
di
ol
og
is
t
A
LA
X
 / 
5C
h 
/ s
up
ra
st
er
na
l
C
D
A
or
tic
 s
te
no
si
s
Pe
ak
 v
el
oc
ity
In
 m
/s
A
LA
X
 / 
5C
h 
/ s
up
ra
st
er
na
l
C
W
M
ea
n 
gr
ad
ie
nt
In
 m
m
H
g
A
LA
X
 / 
5C
h 
/ s
up
ra
st
er
na
l
C
W
In
de
xe
d 
A
VA
In
 c
m
/m
2
PS
A
X
2D
Pu
lm
on
ar
y 
re
gu
rg
ita
tio
n
G
ra
de
G
ra
de
 0
 / 
1 
/ 2
 / 
3,
 e
xp
er
ie
nc
e 
of
 c
ar
di
ol
og
is
t
PS
A
X
C
D
Pu
lm
on
ar
y 
st
en
os
is
Pe
ak
 v
el
oc
ity
In
 m
/s
PS
A
X
 / 
PL
A
X
 t
ilt
ed
C
W
M
itr
al
 r
eg
ur
gi
ta
tio
n
G
ra
de
G
ra
de
 0
 / 
1 
/ 2
 / 
3,
 e
xp
er
ie
nc
e 
of
 c
ar
di
ol
og
is
t
4C
h
C
D
Tr
ic
us
pi
d 
re
gu
rg
ita
tio
n
G
ra
de
G
ra
de
 0
 / 
1 
/ 2
 / 
3,
 e
xp
er
ie
nc
e 
of
 c
ar
di
ol
og
is
t
4C
h
C
D
LV
 fu
nc
tio
n
FS
In
 %
PL
A
X
M
-m
od
e
LV
ED
D
In
 m
m
PL
A
X
 /P
SA
X
M
-m
od
e
LV
ES
D
In
 m
m
PL
A
X
 /P
SA
X
M
-m
od
e
Fi
br
oe
la
st
os
is
G
ra
de
G
ra
de
 0
 / 
1 
/ 2
 / 
3,
 b
as
ed
 o
n 
di
st
ri
bu
tio
n
4C
h
2D
ST
J i
nd
ic
at
es
 s
in
ot
ub
ul
ar
 ju
nc
tio
n;
 A
VA
, a
or
tic
 v
al
ve
 a
re
a; 
FS
, f
ra
ct
io
na
l s
ho
rt
en
in
g; 
LV
ED
D
, l
ef
t 
ve
nt
ri
cu
la
r 
en
d 
di
as
to
lic
 d
im
en
si
on
; L
V
ES
D
, l
ef
t 
ve
nt
ri
cu
la
r 
en
d 
sy
st
ol
ic
 
di
m
en
si
on
s; 
PL
A
X
, p
ar
as
te
rn
al
 lo
ng
 a
xi
s; 
A
LA
X
, a
pi
ca
l l
on
g 
ax
is
; 5
C
h,
 5
 c
ha
m
be
r; 
PS
A
X
, p
ar
as
te
rn
al
 s
ho
rt
 a
xi
s; 
4C
h,
 4
 c
ha
m
be
r; 
C
D
, c
ol
or
 D
op
pl
er
; C
W
, c
on
tin
uo
us
 
w
av
e 
D
op
pl
er
.
14009_AMookhoek_BW.indd   48 20-09-16   10:21
Chapter 4
European Multicentre Experience with Valve-sparing 
Reoperations after the Ross Procedure
Aart Mookhoek, Laurent de Kerchove, Gebrine El Khoury, Timo Weimar, 
Giovanni Battista Luciani, Alessandro Mazzucco, Ad J J C Bogers, Diana Aicher, 
Hans-Joachim Schäfers, Efstratios I Charitos, Ulrich Stierle, Johanna J M Takkenberg
J Thorac Cardiovasc Surg. 2015;5223:1490-1497.
14009_AMookhoek_BW.indd   49 20-09-16   10:21
Chapter 4
50
Abstract
Objectives
Autograft valve preservation at reoperation may conserve some of the advantages of the 
Ross procedure. However, results of long-term follow-up are lacking. In this retrospective 
multicentre study, we present our experience with valve-sparing reoperations after the 
Ross procedure with focus on long-term outcome.
Methods 
A total of 86 patients from 6 European centres who underwent valve-sparing reoperation 
after the Ross procedure between 1997 and 2013 were included in the study.
Results 
Reoperation was performed a median of 9.1 years after the Ross procedure in patients 
with a median age of 38.4 years (interquartile range 27.1-51.6 years). Pre-operative severe 
autograft regurgitation (grade ≥ 3) was present in 46% of patients. In-hospital mortality 
was 1%. During a median follow-up of 4.3 years, 3 more patients died of non-cardiac 
causes resulting in a cumulative survival at 8 years of 89% (95% CI: 65%-97%). Fifteen 
patients required a reintervention after valve-sparing reoperation, mostly due to prolapse 
or retraction of autograft cusps. Freedom from reintervention was 76% (95% CI: 57%-
87%) at 8 years. The reintervention hazard was increased in patients with isolated and/or 
severe aortic regurgitation at valve-sparing reoperation. In patients without reintervention 
after valve-sparing autograft reoperation (N=63), severe aortic regurgitation was present 
in 3% at last follow-up.
Conclusions
Valve-sparing autograft reoperations after the Ross procedure carry a low operative risk, 
with acceptable reintervention rates in the fi rst post-operative decade. Patients with 
isolated and/or severe autograft regurgitation have an increased hazard of reintervention 
after valve-sparing reoperation, and require careful preoperative weighing of surgical 
options.
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Introduction
Aortic valve replacement through the Ross procedure offers patients a living valve 
substitute with good hemodynamics and freedom from long-term use of anticoagulation. 
The main concern following the Ross procedure in adult patients is reoperation on the 
autograft due to progressive root dilatation and/or autograft insuffi ciency.1 
 Historically, reoperations following the Ross procedure consisted of excision of 
autograft material followed by a Bentall procedure.2 Nowadays, surgeons prefer to 
attempt a preservation of the autograft valve when possible by performing a valve-sparing 
reoperation in an attempt to maintain the advantages associated with a functioning 
autograft valve.3,4 However, concern exists about the long-term fate of the autograft cusps 
after the valve-sparing reoperation.
 Evidence on outcome after valve-sparing reoperations after the Ross procedure is 
scarce, as only a few centres have published their short-term results.4,5 This study aims 
to determine the durability of valve-sparing reoperations after the Ross procedure in the 
fi rst postoperative decade in a retrospective European multicentre cohort study.
Methods
Institutional review board permission for this study was obtained in each centre. Informed 
written consent was obtained from all patients. The study was performed in accordance 
with the Declaration of Helsinki.
Patient inclusion and data collection
All patients who received a valve-sparing reoperation after the Ross procedure in one 
of the six participating centres were included in the study. Our cohort includes several 
patients which have been reported upon previously by Luciani et al. (N=17), De Kerchove 
et al. (N=26) and Charitos et al. (N=24). 4-6
 Pre-operative patient characteristics including information on the initial Ross procedure, 
peri-operative surgical data on the valve-sparing reoperation after the Ross procedure and 
post-operative follow-up data were retrospectively collected in each of the participating 
centres. In total, 86 patients operated between 1997 and 2013 were included in the study.
Data analysis
Statistical analyses were performed using IBM SPSS 21.0 (IBM, Somers, NY, USA). Normal 
distribution of continuous data was assessed using the Shapiro-Wilk test. Continuous 
variables are displayed as mean ± standard deviation or median ± (interquartile) while 
discrete variables are displayed as counts and percentages.
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TABLE 1 Patient characteristics at initial Ross procedure
Total patients 86
Sex Male 69 (80%)
Female 17 (20%)
Age at Ross procedure* Median 29.9
Interquartile range 16.5 – 42.2
Range 7.5 – 58.3
Children (<18 years) 23 (27%)
Native aortic valve Unicuspid 6 (7%)
Bicuspid 61 (71%)
Tricuspid 15 (17%)
Unspecifi ed 4 (5%)
Prior cardiac surgery Patients 18 (21%)
Procedures 20
Indication Ross procedure Regurgitation 41 (48%)
Stenosis 16 (19%)
Combined 28 (33%)
Unspecifi ed 1 (1%)
Aetiology Congenital 49 (57%)
Degenerative 23 (27%)
Endocarditis 4 (5%)
Rheumatic 1 (1%)
Prosthesis mismatch 1 (1%)
Prosthesis thrombosis 1 (1%)
Cusp repair failure 1 (1%)
Unspecifi ed 6 (7%)
Ross technique Root replacement 73 (85%)
Inclusion cylinder 10 (12%)
Sub coronary 3 (3%)
RVOT graft type Homograft 84 (98%)
Bioprosthesis 2 (2%)
* Age at Ross procedure does not conform to a normal distribution. RVOT indicates right ventricular outfl ow 
tract.
Overall survival and freedom from reintervention after valve-sparing reoperation were 
analysed using the Kaplan-Meier method. Curves were truncated when the number of 
patients at risk dropped below 9 (<10% of the original population at risk). Ninety-fi ve 
percent confi dence intervals were calculated using log transformation of the cumulative 
hazard function.
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 With Cox regression, a univariable analysis of potential risk factors for reintervention 
after valve-sparing reoperation was performed. Variables included sex, bicuspid aortic 
valve yes/no, indication for initial Ross procedure (aortic regurgitation, aortic stenosis, 
combination), Ross technique (full root, inclusion cylinder, sub coronary), interval from 
the Ross procedure at time of valve-sparing reoperation, age at time of valve-sparing 
reoperation, isolated aortic regurgitation as indication for valve-sparing reoperation yes/
no, prolapse yes/no, severe aortic regurgitation at the time of valve-sparing reoperation 
(grade ≥ 3) yes/no, valve-sparing autograft root replacement yes/no, reimplantation versus 
remodelling technique, annulus repair yes/no and isolated autograft valve repair yes/
no. Pearson’s correlation coeffi cient was used to assess correlations between variables 
included in the univariable analyses. A one-way ANOVA with Tukey’s honestly signifi cant 
difference post-hoc test was performed to assess possible differences in reintervention 
rates after valve-sparing reoperation between the three types of valve-sparing autograft 
root replacement techniques.
Results
In the participating centres, 1783 Ross procedures were performed from 1997 to 2013. 
During this period, 87 patients (44.2%) received a valve-sparing reoperation after the Ross 
procedure out of a total of 197 patients who required at least one reoperation on the 
autograft. One patient was excluded from our study population due to intra-operative 
conversion to autograft valve replacement. An overview of patient and procedural 
characteristics at the time of the initial Ross procedure is provided in Table 1. An overview 
of the peri-operative details of the valve-sparing reoperation after the Ross procedure is 
provided in Table 2, while Table 3 provides details of autograft valve repair. At the time of 
the valve-sparing reoperation after the Ross procedure, median age of patients was 38.4 
years (interquartile range 27.1-51.6 years).
Early outcome
Following the valve-sparing reoperation after the Ross procedure, one patient died on 
day 9 post-operatively following cardiac arrest. With one death, 30-day mortality was 1.2% 
(binomial 95% confi dence interval: 0.03% - 6.24%) .
 One patient, who had isolated autograft valve repair, underwent reintervention 
after valve-sparing reoperation on day fi ve post-operatively due to grade III autograft 
regurgitation. The autograft valve was replaced by a homograft valve. Bleeding complications 
occurred in three patients, requiring resternotomy in two. One patient suffered from a 
transient ischemic attack.
 Median hospital stay was 7 days (interquartile range 6 to 9 days, range 4 to 17 days).
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TABLE 2  Characteristics of valve-sparing reoperation after Ross procedure
Procedures 86
Emergency 1 (1%)
Elective 79 (99%)
Time after Ross procedure Median 9.1 years
Interquartile range 5.8 – 12.6 years
Range 0.0 – 20.7 years
Indication Aneurysm 36 (42%)
Regurgitation 16 (19%)
Combined 28 (33%)
RVOT graft stenosis 1 (1%)
Unspecifi ed 5 (6%)
Aetiology Degenerative 72 (84%)
Endocarditis 6 (7%)
Acute dissection 1 (1%)
Unspecifi ed 7 (8%)
Autograft root diameter * † Annulus 26.6 ± 4.9 mm
Sinus 49.7 ± 5.0 mm
STJ 47.0 ± 5.3 mm
Ascending aorta 49.2 ± 4.9 mm
Autograft regurgitation (N=79) None / trace 3 (4%)
Grade I 17 (22%)
Grade II 23 (29%)
Grade III 23 (29%)
Grade IV 13 (16%)
Annulus repair (N=80) 57 (71%)
Circular annuloplasty ‡ 40
Cabrol stitches 16
Unspecifi ed 1
Valve-sparing autograft root replacement (N=81) 70 (86%)
Reimplantation 37
Remodelling 17
Supra-coronary 16
STJ remodelling (N=74) 20 (27%)
Cusp abnormalities (N=81) § 33 (41%)
Prolapse 31
Fenestration 2
Perforation 3
Retraction 2
Calcifi cation 1
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TABLE 2  Characteristics of valve-sparing reoperation after Ross procedure (Continued)
Autograft valve repair (N=79) § 34 (43%)
Central plication 28
Suture free edge 10
Pericardial patch 2
Perfusion time (N=66) * 145.0 ± 60.3 minutes
Cross-clamp time (N=66) * 107.1 ± 46.2 minutes
Circulatory arrest (N=54) * 4 (7%)
26.3 ± 35.0 minutes
Concomitant surgery § 20 (23%)
RVOT graft replacement 16
Hemi-arch replacement 3
ASD closure 1
VSD closure 1
For several variables, number of patients from which data was available is indicated by “(N=)”. * Values represent 
mean ± standard deviation. † Diameters provided only for patients with autograft root aneurysms without 
severe autograft valve regurgitation ‡ Includes 37 patients with aortic root reimplantation (David procedure). § 
Overlapping categories. RVOT indicates right ventricular outfl ow tract; STJ, sinotubular junction; ASD, atrial septal 
defect; VSD, ventricular septal defect.
TABLE 3 Reinterventions after valve-sparing reoperation
Total (N) 15
Indication Autograft regurgitation 13 (86.7%)
Autograft stenosis 1 (6.7%)
Autograft root dilatation 1 (6.7%)
Cusp abnormalities Cusp prolapse 8 (66.7%)
Cusp retraction 4 (26.7%)
Combination 1 (6.7%)
Cusp calcifi cations 2 (13.3%)
Procedure Autograft valve repair 1 (6.7%)
Replacement with mechanical prosthesis 10 (53.3%)
Replacement with biological prosthesis 4 (26.7%)
Late mortality
Follow-up following the valve-sparing reoperation after the Ross procedure was 95% 
complete, with a median duration of 4.3 years (interquartile range 2.4 to 6.3 years, range 
54 days to 16.2 years, 343 patient years). There were 3 cancer-related deaths at 5.8, 7.5 and 
10.0 years. Estimated freedom from all-cause mortality at eight years follow-up was 89% 
(95% confi dence interval: 65%-97%).
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Reintervention after valve-sparing reoperation
Surgical reintervention after valve-sparing reoperation was performed in 15 patients 
(Table 3). Estimated freedom from reintervention was 76% at eight years follow-up (95% 
confi dence interval: 57%-87%) (Figure 1). While most autograft cusps appeared thin and 
pliable at explantation, two patients presented with autograft cusp calcifi cations. 
 Univariable analysis revealed several variables that were potentially associated with the 
hazard of reintervention after valve-sparing reoperation (Table 4). Isolated autograft valve 
repair was associated with an increased hazard of reintervention. Estimated freedom from 
reintervention at eight years follow-up was 33% in patients with isolated autograft valve 
repair (7 out of 11 patients) compared to 85% in patients with valve-sparing autograft root 
replacement with or without valve repair (8 out of 70 patients). Reintervention rates after 
valve-sparing reoperation were not signifi cantly different between patients who received 
valve-sparing autograft root replacement using the reimplantation (4 out of 37 patients), 
remodelling (3 out of 17 patients) or supra-coronary technique (1 out of 16 patients) 
(P=0.503).
 Since the low number of events precluded performing a multivariable analysis, we 
performed correlation analysis between the variables that were signifi cant in the univariable 
analysis. Isolated autograft regurgitation as indication for valve-sparing reoperation after 
the Ross procedure was negatively correlated with use of the full root technique at the 
initial Ross procedure (coeffi cient -0.459, P<0.001) and valve-sparing autograft root 
replacement (coeffi cient -0.891, P<0.001). It was not correlated with age at the time of 
valve-sparing reoperation (coeffi cient -0.060, P=0.594).
TABLE 4 Univariable analysis of the hazard of reinterventions after valve-sparing reoperation
Variable Hazard ratio * P-value
Ross technique Full root 1.000
Inclusion cylinder 4.358 (1.454 – 13.064) 0.009
Sub coronary 4.005 (0.497 – 32.286) 0.193
Age 0.944 (0.906 – 0.985) 0.007
Isolated aortic regurgitation † 5.021 (1.721 – 14.649) 0.003
Severe aortic regurgitation (grade ≥ 3) ‡ 3.736 (1.165 – 11.978) 0.027
Isolated autograft valve repair 5.041 (1.677 – 15.154) 0.004
Valve-sparing autograft root replacement 0.199 (0.070 – 0.565) 0.002
*Hazard ratio with ninety-fi ve percent confi dence interval in brackets. † As indication for repair. ‡ At the time of 
valve-sparing reoperation after Ross procedure.
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FIGURE 1 Kaplan-Meier curve of freedom from reintervention after valve-sparing reoperation 
(A) entire cohort and (B) cohort split according to operation technique used at the time of the 
Ross procedure. FR indicates full root technique; IC, inclusion cylinder technique; SC, sub coronary 
technique.
Clinical status
At latest follow-up, 80% of patients were in NYHA class I, 12% in class II and 8% in class 
III. Ninety-fi ve percent of patients were in sinus rhythm, 3% had a permanent pacemaker 
and 2% were diagnosed with atrial fi brillation. Oral anticoagulation was used by 10% of 
patients. Several patients experienced cardiac-related complications during follow-up 
including stroke (8%), heart failure (5%) and myocardial infarction (2%). Following valve-
sparing reoperation after the Ross procedure, at least four women had a total of fi ve 
successful pregnancies.
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 At latest follow-up, 63 patients were still alive and under active follow-up without 
having had a reintervention after valve-sparing reoperation. Autograft valve regurgitation 
was absent in 41% patients, grade I in 43%, grade II in 13% and grade III in 3% of patients.
Discussion
This multicentre European study provides important information for surgeons on the 
characteristics and outcome following valve-sparing reoperations after the Ross procedure. 
It illustrates that the indication for surgery and the presentation of the patient at the 
time of valve-sparing reoperation varies widely. The majority of patients in our cohort 
underwent the initial Ross procedure as young adults. Therefore, a substantial proportion 
of patients presented with a bicuspid aortic valve. Somewhat surprisingly, the indication 
for the Ross procedure was isolated aortic regurgitation in almost half of the patients. 
The absence of aortic stenosis as indication in such a large proportion of patients might 
be explained in part by prior balloon valvotomy or surgical valvuloplasty in these patients. 
Another part of the explanation may be that patients in whom the indication for the Ross 
procedure is aortic stenosis have a lower risk of autograft-related complications.
 In experienced hands, valve-sparing reoperation after the Ross procedure is safe with 
acceptable early morbidity and mortality. Low reported early mortality is especially striking 
considering that in 21% of patients the valve-sparing reoperation was their third or even 
fourth cardiac surgical procedure. After the valve-sparing reoperation, patients may again 
enjoy the claimed benefi ts of their autograft valve and avoid use of oral anticoagulation. This 
is superbly illustrated by the four women in our cohort who became pregnant after the 
valve-sparing reoperation. In our cohort, no cardiac-related deaths were observed during 
follow-up. This fi nding suggests that valve-sparing reoperations after the Ross procedure 
conserve the survival advantage observed following the Ross procedure.7 However, the 
three cancer-related deaths resulted in a slightly lower estimated survival at 8 years 
compared to the age-matched general population in The Netherlands (89% versus 98%).8 
 Reintervention after valve-sparing reoperation is not uncommon. Interestingly, the 
majority of reinterventions were performed within the fi rst two post-operative years. This 
may explain why the case reports on valve-sparing reoperations after the Ross procedure 
do not report failure, as follow-up in these reports rarely extends beyond a few months 
post-operatively.9,10 It is important to note that the majority of patients who did not 
require a reintervention were in excellent clinical condition and presented with good 
autograft valve function at latest follow-up. 
 We have identifi ed several factors related to characteristics of the patient and initial 
Ross procedure as well as autograft valve function at the time of the valve-sparing 
reoperation that are associated with reintervention. These fi ndings may help to guide the 
decision-making process when a reoperation on the pulmonary autograft is necessary.
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 Interestingly, the technique used at the initial Ross procedure was associated with 
outcome following the valve-sparing reoperation after the Ross procedure. When 
compared to the full root technique, the inclusion cylinder technique was associated 
with an increased hazard of failure of the valve-sparing reoperation. Although a similar 
association in the sub coronary group was not statistically signifi cant, this may be 
attributed to the limited number of patients in this group. We believe that the inclusion 
cylinder and sub coronary techniques may lead to distortion of the complex geometry 
of the autograft cusps. Over time, this may lead to cusp prolapse and other degenerative 
cusp changes in some patients. Not surprisingly, the majority of patients in whom the 
initial Ross procedure was performed according to the inclusion cylinder or sub coronary 
technique presented with isolated, and often severe, autograft regurgitation at the time 
of valve-sparing reoperation. Prolapse and degenerative cusp changes present at the 
time of valve-sparing reoperation after the Ross procedure may prevent durability of 
the valve-sparing reoperation. In addition, valve-sparing reoperations may be technically 
more challenging in patients following a Ross procedure with the inclusion cylinder or sub 
coronary technique due to scarring and possible reduced compliance of the autograft wall. 
A substantial proportion of these patients who required a reintervention after the valve-
sparing reoperation presented with prolapse and/or retraction of one or more cusps at 
the time of reintervention. Of note, the two patients in whom cusp calcifi cations were 
reported at the time of autograft valve explantation had an inclusion cylinder Ross.
 In contrast, use of the full root technique at the initial Ross procedure preserves 
the complex geometry of the autograft root. Following the full root technique, the 
predominant mechanism of failure is autograft root dilatation with generally no to only 
moderate autograft regurgitation. Degenerative cusp changes are expected to be limited. 
Supporting this theory is our fi nding that in patients in whom the full root technique 
was used, autograft root aneurysm was the indication for a valve-sparing autograft root 
replacement in the majority of patients. Interestingly, the interval between the initial Ross 
procedure and valve-sparing reoperation was longer when the indication for reoperation 
was autograft root aneurysm (10.7 years) compared to isolated autograft regurgitation 
(3.4 years).
 Our fi ndings are in accordance with two smaller cohort studies that showed an 
association between isolated autograft valve pathology and reintervention after valve-
sparing reoperation.4,5 In a case series with seven patients, the authors did not report 
any reintervention after a mean echocardiographic follow-up of 3.2 years.11 Their 
excellent results may be explained in part by the absence of patients with isolated 
autograft regurgitation. In the literature, results following primary valve-sparing aortic 
root operations are excellent. De Kerchove et al. report a freedom from reoperation 
after primary valve-sparing aortic root operation at eight years of 90%, while Aicher et 
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al. report 96% at ten years.12,13 These results are comparable to our reported freedom 
from reintervention of 85% at eight years in the subgroup of patients who received valve-
sparing autograft root replacement.
 Durable valve-sparing reoperations after the Ross procedure in patients with 
diseased autograft cusps may not be possible in some patients, especially when isolated 
autograft regurgitation is present, or may require careful reconsideration of the surgical 
approach. Several participating centres do not consider patients with leafl et calcifi cations, 
fenestrations or retraction suitable candidates for valve-sparing reoperations after the Ross 
procedure. In this light, some centres advocate the use of intra-operative measurements of 
the autograft cusps to guide the reoperation. While this approach may prove to be more 
reliable than eye-balling, no difference in outcome of autograft valve repair was observed 
in the current study between centres that use intra-operative measurements versus those 
that do not. In patients in whom a durable repair is unlikely, surgeons may consider the 
Bentall procedure with implantation of a mechanical or biological prosthesis.
Limitations
The retrospective nature of this study resulted in limitations with respect to data collection 
as information on several variables was not available for all patients. This underscores the 
need for a prospective registry to assess (variables associated with) outcome following 
valve-sparing reoperations after the Ross procedure. This may be achieved in the recently 
initiated AVIATOR registry, a prospective international registry of patients undergoing 
surgery for ascending aorta aneurysm and/or isolated aortic regurgitation (http://
heartvalvesociety.org/working-groups.cgi).
Conclusions
Valve-sparing reoperations after the Ross procedure may be performed with limited 
early morbidity and mortality in the majority of patients. This approach allows patients 
the continued benefi t of the advantages associated with a functioning autograft valve. 
However, reintervention after valve-sparing reoperation is a common fi nding in the fi rst 
two post-operative years in patients with isolated and/or severe autograft regurgitation 
and warrants careful consideration of the surgical approach in these patients.
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Abstract
The Ross operation offers patients an aortic valve substitute with good hemodynamics 
and freedom from oral anticoagulation use. In patients requiring reoperation after the 
Ross operation, valve-sparing autograft root replacement may conserve advantages of the 
initial Ross operation. This case report describes a 24-year-old patient who underwent 
elective valve-sparing autograft root replacement according to David ten years after the 
Ross operation for severe autograft root dilatation with moderate to severe autograft 
regurgitation. Post-operative echocardiography revealed trivial aortic valve regurgitation. 
Two years after the reoperation, severe symptomatic autograft regurgitation and progressive 
reduction in left ventricular function was observed. Surgical inspection demonstrated 
thickened autograft leafl ets with prolapse in two. Histological analysis showed features 
characteristic of autograft leafl ets explanted at reoperation for autograft root dilatation. 
The prominent aortalis layer, consisting of poorly aligned elastin and collagen fi bers, was 
a novel fi nding. We believe it may be associated with leafl et prolapse, as either cause 
or consequence. We advocate collection of pulmonary autograft leafl ets explanted upon 
reintervention after valve-sparing autograft root replacement to help answer why prolapse 
occurs after valve-sparing reoperations.
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Introduction
The Ross operation offers patients an aortic valve substitute with good hemodynamics and 
freedom from oral anticoagulation use.1 However, progressive dilatation of the autograft 
root, often accompanied by autograft regurgitation, is a major cause for reoperation in the 
second post-operative decade.2 In patients requiring reoperation after the Ross operation, 
valve-sparing autograft root replacement may conserve several advantages of the initial 
Ross operation. This case report describes a patient requiring early reintervention after 
valve-sparing reoperation.
Case report
The institutional review board of the Erasmus MC approved this study (MEC 2013-219) 
and the patient gave informed consent.
 A 24-year-old woman underwent elective reintervention on the pulmonary autograft 
12 years after the Ross operation. Indication for the initial Ross operation was progressive, 
symptomatic aortic stenosis and regurgitation in the presence of a bicuspid aortic valve. 
The pulmonary autograft was transplanted as a full root without external support. A 
pulmonary homograft was used to reconstruct the right ventricular outfl ow tract. Ten 
years after the Ross operation, with an autograft root diameter in excess of 45 mm, the 
patient became pregnant. Due to a perceived increased risk of autograft rupture, a primary 
caesarean section was performed at 35 weeks. No clinical adverse events occurred. The 
patient returned to the clinic six months later with complaints of progressive fatigue, 
dizziness and shortness of breath on exertion. Echocardiography revealed a severely 
dilated autograft root (56 mm) with moderate to severe autograft regurgitation. Surgery 
was indicated. Upon surgical inspection, the tricuspid autograft valve appeared symmetrical 
with thin, pliable leafl ets. Therefore, a valve-sparing autograft root replacement according 
to David was performed without autograft valve repair. Post-operative echocardiography 
revealed trivial aortic valve regurgitation. Two years later, a diagnosis of severe symptomatic 
autograft regurgitation and progressive reduction in left ventricular function was made. 
Surgical inspection demonstrated thickened autograft leafl ets with prolapse in two. The 
autograft leafl ets were excised and a mechanical valve prosthesis was implanted.
 Tissue remodeling has been demonstrated in explanted autograft leafl ets obtained 
from patients with autograft root dilatation.3 We had the opportunity to study the 
remodeling response in autograft leafl ets two years after normalizing autograft root 
diameter. One explanted autograft leafl et was preserved in formalin and cut in half along 
the radial direction (from wall to free edge) to study the central belly region. The specimen 
was embedded in paraffi n, sectioned at 4 µm and stained to visualize collagen and elastin 
fi bers. Leafl et thickness in the central belly region was 647 µm. Five distinct layers of 
connective tissue could be identifi ed (Figure 1). The cell-rich radialis layer consisted of 
densely-packed, well-aligned, radially oriented collagen fi bers (Figure 2A). The fi brosa, the 
thickest layer (202 µm), contained mostly circumferentially oriented collagen fi bers. The 
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prominent aortalis layer (181 µm) consisted of poorly aligned elastin and collagen fi bers 
(Figure 2B).
200 µm 
V 
IV  
III  
II  
I  
FIGURE 1 Radial cross-section through the central belly region stained with Verhoeff-Van Gieson. 
I denotes lamina ventricularis; II, radialis; III, spongiosa; IV, fi brosa; V, aortalis.
100 µm A 
*  
100 µm B 
FIGURE 2 Visualization of collagen fi ber orientation with Sirius red staining in the lamina radialis 
(panel A) and aortalis (panel B). * denotes the lamina radialis in panel A.
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Discussion
In this case report, we offer the detailed history of a patient in whom valve-sparing autograft 
root replacement required reintervention after only two years. While the patient history 
offers interesting insights, several studies have previously reported on reinterventions 
following valve-reoperation after the Ross operation.2,4 This report offers valuable new 
information and raises important questions about the remodeling response of pulmonary 
autograft leafl ets. 
 Although the autograft leafl ets were thin and pliable at the valve-sparing reoperation, 
they were shown to be thickened only two years later at the time of the reintervention. 
Our histological analysis showed a preserved fi ve-layer architecture typical of semilunar 
valves.5 However, thickness and composition of the fi ve layers did not resemble native 
pulmonary or aortic leafl ets. High cellularity and collagen fi ber deposition in the radialis 
layer were similar to the characteristic changes reported in autograft leafl ets explanted at 
reoperation for autograft root dilatation.3
 A novel fi nding is the presence of a prominent aortalis layer. This layer, not often 
described in literature, is present as a thin layer of fi ne elastic fi bers in native pulmonary 
and aortic leafl ets as well as in explanted autograft leafl ets. We believe that macroscopic 
thickening of the leafl ets presented in this case report is due to a substantial increase in 
aortalis layer thickness. We do not think this is active remodeling towards a native aortic 
phenotype. Given the orientation of collagen and elastin fi bers, it is more likely to be 
associated with leafl et prolapse, as either cause or consequence.
Conclusions
In this case report, we have presented the histological features of a prolapsed pulmonary 
autograft leafl et explanted two years after valve-sparing autograft root replacement. We 
advocate collection of pulmonary autograft leafl ets explanted upon reintervention after 
valve-sparing autograft root replacement. Detailed histological analysis of these leafl ets 
may help to answer why prolapse occurs after valve-sparing reoperations.
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Abstract
Objectives 
To evaluate the microscopic characteristics of pulmonary autograft valve explants.
Methods
Cell density and thickness of the autograft valve ventricularis were determined and 
compared with those of normal aortic and pulmonary valves (n=11). Cellular phenotype 
and extracellular matrix involvement were assessed with immunohistochemistry. Collagen 
three-dimensional architecture was studied by means of confocal microscopy.
Results
The autograft valve exhibited characteristic thickening of the ventricularis as compared 
to the normal aortic and normal pulmonary valve (137 versus 77 (P= .058) versus 37 
µm (P= .002)). Its cell number was increased compared to the normal aortic and normal 
pulmonary valve (396 versus 230 (P= .02) versus 303 (P= .083)). Myofi broblasts and 
stressed endothelial cells, both present in pulmonary autografts, were absent in control 
valves. The exclusive presence of MMP1 was an additional sign of extracellular matrix 
turn-over. Apoptosis, elastinolysis, cell proliferation, or senescence were not expressed. 
Dense fi brosis of the autograft ventricularis, with relatively well aligned collagen fi bers was 
observed with confocal microscopy.
Conclusions
Fibrous hyperplasia of the ventricularis and cellular and extracellular matrix characteristics 
of active remodelling were a consistent fi nding in pulmonary autograft valve explants. The 
observations suggest a primary valve related cause to be involved in pulmonary autograft 
valve failure.
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Introduction
Pulmonary autograft valve regurgitation and root dilatation have emerged as important 
complications of the Ross operation at short and midterm follow up (1-3). Valve 
regurgitation has generally been assumed to be secondary to root dilatation, although 
a primary valve related cause has never been excluded. In our previous study, fi brotic 
thickening of the autograft ventricularis was identifi ed as a common feature (4). Now, we 
systematically studied eleven explanted autografts and eleven control valves to assess and 
quantify the histopathological characteristics to support any clinico-pathologic correlates.
Methods
Pulmonary autografts (n=11) were obtained from adults reoperated for pulmonary 
autograft failure between 2003 and 2007 in the University Medical Centres of Rotterdam 
and Leiden (Table 1). Age matched heart valves (n=11) (aortic 5, pulmonary 6), obtained 
from the Heart Valve Bank of the Erasmus MC Rotterdam, served as controls.
TABLE 1 Clinical data of Ross patients and controls
Autograft (n=11) Control (n=11)
Age at operation (yrs) 24.4 (10.5 - 39.2) NA
Age at explantation (yrs) 35.8 (23.6 - 47.8) 31.9 (19.7 - 49.7)
Interval (yrs) 11.2 (7.3 – 15.4) NA
Male 9 7
Female 2 3
Bicuspid native valves 7 0
Indication for reoperation
Aortic dilatation/aneurysm 11 NA
Aortic regurgitation 10 NA
NA = not applicable.
Sample staining
Radial valve sections (4 μm) were cut from paraffi n embedded leafl ets and mounted on 
slides. Von Gieson staining was used to visualize elastin and collagen fi bers and alcian 
blue staining to visualize glycosaminoglycans and nuclei. Sections were photographed 
using a Zeiss microscope (Zeiss, Oberkochen, Germany) with a Sony DXC 950p full-
colour 3CCD camera (Sony Corp., Tokyo, Japan) and captured with KS-400 image analysis 
software version 3.0 (Zeiss, Oberkochen, Germany). Von Gieson stained sections were 
analysed using ImageJ version 1.37V to determine the thickness of the ventricularis and 
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total valve thickness. The mean number of nuclei was calculated in alcian blue stained 
sections by counting four different sample fi elds.
 Immunohistochemical analysis using 13 different markers was performed to compare 
autograft valves (n=11) with control valves (n=11) (Table 2). In general, sections were 
deparaffi nised, followed by antigen retrieval by boiling in 0.1 M citrate buffer, pH 6.0, blocked 
for endogenous peroxidases and incubated for one hour with the primary antibody. Next, 
sections were washed and incubated with an Envision horseradish-peroxidase conjugated 
secondary antibody (DAKO, Glostrup, Denmark). Subsequently, all slides were incubated 
with diaminobenzidine and analysed with KS-400 image analysis software to quantify 
staining percentage of the ventricularis.
TABLE 2 Antibodies used in immunohistochemical analysis
Markers Cellular aspects
Antigen 
retrieval
Primary 
antibody
Secondary 
antibody
Company
α-SMA Myofi broblasts - 1:400 Mouse Sigma
Active caspase 3 * Apoptosis + 1:200 Rabbit Cell signalling
Cathepsin K Elastinolysis + 1:1000 Rabbit TNO
Cathepsin S Elastinolysis + 1:1000 Rabbit TNO
CD31* Endothelium + 1:400 Mouse DAKO
CD45 Infl ammatory infi ltrate + 1:100 Mouse DAKO
Desmin Myofi broblasts - 1:20 Mouse LUMC
IL-6 Differentiation + 1:500 Goat ‡ Biogenesis
Ki67 Proliferation + 1:200 Mouse DAKO
MMP1 Collagen breakdown - 1:1000 Mouse Chemicon
MMP9 Collagen breakdown + 1:250 Rabbit TNO
p16INK4a † Senescence + 1:800 Mouse Neomarkers
TGF-β Differentiation + 1:500 Rabbit LUMC
* diaminobenzidine enhancement by incubation with Cu
2
SO
4
 for 5 min, † antigen retrieval using Tris/EDTA, ‡ rabbit α 
goat + SABC.
 
Confocal microscopy
Three-dimensional images were made from 20 µm thick, paraffi n embedded, Sirius red 
stained leafl ets with an LSM510 confocal microscope with a C-Apochromat® 40x/1.2W 
Corr water immersion objective (Zeiss, Oberkochen, Germany). 
Statistical methods
Continuous data, such as those obtained from histochemical analyses, were compared using 
the unpaired T-test. Discrete data, such as those obtained from the immunohistochemical 
analysis of desmin and α-SMA, were analysed using the Fisher’s exact test. All comparative 
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analyses were performed using SPSS 12.0.1 Windows (SPSS, Chicago, USA). P values < .05 
were considered signifi cant.
Results
Histochemical analysis
Autograft valves differed greatly from normal aortic and pulmonary valves (Figure 1) in 
their mean total thickness (372 µm versus 474 µm (normal aortic) and 292 µm (normal 
pulmonary), P> .2 and P= .067 respectively). Thickness of the ventricularis of autograft 
valve (137 µm) was signifi cantly more than normal than normal aortic (77 µm) or 
pulmonary valve (37 µm), P= .058 and P= .002 respectively. It comprised 36% of total 
autograft thickness, compared to normal aortic (17%) and pulmonary (12%) valve, P= 
.02 and P< .001 respectively. Number of cells per square mm in the ventricularis was 
396 in autografts compared to normal aortic (230) and pulmonary (303) valves, P= .02 
and P= .083 respectively. Matrix cell morphology was spindle shaped and cells lining the 
ventricularis surface appeared large and cubical.
FIGURE 1 Morphological analysis shows a thickened autograft (Au) ventricularis compared to normal 
aortic (Ao) and pulmonary (P) valves (upper mid panel, original magnifi cation x 135). Detailed photos 
of the autograft valves show cubical endothelium (lower left, V), collagen-rich extracellular matrix 
(lower mid) and high density of spindle shaped cells (lower right) (original magnifi cation x 540).
Immunohistochemical analysis
The autograft ventricularis was lined by endothelial cells, as identifi ed by CD31 staining. 
Autograft valves showed α-SMA-positive cells and desmin-positive cells in 91% and 36% 
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of samples respectively, compared to 36% and 0% respectively in control samples, P= .024 
and P= .035 respectively. The expression of these markers indicates a myofi broblast-like 
phenotype of the cells present in the extracellular matrix of the autograft ventricularis. 
In contrast to controls, the autograft ventricularis stained positive for IL-6, MMP1 and 
TGF-β. A very low number of infl ammatory cells were present in the ventricularis of 
both autograft and control samples, as identifi ed by CD45 staining. Apoptosis, matrix 
degradation, cell proliferation or senescence markers were not expressed.
Confocal microscopy
Collagen fi ber density was more pronounced in the ventricularis of autograft valves 
compared to normal aortic and pulmonary valves (Figure 2). Moreover, these fi bers 
showed a high degree of geometric organisation. Fiber alignment was typically in the radial 
direction (i.e. from wall to rim).
FIGURE 2 Confocal images of valvular collagen structures show an increase in collagen density in 
pulmonary autograft valves (lower left) compared to normal aortic and pulmonary valves (upper 
panels) (original magnifi cation x 800). Distinct radial orientation of the collagen fi bers is shown at 
high magnifi cation (lower right, original magnifi cation x 1600) (V = ventricularis).
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Discussion
Pulmonary autograft valve explants consistently showed a thickened ventricularis. Its 
presence along the entire cusp as well as focal expression of fi broblast activator TGF-
beta and IL-6, suggest this thickening is the result of a local adaptive response rather 
than fi brous overgrowth (pannus) as suggested by Rabkin-Aikawa et al. who observed 
similar thickening of the pulmonary autograft valve (5). In addition, we found that collagen 
fi bres were abundant in this area and particularly well aligned, which may implicate that 
the architectural changes are a result of adaptive remodelling secondary to increased 
mechanical stress. Interestingly, the remodelling tissue marker MMP1 as well as the 
presence of numerous myofi broblasts were found in explants that functioned over 10 
years in the systemic circulation. It suggests that the adaptation process in the explanted 
valves did not reach homeostasis. Such an ongoing process of remodelling may eventually 
be exhausted and lead to degeneration. Interestingly, we found the same changes in an 
explant from a patient who died of a non-valve related cause (not included in this study) 
(4) and comparable changes were found in pulmonary autografts of hearts from patients 
who needed a transplantation following the Ross operation (5). This suggests a common 
mode of adaptation that may occur to some extent in all autograft valves and therefore 
the relation with clinical valve failure is uncertain. However, speculating on a cause of valve 
failure, the presence of a thick fi brous layer is likely to negatively infl uence the delicate 
microdynamics of the valve, in particular its radial extensibility. Obviously, biaxial stress 
testing should be performed to substantiate this. We believe that the observed remodelled 
ventricularis is the result of benefi cial adaptation, but may eventually play a role in failure 
of the pulmonary autograft valve.
Conclusion
Fibrous hyperplasia of the ventricularis is a consistent fi nding in pulmonary autograft valve 
explants. Its cellular and extracellular matrix characteristics at explantation suggest it to 
be the result of sustained remodeling. The architectural changes may cause failure of the 
pulmonary autograft valve in the long term.
Limitations
The valves used in this study were all acquired from failing autografts. This impedes the 
extrapolation of our results to autograft valves in general. To enable such an extrapolation, 
valves from failing autografts should ideally have been compared with valves from non 
failing autografts.
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Future perspectives
It would be useful to perform a similar study with explanted valves from patients who 
underwent a classic Ross operation using the subcoronary implantation technique or 
from roots supported with Dacron. Since these autografts are unaffected by progressive 
root dilatation, the valve’s intrinsic tendency for failure can be more accurately studied. 
Detailed characterization of the collagen fi bers in the ventricularis could provide additional 
information on the structure and quality of collagen.
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Abstract
Background
Progressive dilatation of pulmonary autografts after the Ross operation may refl ect 
inadequate remodeling of the native pulmonary root to adapt to systemic circulation. 
Understanding the biomechanics of autograft root dilatation may aid designing strategies 
to prevent dilatation. We have previously characterized normal human pulmonary root 
material properties; however, mechanical properties of failed autografts are unknown. In 
this study, failed autograft roots explanted during reoperation were acquired and their 
material properties determined.
Methods
Failed pulmonary autograft specimens were obtained from patients undergoing 
reoperation after the Ross operation. Fresh human native pulmonary roots were obtained 
from the transplant donor network as controls. Biaxial stretch testing was performed to 
determine tissue mechanical properties. Tissue stiffness was determined at patient-specifi c 
physiologic stresses at pulmonary pressures.
Results
Non-linear stress-strain response was present in both failed autografts and normal 
pulmonary roots. Explanted pulmonary autografts were less stiff than their native 
pulmonary root counterparts at 8mmHg (134±42 vs. 175±49kPa, respectively, p=0.086) 
and 25mmHg (369±105 vs. 919±353kPa, respectively, p=0.006). Autograft wall stiffness 
at both 8 and 25mmHg was not correlated with age at the Ross operation (p=0.898 
and p=0.813, respectively) or time in the systemic circulation (p=0.609 and p=0.702, 
respectively).
Conclusions
Failed pulmonary autografts retained non-linear response to mechanical loading typical 
of healthy human arterial tissue. Remodeling increased wall thickness but decreased wall 
stiffness in failed autografts. Increased compliance may explain progressive autograft root 
dilatation in autograft failures.
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Introduction
The Ross operation offers several advantages compared to other aortic valve replacement 
strategies(1). Excellent hemodynamics and freedom from oral anticoagulation led to 
adoption of Ross operation for young adults(2-5). Patients after Ross operation have 
a demonstrated life expectancy similar to the general population(1, 6, 7). However, 
enthusiasm among cardiologists and surgeons to apply this operation more widely in adults 
has been limited, due to technical complexity of the operation and autograft reoperation 
risk beyond the fi rst decade(8-13). Late autograft dysfunction in the root replacement 
technique is primarily caused by progressive root dilatation, which may lead to aneurysm 
formation and valvular regurgitation, while autograft failure in the subcoronary technique 
is often due to leafl et dysfunction(9-15).
 Progressive autograft dilatation likely refl ects the inability of the native pulmonary 
root to adapt to demands of the systemic circulation. Histological analyses have offered 
insights into the remodeling response in failed explanted autografts(16-18). Loss and 
fragmentation of medial elastin fi bers and increased adventitial collagen fi ber deposition 
have been demonstrated(18). We hypothesized that these extracellular matrix changes 
were refl ected as marked changes in tissue material properties. Study of the mechanical 
properties of failed autografts provides understanding of the autograft dilatation process 
as the biomechanical remodeling response upon exposure to systemic pressure. The goal 
of this study was to determine the material properties of failed explanted autograft roots 
compared to healthy native pulmonary roots. 
Materials and Methods
This study was approved by Institutional Review Boards of Erasmus University Medical 
Center and San Francisco Veterans Affairs Medical Center and exempted by Committee 
of Human Research at University of California San Francisco Medical Center.
Sample Collection
Patients who required reoperation after Ross operation for aneurysm formation and 
autograft valvular regurgitation were recruited from Erasmus University Medical Center 
(Table 1). They consented to tissue collection of pulmonary autograft specimens. The 
original operation was performed using Ross full root replacement technique, leaving 
minimal amount of tissue distal to sinotubular junction (STJ) and without applying external 
support. Tissue specimens were excised proximal to the distal suture line, corresponding 
to STJ area. Specimens were frozen and stored at -80°C. To compare autograft to native 
pulmonary roots, fresh human specimens were obtained from California Transplant Donor 
Network (CTDN, Oakland, CA, USA) unused donor hearts. CTDN specimens were taken 
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from subjects who consented for research and died of non-cardiac causes. Furthermore, 
CTDN patients chosen were as closely age-matched to the Ross explant patients as was 
feasible based on availability. Tissue samples were obtained from two regions: sinuses and 
1cm distal to STJ. Care was taken to preserve tissue alignment in circumferential and 
longitudinal directions. Mechanical testing for CTDN specimens was completed within 24 
hours of cross-clamping; autograft specimens were thawed prior to stretching.
TABLE 1 Characteristics of Study Population
Ross patients Control subjects
Total subjects 10 7
Gender Male 8 3
Female 2 4
Aortic valve Bicuspid 8 0
Tricuspid 2 7
Wall thickness (zero pressure) 2.2±0.2mm 1.4±0.2mma
Diameter (zero pressure) 26.7±1.9mm 22.3±3.5mmb
Diameter (systemic pressure) 45.8±4.0mm -
Diameter pulmonary artery at Ross operation (n=2) 25.0±0.0mm -
Diameter aorta at Ross operation (n=8) 27.6±6.2mm -
Age at Ross operation 26.7±11.1
Age at explantation 39.7±10.9 50.9±11.3c
Time in systemic circulation 13.0±2.1 -
ap=0.001, bp=0.055, cp=0.058
Equibiaxial stretch testing
A custom-built planar biaxial stretching system was used to determine material properties. 
Details of biaxial tensile testing methods and analyses have been described previously(19). 
Specimen wall thickness was measured using digital caliper (model 500-754-10; Mitutoyo 
America Corporation, Aurora, IL, USA) by lightly sandwiching tissue between two glass 
slides. Three 5-0 silk sutures were anchored to each specimen edge using small, barbless 
fi shhooks. These sutures were attached to four stretcher arms, aligning circumferential and 
longitudinal edges with the direction of deformation. Five black ceramic markers (250–
355 µm; MO-SCI Corporation, Rolla, MO, USA) were placed on tissue surface, creating 
a grid in the specimen center. Specimen was fl oated in a water bath with Dulbecco’s 
phosphate buffered saline without calcium and magnesium. Load cells (model 31/3672–
02, 1000 g; Honeywell Sensotec Inc., Columbus, OH, USA) located on two orthogonal 
arms were zeroed. During extension, load cell data was amplifi ed to determine force 
on specimen during deformation. Real-time displacement of marker beads was obtained 
using CCD camera placed over tissue surface (model TM 9701; 30fps, 0.1pixels/mm; Pulnix 
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Inc., Sunnyvale, CA, USA). Images of tissue surface during deformation were digitized in 
MATLAB (version 7.0; MathWorks, Natick, MA, USA), and markers were identifi ed based 
on their contrast to surrounding tissue. Coordinates of each marker were tracked through 
loading cycle, and their relative movement was used to calculate strains in the principal 
directions. Specimens were tested over a large strain range using equibiaxial displacement-
controlled protocols. First, 10 preconditioning cycles of 10% stretch, using a triangular 
waveform at 0.5 Hz, were applied. Subsequently, each specimen was repeatedly cycled up 
to 55% peak strain. 
Constitutive Modeling
Explanted autograft and pulmonary roots were assumed to be incompressible and 
nonlinear hyperelastic materials. Stress was defi ned as measure of the average force acting 
per unit area of a surface within a deformable body in the deformed confi guration. Planar 
forces ( f ) measured by load cells during deformation were converted to Cauchy stresses 
( T ) in the principal directions, given by 
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Data analysis 
Stiffness was defined as slope of the stress-strain curve at a given point. To investigate stiffness under 
physiologic conditions, stiffness was calculated at patient-specific physiologic stresses at pulmonary 
diastolic and systolic pressures (8 and 25 mmHg, respectively). For normal pulmonary roots, patient-
specific physiologic stresses were determined from finite element (FE) modeling with LS-DYNA 
(Livermore Software Technology Corporation, Livermore, CA, USA), using a cylindrical model with 
tissue material properties from biaxial stretching, diameter and wall thickness at 0mmHg (unloaded 
diameter and wall thickness, respectively)(20). Simulations were run from 0mmHg to pulmonary 
pressures to determine patient-specific physiologic stresses. For explanted autografts, unloaded wall 
thickness but not diameter was known. Autograft diameter was measured pre-operatively using TTE at 
systemic pressure. FE simulations were run from 0mmHg to systemic pressure using unloaded wall 
thickness, autograft material properties from biaxial stretching, and iterative estimations of unloaded 
diameter until autograft diameter at systemic pressure matched measured diameter by TTE. After 
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Data analysis
Stiffness was defi ned as slope of the stress-strain curve at a given point. To investigate 
stiffness under physiologic conditions, stiffness was calculated at patient-specifi c physiologic 
stresses at pulmonary diastolic and systolic pressures (8 and 25 mmHg, respectively). For 
normal pulmonary roots, patient-specifi c physiologic stresses were determined from fi nite 
ele nt (FE) modeling with LS-DYNA (Livermo  Software Technology Corporation, 
Livermore, CA, USA), using a cylindrical mod l with tissue material properties from biaxial 
stretching, diameter and wall thickness at 0mmHg (unloaded diameter and wall thickness, 
respectively)(20). Simulations were run from 0mmHg to pulmonary pressures to determine 
patient-specifi c physiologic stresses. For explanted autografts, unloaded wall thickness but 
not diameter was known. Autograft diameter was measured pre-operatively using TTE 
at systemic pressure. FE simulations were run from 0mmHg to systemic pressure using 
unloaded wall thickness, autograft material properties from biaxial stretching, and iterative 
estimations of unloaded diameter until autograft diameter at systemic pressure matched 
measured diameter by TTE. After determining unloaded autograft diameter, FE simulations 
were run from 0mmHg to pulmonary pressures to determine patient-specifi c physiologic 
stresses. 
 Tissue stiffness for each normal pulmonary and explanted autograft root was then 
obtained at their respective physiologic stress based on slope of their respective stress-
strain curves obtained from biaxial stretching. Occasionally, for a specifi c Ross patient, 
FE models could not determine physiologic stress when simulation results would not 
converge; in that situation, stiffness was calculated based on average physiologic stress for 
explanted autografts at pulmonary pressures. When tissue specimens were not stretched 
to desired stress level, stiffness was calculated from extrapolated curves based on Fung 
strain energy function fi tted to raw data.
 For statistical analysis, normal distribution of data was assessed using Shapiro-Wilk test. 
Differences between patients and control subjects in age at explantation, wall thickness, and 
stiffness were analyzed by independent-samples t-tests. Paired sample t-tests were used for 
additional stiffness analyses. Pearson’s correlation coeffi cient was used to study autograft 
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stiffness with respect to age at Ross operation and time in systemic circulation. Reported 
values are quoted as mean±standard deviation. Statistical analyses were performed using 
IBM SPSS (version 21.0; IBM, Somers, NY, USA).
Results
Patient demographics of explanted autografts and native pulmonary roots are shown (Table 
1). None of the patients undergoing the Ross operation were noted to have preoperative 
pulmonary arterial hypertension. Average preoperative pulmonary artery systolic and 
diastolic pressures are 21.8±6.2 and 12.0±4.2mmHg, respectively (n=4). Notably, explanted 
autografts were signifi cantly thicker than pulmonary roots. Average autograft time in the 
systemic circulation was 13 years. Raw stress-strain data obtained from equibiaxial stretch 
testing of autograft and native pulmonary roots is displayed as Cauchy stress–Green strain 
plots (Figures 1-2, respectively).
 Non-linear stress-strain response was evident for both root types in both 
circumferential and longitudinal directions. FE analyses determined pressurized wall 
thickness, root diameter, and patient-specifi c physiologic stress at 8 and 25mmHg (Table 2).
 Stiffness (elastic moduli) was greater at systolic than diastolic pulmonary pressures for 
both explanted autografts and native pulmonary roots in both circumferential (p<0.001) 
and longitudinal (p<0.001) directions (Figure 3). Strikingly, explanted autografts were 
signifi cantly less stiff than their native pulmonary root controls in both circumferential 
and longitudinal directions at 8mmHg (p=0.086 and p=0.043, respectively) and 25mmHg 
(p=0.006 and p=0.005, respectively). Wall stiffness in explanted autografts obtained from 
patients with bicuspid aortic valve (BAV) appeared greater compared to patients with 
tricuspid aortic valve (TAV) at 8mmHg (145±40 vs 91k±3kPa) and at 25mmHg (397±97 
vs. 258±49kPa). Anisotropy, directional dependence of material properties, exists when 
material properties differ in the circumferential vs longitudinal direction. In native pulmonary 
roots, anisotropy was present at 25mmHg (p=0.016), but not at 8mmHg (p=0.188). 
Anisotropy for native pulmonary roots showed greater stiffness in the longitudinal than 
circumferential direction. Explanted autografts displayed no differences in stiffness in the 
circumferential and longitudinal directions (isotropic responses to mechanical loading) at 
both 8 and 25mmHg (p=0.400 and p=0.924, respectively). Explanted autograft stiffness at 
both 8 and 25mmHg was not correlated with patient age at the time of Ross operation 
(p=0.898 and p=0.813, respectively) nor time in the systemic circulation (p=0.609 and 
p=0.702, respectively).
14009_AMookhoek_BW.indd   85 20-09-16   10:21
Chapter 7
86
0
30
60
90
120
0 0,1 0,2 0,3 0,4 0,5 0,6
C
au
ch
y 
St
re
ss
 (
in
 k
P
a)
 
Green Strain  
0
30
60
90
120
0 0,1 0,2 0,3 0,4 0,5 0,6
C
au
ch
y 
St
re
ss
 (
in
 k
P
a)
 
Green Strain  A B 
FIGURE 1 Stress-strain curves for explanted pulmonary autografts in circumferential (A) and 
longitudinal directions (B).
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FIGURE 2 Stress-strain curves for native pulmonary arteries (A, B) and pulmonary sinuses (C, D) 
in circumferential (A, C) and longitudinal directions (B, D).
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TABLE 2 Wall Thickness, Root Diameter, and Patient-Specifi c Physiologic Stress from FE Models
8mmHg 25mmHg
Thickness
(mm)
Diameter
(mm)
Stress
(kPa)
Thickness
(mm)
Diameter
(mm)
Stress
(kPa)
Autograft 1.7±0.2 31.6±2.6 10.4±1.6 1.5±0.2 38.0±3.4 45.4±7.8
Pulmonary artery 1.0±0.2a 26.9±1.1c 15.4±3.9e 0.9±0.1b 32.2±1.8d 73.7±9.9f
Statistical analysis of differences between pulmonary autograft and native pulmonary root: wall thickness 
ap=0.002, bp=0.001; diameter cp=0.027, dp=0.035; physiologic stress ep=0.039, fp=0.004.
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FIGURE 3 Stiffness of explanted pulmonary autograft and native pulmonary roots at 8 and 25mmHg 
in circumferential (A) and longitudinal (B) directions.
Comment
The collection of explanted autograft tissue at Erasmus University Medical Center permitted 
a unique and unprecedented opportunity to study the material properties of a series of 
failed pulmonary autografts. Our study provides interesting evidence of biomechanical 
remodeling in autografts which have been exposed to the systemic circulation for more 
than a decade. Wall stiffness was signifi cantly less in explanted autografts compared to 
native pulmonary roots. This remodeling may explain why autografts that do not dilate 
immediately after the Ross operation, can fail by autograft dilatation a decade later. This 
fi nding is corroborated by operative descriptions of the autograft wall as delicate and 
pliable by surgeons during explantation.
Histopathology
Arterial tissues are complex laminar structures in which responses to mechanical loading 
are principally determined by elastin fi bers, collagens bundles and interstitial smooth 
muscle cells(21, 22). Although previous histological characterization of both failed and 
non-failing pulmonary autografts demonstrated viable interstitial and endothelial cells, 
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Schoof et al. also described marked fragmentation and loss of elastin fi bers as well as 
adventitial fi brosis(17, 18). In this study, we provided evidence that these histological 
fi ndings refl ect a marked difference in material properties between explanted autografts 
and native pulmonary roots. At the relatively low stress levels of pulmonic circulation, 
arterial load-bearing is elastin-dominated. Loss and fragmentation of elastin fi bers and 
increased collagen content due to adventitial fi brosis in explanted autografts might suggest 
increased wall stiffness. However, impaired collagen biosynthesis and post-translational 
modifi cation may have greater effect on aneurysm formation than collagen quantity as 
previously shown in the aorta of patients with a bicuspid aortic valves(23). 
Pulmonary Biomechanics
Our fi ndings refl ect the intrinsic material properties of autograft and native pulmonary 
artery tissues. Intrinsic values of wall stiffness were calculated independent of vessel wall 
thickness, diameter and geometry. This approach allows the direct study of biomechanical 
remodeling at the tissue level. While this approach provides interesting information on 
the remodeling response after the Ross operation, it does not directly refl ect the in vivo 
mechanical behavior of the whole vessel. If a decrease in intrinsic wall stiffness would have 
been the only result of biomechanical remodeling after the Ross operation, we would see 
increased compliance in vivo. However, we have observed a complex interplay between 
the intrinsic material properties, vessel wall thickness, diameter and geometry.
 Limited data is available on human autograft material properties. Carr-White et al., 
reported increased autograft stiffness in one 14-year old patient whose autograft was 
explanted four months after initial Ross operation(24). The single sample, younger patient 
age, earlier time to explantation, and different biomechanical testing methods, makes 
direct comparison with our fi ndings not possible. Increased stiffness could refl ect time 
differences in mechanical remodeling, early vs late, or mechanical differences based on 
patient age, pathology, etc. 
 Lammers described pulmonary mechanics and vascular stiffness in pulmonary arterial 
hypertension (PAH) compared to native pulmonary artery(21, 25). In PAH, pulmonary 
vascular stiffness increases due to 1) vascular remodeling with changes in thickness, 
composition, and alignment of the extracellular matrix, primarily elastin and collagen, 2) 
vascular dilation which shifts stiffness from the elastin-dominated to collagen-dominated 
portion of the stress-strain curve, and 3) active contraction of arterial smooth muscle 
cells and myofi broblasts. PAH provides an interesting comparison to the Ross operation, 
which is an extreme form of PAH where the autograft is subjected instantaneously to 
systemic pressure, in contrast to PAH, where the increase in pulmonary pressure is more 
gradual and to a lower peak pressure. In sheep and bovine neonatal PAH studies, proximal 
pulmonary artery increased in wall stiffness despite an increase in wall thickness(25, 26). 
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Vascular remodeling showed increased collagen and decreased elastin contribution to the 
mechanical response. In sheep, increased adventitia with decreased media was present(26). 
These animal studies differed from our autograft study in several aspects: 1) induction of 
increased pulmonary pressure in animal models was sub-acute, 2) studies were in neonatal 
sheep and cow rather than our study in young adult humans, and 3) animal specimens 
were explanted from non-failing pulmonary roots acutely 7-15 days after inducing PAH. 
We previously demonstrated via FE modeling that upon exposure to systemic circulation, 
pulmonary autograft experienced signifi cantly increased wall stress with resultant 
decreased distensibility and minimal change in diameter(20). Decreased distensibility was 
refl ective of increased wall stiffness which prevented acute dilatation. We speculated that 
an early biomechanical response to increased wall stress is development of increased wall 
thickness as demonstrated in animal studies, to effectively reduce wall stress. Since our 
patients underwent autograft explant on average over a decade after Ross operation, our 
study suggests that late failure may occur due to further pathological remodeling which 
increased compliance, reduced wall stiffness with resultant autograft dilatation. 
 Vascular adaptation has been shown to be age-dependent(22). Although autograft 
remodeling response is probably more versatile in neonates than in adults, we did not 
observe a correlation between age and autograft stiffness in our young adult population. 
The age range of our patients was fairly narrow and sample size limited. Therefore, our 
study did not have suffi cient power to answer whether age-dependent differences exist. 
Similarly, we found no correlation between autograft stiffness and duration of autograft 
exposure to systemic circulation. We had expected changes in material properties after 
Ross operation to be progressive, in parallel with changes in root diameter. However, 
material properties in failed autografts may represent a common failed state.
 In our study, explanted autografts demonstrated increased compliance which may 
explain late dilatation. This surprising maladaptive biomechanical response to long-term 
exposure to systemic blood pressure supports the inclusion cylinder technique with 
native aorta or synthetic external support for stabilizing autograft root. Autograft can be 
stabilized by a cylindrical sleeve of synthetic reinforcement such as Dacron to prevent 
dilatation(27, 28). Dacron is signifi cantly stiffer than autograft wall, thus it acts as an 
external barrier to prevent root dilatation. Yacoub’s root replacement technique without 
support has been described to prevent late autograft dilatation—key features include 
implanting autograft at subannular level and cutting root 2-3mm above commissures to 
minimize pulmonary artery length(1). Our specimens were closer to STJ and may refl ect 
dilatation from use of longer autograft length with inclusion of pulmonary artery. We have 
previously suggested that STJ/pulmonary artery should be excluded or reinforced as the 
material properties suggest a propensity for autograft dilatation(19, 20) and this study 
here also supports those conclusions. 
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Study Limitations
We compared fresh native pulmonary roots with explanted autograft roots stored at -80°C. 
Given the distance of our two institutions, Erasmus where autografts were harvested and 
UCSF where biaxial stretching was performed, it was not be possible for fresh autograft 
explant analysis. Furthermore, Ross reoperation was rare and infrequent given decline in 
use of the technique, thus explanted autografts were stored in tissue bank. As such, access 
to explanted autograft specimens represented a unique opportunity to investigate failure 
of remodeling response to systemic blood pressure despite the limitations. Freezing has the 
potential to infl uence our stiffness results. Experimental studies of the effects of freezing 
and cryopreservation on elastic modulus measurements have mixed conclusions(29-32). 
Some studies demonstrated similar material properties for fresh and frozen arteries, 
while others showed differences. Interestingly, for those that demonstrated material 
property differences, stiffness was increased by the cryopreservation process rather than 
decreased(31, 32). Based on such fi ndings, the decreased stiffness of explanted autografts 
compared to native pulmonary roots seen in our study likely refl ects tissue remodeling 
rather than the effect of freezing. 
 Differences in characteristics between patients and controls were inevitable given the 
inherently limited supply of donor hearts from the transplant donor network. We did not 
receive any donor hearts from BAV patients. Currently, tissue mechanical properties have 
not been reported in the literature from pulmonary roots taken from patients with BAV. 
In our study, wall stiffness in explanted autografts from BAV patients appeared greater 
compared to patients with TAV. These results agree well with a recent echocardiographic 
study demonstrating increased pulmonary artery stiffness in BAV patients compared to 
TAV controls (33). As such, the decrease in autograft wall stiffness compared to native 
pulmonary artery we have reported most likely refl ects the effect of autograft remodeling.
Conclusions
More than a decade after initial exposure to the high pressure environment of systemic 
circulation, explanted autografts retained the non-linear response to mechanical loading 
typical of healthy human arteries. Remodeling increased wall thickness and reduced 
circumferential wall stress. Interestingly, wall stiffness in explanted autografts was reduced 
compared to native pulmonary roots, which explained progressive autograft root dilatation.
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Abstract
Background
Progressive autograft dilatation after Ross operation suggests that remodeling does 
not effectively reproduce native aortic root biomechanics. In the fi rst of this two-part 
series, we compared autograft and pulmonary root mechanical properties at pulmonary 
pressures. The goal of this study was to compare mechanical properties of explanted 
pulmonary autografts to native aortic roots at systemic pressures.
Methods
Autograft specimens were obtained from patients undergoing reoperation after Ross 
operation. For comparison, native aortic roots were obtained from unused donor hearts. 
Biaxial stretch testing was performed to determine vessel wall mechanical properties. 
Wall stiffness was determined at patient-specifi c physiologic stresses corresponding to 
systemic pressures (80 and 120mmHg) as well as hypertensive state (200mmHg). 
Results
Non-linear stress-strain curves were present for both failed autografts and native aortic 
roots. Explanted autografts were signifi cantly more compliant than native aortic roots 
at 80mmHg (1527±676 versus 2993±1343kPa, p=0.011), 120mmHg (2537±1183 versus 
4931±2211kPa, p=0.013) and 200mmHg (4788±2303 versus 9207±4159kPa, p=0.015). 
Autograft wall stiffness at 80, 120 and 200mmHg was not correlated with age at time 
of Ross operation (p=0.666, p=0.639 and p=0.616, respectively) or time in the systemic 
circulation (p=0.635, p=0.637 and p=0.647, respectively).
Conclusions
Failed pulmonary autografts retained non-linear response to mechanical loading typical 
of healthy arterial tissue. Despite similar wall thickness in autografts, wall stiffness was 
signifi cantly reduced compared to native aortic roots. We demonstrated that biomechanical 
remodeling was inadequate to achieve native aortic mechanical properties, which may 
have resulted in progressive autograft root dilatation.
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Introduction
The Ross operation offers several advantages compared to conventional aortic valve 
replacement such as freedom from oral anticoagulation and good hemodynamics(1). In 
addition, Ross operation may restore life expectancy to that of the general population(2-4). 
However, recent guidelines only consider Ross operation when performed by experienced 
surgeons in young adults with contraindication to anticoagulation use(5). These guidelines 
weighed the advantages against technical complexity of the operation and risk of autograft 
reoperation(6-10). Late autograft dysfunction after the Ross operation using the full root 
technique was primarily due to progressive root dilatation leading to aneurysm formation 
and valvular regurgitation(6-11).
 Progressive root dilatation likely refl ects inability of the autograft to adapt to demands 
of the systemic circulation. Understanding the biomechanics of vascular remodeling in 
explanted autografts is important for designing strategies to prevent dilatation. We 
previously demonstrated that vascular remodeling in explanted autografts resulted in 
increased compliance in native pulmonary roots at pulmonary pressures(x). We hypothesize 
that pulmonary autografts explanted after progressive dilatation were also more 
compliant than native aortic root at systemic pressures. In this study, we compared wall 
biomechanical properties of explanted pulmonary autografts to healthy native aortic roots 
at patient-specifi c stresses corresponding to systemic pressures and systemic hypertension.
Patients and Methods
This study was approved by the institutional review boards of Erasmus University 
Medical Center and San Francisco Veterans Affairs Medical Center and was exempted by 
Committee of Human Research at University of California San Francisco Medical Center.
Sample Collection
Patients who required reoperation after a Ross operation performed between 1992 and 
2000 at the Erasmus University Medical Center and consented for autograft specimen 
collection were recruited (Table 1). The Ross operation was performed using the root 
replacement technique without external support, leaving a minimal amount of tissue distal 
to the sinotubular junction (STJ). Specimens were excised proximal to the distal suture 
line, frozen, and stored at -80°C. 
 Human native aortic roots were obtained from unused California Transplant Donor 
Network (CTDN, Oakland, CA, USA) donor hearts from age-matched subjects who 
consented for research and died of non-cardiac causes. Tissue samples were obtained 
from sinuses and at 1cm distal to STJ.
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 Care was taken to preserve tissue alignment in circumferential and longitudinal 
directions. Mechanical testing for CTDN specimens was completed within 24 hours of 
cross-clamping; autograft specimens were thawed prior to stretching.
TABLE 1 Patient Population
Ross patients Control subjects
Patients 10 6
Sex Male 8 3
Female 2 3
Native aortic valve Bicuspid 8 0
Tricuspid 2 6
Wall thickness (zero pressure) 2.2±0.2mm 1.7±0.3mma
Diameter (zero pressure) 26.7±1.9mm 22.3±0.6mmb
Diameter (systemic pressure) 45.8±4.0mm -
Diameter pulmonary artery at Ross 
operation (n=2)
25.0±0.0mm -
Diameter aorta at Ross operation (n=8) 27.6±6.2mm -
Age at Ross operation 26.7±11.1 -
Age at explantation 39.7±10.9 49.0±10.3c
Time in systemic circulation 13.0±2.1 -
Ross patients compared with control subjects: ap=0.011, bp=0.009, cp=0.112.
Equibiaxial stretch testing
Custom-built planar biaxial stretcher was used to determine material properties. Biaxial 
tensile testing methods were described previously(12). Specimen wall thickness was 
measured using digital caliper (model 500-754-10; Mitutoyo America Corporation, Aurora, 
IL, USA) by lightly sandwiching tissue between two glass slides. Three 5-0 silk sutures 
were anchored to each specimen edge using small, barbless fi shhooks, and were attached 
to four stretcher arms, aligning circumferential and longitudinal edges with direction 
of deformation. Five black ceramic markers (250–355µm; MO-SCI Corporation, Rolla, 
MO, USA) were placed on tissue surface, creating grid in specimen center. Specimen was 
fl oated in a water bath with Dulbecco’s phosphate buffered saline without calcium and 
magnesium. Load cells (model 31/3672–02, 1000 g; Honeywell Sensotec Inc., Columbus, 
OH, USA) located on two orthogonal arms were zeroed. During extension, load cell data 
was amplifi ed to determine force on specimen during deformation. Real-time displacement 
of marker beads was obtained using CCD camera placed over tissue surface (model TM 
9701; 30fps, 0.1pixels/mm; Pulnix Inc., Sunnyvale, CA, USA). Images of tissue surface during 
deformation were digitized in MATLAB (version 7.0; MathWorks, Natick, MA, USA), and 
markers were identifi ed based on their contrast to surrounding tissue. Coordinates of 
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each marker were tracked through loading cycle, and their relative movement was used 
to calculate strains in the principal directions. Specimens were tested over a large strain 
range using equibiaxial displacement-controlled protocols. First, 10 preconditioning cycles 
of 10% stretch, using triangular waveform at 0.5 Hz, were applied. Subsequently, each 
specimen was repeatedly cycled up to 55% peak strain. 
Data analysis
Constitutive modeling to calculate Cauchy stress and Green strain was performed as 
described previously(x). Wall stiffness was defi ned as slope of the stress-strain curve at a 
given point. To investigate stiffness under physiologic conditions, stiffness was calculated 
at patient-specifi c physiologic stresses at systemic pressures (80 and 120mmHg) and 
systemic hypertension (200mmHg). For native aortic roots, patient-specifi c physiologic 
stresses were determined from fi nite element (FE) modeling with LS-DYNA (Livermore 
Software Technology Corporation, Livermore, CA, USA), using a cylindrical model with 
mechanical properties obtained from biaxial stretching, unloaded root diameter and wall 
thickness at 0mmHg(13). Simulations were run from 0mmHg to systemic pressures and 
hypertensive pressures to determine respective patient-specifi c physiologic stresses. For 
explanted autografts, unloaded root diameter was calculated based on pre-operatively 
echocardiographic measurements. FE simulations were run from 0mmHg to systemic 
pressure using unloaded wall thickness, autograft material properties from biaxial 
stretching, and iterative estimations of unloaded diameter until autograft diameter at 
systemic pressure matched measured diameter by echocardiography. After determining 
unloaded autograft root diameter, FE simulations were run from 0mmHg to systemic 
pressures and hypertensive pressures to determine patient-specifi c physiologic stresses. 
 Wall stiffness was obtained at respective physiologic stresses based on slope of stress-
strain curves obtained from biaxial stretching. For two Ross patients, when FE models failed 
to determine physiologic stress as simulation results would not converge, stiffness was 
calculated based on average physiologic stress for explanted autografts at the respective 
blood pressure.
 For statistical analysis, normal distribution of data was assessed using Shapiro-Wilk test. 
Differences between patients and control subjects in age at explantation, wall thickness, 
and wall stiffness were analyzed by independent-samples t-tests. Paired sample t-tests were 
used for additional stiffness analyses. Pearson’s correlation coeffi cient was used to study 
autograft stiffness with respect to age at Ross operation and time in systemic circulation. 
Reported values are quoted as mean ± standard deviation. Statistical analyses were 
performed using IBM SPSS (version 21.0; IBM, Somers, NY, USA).
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Results
A total of 101 patients underwent the Ross operation between 1992 and 2000 at the 
Erasmus University Medical Center. As of January 1st 2015, 39 of those patients required 
a reoperation on the pulmonary autograft. Nine out of ten patients included in this study 
presented with congenital aortic stenosis at the Ross operation, one patient presented 
with aortic regurgitation based on single leafl et prolapse of a tricuspid aortic valve. 
None of the patients undergoing the Ross operation were noted to have preoperative 
pulmonary arterial hypertension. Average preoperative pulmonary artery systolic and 
diastolic pressures were 21.8±6.2 and 12.0±4.2mmHg, respectively (n=4).
 Raw stress-strain data obtained from equibiaxial stretch testing of explanted autografts 
and native aortic roots is displayed as Cauchy stress–Green strain plots (Figures 1 and 2, 
respectively).
 Non-linear stress-strain response was evident for both root types in both circumferential 
and longitudinal directions. FE modeling allowed calculation of pressurized wall thickness, 
root diameter and patient-specifi c physiologic stress at 80, 120 and 200mmHg (Table 2).
 Wall stiffness was greater at 120mmHg than 80mmHg for both explanted autografts 
and native aortic roots in both circumferential (p<0.001 and p<0.001, respectively) and 
longitudinal (p<0.001 and p<0.001, respectively) directions. Stiffness was also greater at 
200mmHg than at 120mmHg for both explanted autografts and native aortic roots in both 
circumferential (p<0.001 and p<0.001, respectively) and longitudinal directions (p<0.001 
and p<0.001, respectively). Wall stiffness in explanted autografts was lower compared to 
native aortic roots in both circumferential and longitudinal directions at 80mmHg (p=0.011 
and p=0.011, respectively), 120mmHg (p=0.013 and p=0.014, respectively) and 200mmHg 
(p=0.015 and p=0.016, respectively).
 In native aortic roots, the response to mechanical loading was similar in the 
circumferential and longitudinal directions (isotropy) at 80, 120, and 200mmHg (p=0.437, 
p=0.595 and p=0.646, respectively). Explanted autografts also displayed isotropic responses 
at 80, 120 and 200mmHg (p=0.301, p=0.318 and p=0.170, respectively).
 Autograft wall stiffness at 80, 120 and 200mmHg was not correlated with patient age 
at time of original Ross operation (p=0.666, p=0.639 and p=0.616, respectively) nor time 
in systemic circulation prior to explantation (p=0.635, p=0.637 and p=0.647, respectively). 
Wall stiffness in explanted autografts obtained from patients with a bicuspid aortic valve 
(BAV) appeared greater compared to patients with a tricuspid aortic valve (TAV) at 
80mmHg (1632±711 vs 1107k±363kPa), at 120mmHg (2708±1253 vs. 1855±659kPa) and 
at 200mmHg (5104±2451 vs. 3527±1311kPa).
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FIGURE 1 Stress-strain curves for pulmonary autografts in circumferential (A) and longitudinal 
directions (B).
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FIGURE 2  Stress-strain curves for native ascending aorta (A, B) and aortic sinuses (C, D) in 
circumferential (A, C) and longitudinal directions (B, D).
14009_AMookhoek_BW.indd   99 20-09-16   10:21
Chapter 8
100
TABLE 2 FE Model Calculations of Patient-Specifi c Physiologic Stress
80mmHg 120mmHg 200mmHg
Thickness
mm
Diameter
Mm
Stress
kPa
Thickness
mm
Diameter
mm
Stress
kPa
Thickness
mm
Diameter
mm
Stress
kPa
Autograft 1.3±0.1 44.2±3.8 191.8±32.5 1.2±0.1 45.8±4.0 309.8±52.3 1.2±0.1 47.8±4.2 561.3±94.5
Aorta 1.2±0.2 35.0±2.5 173.5±34.9 1.2±0.2 36.2±2.5 276.8±56.2 1.1±0.2 37.3±2.6 494.3±101.3
p=0.512 p=0.010 p=0.481 p=0.566 p=0.010 p=0.432 p=0.629 p=0.008 p=0.380
1.527 2.537 
4.788 2.993 4.931 
9.207 
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FIGURE 3 Stiffness of pulmonary autografts and native aortic roots at 80, 120 and 200mmHg in 
circumferential (A) and longitudinal directions (B).
Discussion
Availability of explanted pulmonary autograft specimens offered a unique opportunity 
to study the biomechanical consequences of remodeling after the Ross operation. In a 
previous study, altered biomechanical characteristics were shown in explanted autografts 
compared to native pulmonary roots at pulmonary pressures(x). In this study, we have 
demonstrated that autograft roots, explanted after progressive dilatation, did not remodel 
to biomechanically represent native aortic roots at systemic pressures. On the contrary, 
explanted autografts, which on average had been exposed to the systemic circulation for 
more than a decade, remodeled to become more compliant than age-matched native 
aortic roots.
 Arterial tissues have complex laminar structures in which responses to mechanical 
loading are principally determined by collagen and elastin fi bers(14, 15). At low stresses, 
arterial load-bearing is elastin-dominated and more compliant. At high stresses, load-
bearing is collagen-dominated and stiffness increases. Finite element analysis of native 
pulmonary roots demonstrated a dramatic increase in maximal wall stress when an 
increase from pulmonary to systemic pressures was simulated(13). Using native pulmonary 
root geometry and biomechanical characteristics, a six fold increase in maximal wall stress 
was demonstrated between 25mmHg and 120mmHg. Based on these fi ndings, release of 
the aortic cross-clamp during the Ross operation is expected to immediately shift the 
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response to mechanical loading of the pulmonary autograft to the collagen-dominated 
portion of the stress-strain curve. Moreover, the magnitude of stress increase may be the 
driving force for remodeling.
 Interestingly, explanted autografts have been shown to display prominent deposition 
of collagen in the adventitia and loss as well as fragmentation of elastin fi bers in the 
media compared to native aortic roots(16, 17). Therefore, one might expect an increase in 
autograft wall stiffness compared to native aortic roots. However, wall stiffness is infl uenced 
by more than collagen quantity alone. Load-bearing of collagen fi bers is determined by 
collagen micro-architecture, such as the number and nature of cross-links(18). In the 
aortic wall of patients with a BAV, impaired collagen biosynthesis and post-translational 
modifi cation appears to be associated with aneurysm formation (19). Our fi nding of 
decreased autograft wall stiffness may be explained by similar changes in collagen micro-
architecture. This intriguing hypothesis should be subject to future studies.
 To date, a single study has reported on the biomechanical properties of the autograft 
wall (20). Interestingly, the authors also reported lower autograft wall stiffness, compared 
to the native aortic root, in a specimen explanted four months after the Ross operation in 
a 14-year old patient. However, it is important to mention the limited sample size and time 
to explantation as well as differences in the methods used to obtain the biomechanical 
characteristics.
 The absence of a correlation between wall stiffness and duration of autograft exposure 
to systemic the circulation may be explained by the limited range of exposure duration as 
well as limited sample size. The same may apply to the correlation between wall stiffness 
and patient age at the time of the original Ross operation. An interesting avenue for future 
studies may be to investigate whether these correlations are present in patients without 
progressive autograft root dilatation.
Study Limitations
The main limitation of our study was that native aortic roots were analyzed fresh, while 
explanted autograft roots had to be frozen for transport to our facility in San Francisco and 
subsequently thawed prior to stretch testing. While freezing may be expected to infl uence 
wall stiffness measurements, experimental studies of the effects of freezing have shown 
mixed results in (21-24). Some studies reported similar biomechanical characteristics for 
fresh and frozen arteries, while others surprisingly demonstrated an increase in stiffness 
in the physiologic range after freezing(23, 24). As such, the differences in wall stiffness 
reported in our study likely refl ect tissue remodeling.
 Differences in characteristics between patients and controls were due to the limited 
supply of donor hearts from the transplant donor network. We did not receive any donor 
hearts from patients with a BAV. In our study, wall stiffness in explanted autografts from 
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BAV patients appeared greater compared to patients with a TAV. These results agree well 
with a recent echocardiographic study demonstrating increased pulmonary artery stiffness 
in BAV patients compared to TAV controls (25). Therefore, our fi nding of decreased 
autograft wall stiffness in explanted autograft compared to native aortic roots most likely 
refl ects the effect of autograft remodeling.
Future perspectives
The value of current prediction models used to determine when to operate on patients with 
autograft root dilatation are limited. Prediction of patient-specifi c evolution of autograft 
root dimensions as well as determination of the maximum diameter at which dissection 
risk is still acceptable would benefi t patients. Our study improves our understanding of 
biomechanical remodeling in the setting of autograft dilatation and may act as a starting 
point for future studies. To arrive at a prediction models based on biomechanical 
characteristics, we aim to develop advanced imaging techniques to determine in vivo 
biomechanical characteristics and study changes over time in Ross patients.
Conclusions
We have shown that in failed pulmonary autografts, explanted for aneurysmal dilatation 
more than a decade after the initial Ross operation, biomechanical remodeling resulted 
in increased compliance compared to the native aortic root. This fi nding may explain why 
progressive autograft root dilatation occurs late after the Ross operation.
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Abstract
Background
Pulmonary autograft reoperation after the Ross operation is a concern. Surgeons advocate 
autograft valve preservation to restore the advantages associated with a functioning 
autograft valve. Long-term outcome after valve-sparing autograft reoperations is unknown. 
In this study, we compared the material properties of explanted pulmonary autograft 
leafl ets with native aortic and pulmonary leafl ets.
Methods
Autograft leafl ets from seven patients (86% male, mean age 40 ± 12 years), explanted at 
reoperation 12 ± 3 years after the Ross operation, were analyzed using equibiaxial stretch 
testing. For comparison, native aortic and pulmonary leafl ets from human donor hearts 
were analyzed. Leafl et stiffness was calculated at a standardized stress level.
Results 
Stiffness of explanted pulmonary autograft leafl ets did not differ from native pulmonary 
leafl ets in both the circumferential (11273 ± 3768 versus 9746 ± 4370 kPa, p=0.908) 
and radial direction (11184 ± 3209 versus 9726 ± 4578 kPa, p=0.926). Stiffness of native 
aortic leafl ets was higher than that of both autograft and native pulmonary leafl ets in the 
circumferential (26866 ± 7208 kPa, p=0.001 and p=0.002 respectively) and radial direction 
(27979 ± 8308kPa, p=0.001 and p=0.002 respectively).
Conclusions
After more than a decade in the systemic circulation, pulmonary autograft leafl ets retained 
material properties similar to native pulmonary leafl ets. Despite changes to autograft 
root geometry and tissue structure shown in previous studies, equibiaxial stretch testing 
did not demonstrate mechanical remodeling. In our view, these fi ndings do not preclude 
autograft valve preservation at reoperation after the Ross operation.
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Introduction
The Ross operation offers patients a living aortic valve substitute with good hemodynamics 
and freedom from oral anticoagulation use. In adult patients, reoperation due to 
progressive autograft root dilatation and/or autograft insuffi ciency is a concern, especially 
in the second post-operative decade.1 The original reoperation strategy involved excision 
of all autograft material followed by a Bentall procedure.2 Nowadays, surgeons advocate 
autograft leafl et preservation by performing valve-sparing autograft root replacement and/
or autograft valve repair.3,4 While this approach preserves some advantages of the Ross 
operation, long-term outcome of autograft leafl et preservation is not yet available.
 Experimental studies may help to predict future events and long-term outcome. The 
structural integrity and biomechanical remodeling response of explanted pulmonary 
autograft leafl ets may be assessed by exploring the material properties. Until recently, 
the Bentall procedure was the reoperation strategy of choice after the Ross operation 
in our center. Therefore, we have been able to collect a substantial number of pulmonary 
autograft leafl ets at the Erasmus University Medical Center over the years.
 In this study, equibiaxial stretch testing was used to determine the material properties 
of explanted pulmonary autograft leafl ets and compare them with native aortic and 
pulmonary leafl ets.
Patients and Methods
This study was approved by the institutional review boards of the Erasmus University 
Medical Center and the San Francisco Veterans Affairs Medical Center and exempted by 
the Committee of Human Research at University of California at San Francisco Medical 
Center.
Specimen Collection
Pulmonary autograft leafl ets were obtained from consenting patients at the Erasmus 
University Medical Center. The initial Ross operation in these patients was performed 
using the full root replacement technique without applying external support. Leafl ets were 
obtained when patients received a Bentall procedure for autograft root aneurysm and 
autograft valve insuffi ciency. Specimens were frozen and stored at -80°C. To compare 
autograft leafl ets to native aortic and pulmonary leafl ets, fresh human specimens were 
obtained from unused California Transplant Donor Network (CTDN, Oakland, CA, USA) 
donor hearts. Inclusion of CTDN specimens was limited to donors who consented for 
research and died of non-cardiac causes.
 A square specimen was excised from the central belly region of each leafl et, while 
care was taken to preserve tissue alignment in the circumferential and radial directions. 
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Mechanical testing for CTDN specimens was completed within 24 hours of cross-clamping, 
autograft specimens were thawed prior to stretching.
Equibiaxial stretch testing
A custom-built planar biaxial stretching system was used to determine material properties. 
Details of biaxial tensile testing methods and analyses have been described previously [5]. 
Leafl et thickness was measured using a digital caliper (model 500-754-10; Mitutoyo America 
Corporation, Aurora, IL, USA). Three 5-0 silk sutures were anchored to each edge of the 
specimen using small, barbless fi shhooks. These sutures were attached to four stretcher 
arms, aligning circumferential and radial edges with the direction of deformation. Five black 
ceramic markers (250–355 µm; MO-SCI Corporation, Rolla, MO, USA) were placed on the 
leafl et surface, creating a grid in the center of the specimen. The specimen was then fl oated 
in a water bath with Dulbecco’s phosphate buffered saline without calcium and magnesium 
at room temperature. Load cells (model 31/3672–02, 1000 g; Honeywell Sensotec Inc., 
Columbus, OH, USA) located on two orthogonal arms were zeroed. During extension, 
load cell data was amplifi ed to determine force on the specimen during deformation. 
Real-time displacement of marker beads was obtained using a CCD camera placed over 
the leafl et surface (model TM 9701; 30fps, 0.1 pixels/mm; Pulnix Inc., Sunnyvale, CA, USA). 
Images of the leafl et surface during deformation were digitized in MATLAB (version 7.0; 
MathWorks, Natick, MA, USA), and the markers were identifi ed based on their contrast 
to the surrounding tissue. Coordinates of each marker were tracked through the loading 
cycle, and their relative movement was used to calculate Green strains in the principal 
directions. Specimens were tested over a large strain range using equibiaxial displacement-
controlled protocols. First, 10 preconditioning cycles of 10% stretch, using a triangular 
waveform at 0.5 Hz, were applied. Subsequently, each specimen was repeatedly cycled up 
to 55% peak strain. 
Data analysis
Experimental stretch data was fi tted to the two-dimensional Fung strain energy function. 
Leafl et stiffness was calculated by taking the fi rst derivative of the stress-strain response at 
a fi xed stress level of 277 kPa. This stress level represents physiologic stress in the native 
aortic root at 120 mmHg (data not shown). When specimens were not stretched to the 
desired stress level, stiffness was obtained from extrapolated curves based on the Fung 
strain energy function fi tted to the raw data.
 For statistical analysis, normal distribution of data was assessed using the Shapiro-Wilk 
test. Anisotropy, directional dependence of the material response to mechanical loading, 
was tested using paired-samples t-tests. A one-way ANOVA with Tukey’s honestly signifi cant 
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difference post-hoc test was performed to assess possible differences in leafl et stiffness 
between the three leafl et types. Reported values are quoted as mean ± standard deviation. 
Statistical analyses were performed using IBM SPSS (version 23.0; IBM, Somers, NY, USA).
Results
Pulmonary autograft leafl ets were explanted in seven patients (86% male) at a mean age 
of 40 ± 12 years. Indication for explantation, performed a mean of 12 ± 3 years after the 
initial Ross operation, was a combination of autograft root aneurysm and autograft valve 
insuffi ciency in all patients. Native aortic leafl ets were collected from fi ve donor hearts, 
pulmonary leafl ets from three.
 Raw stress-strain data obtained from equibiaxial stretch testing of autograft, native 
aortic and pulmonary leafl ets is displayed as stress–strain plots in Figure 1. A non-linear 
stress-strain response was evident for all leafl et types in both circumferential and radial 
directions.
FIGURE 1 Stress-strain plot of autograft, native aortic and pulmonary leafl ets in the circumferential 
direction. When more than one leafl et was tested from a subject, results from each leafl et are 
displayed separately. Dashed line represents stress level at which leafl et stiffness was calculated.
 The response to mechanical loading was isotropic in explanted pulmonary autograft 
leafl ets (p=0.903) as well as in native aortic (p=0.259) and pulmonary leafl ets (p=0.897). 
The one-way ANOVA showed signifi cant differences between the three leafl et types in 
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both circumferential and radial directions. As shown in Figure 2, mean stiffness of autograft 
leafl ets was similar to native pulmonary leafl ets in both the circumferential (p=0.908) 
and radial direction (p=0.926). Stiffness of native aortic leafl ets was higher than that of 
autograft (p=0.001) and native pulmonary (p=0.002) leafl ets in both directions.
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FIGURE 2 Overview of mean leafl et stiffness in both circumferential and radial direction. Error bars 
represent the standard deviation.
Discussion
Leafl et stiffness was similar in explanted autograft and native pulmonary leafl ets. Exposure 
to the high pressure environment of the systemic circulation for more than a decade 
did not induce biomechanical remodeling in autograft leafl ets. Absence of biomechanical 
remodeling is remarkable given the histological changes in leafl ets observed after the Ross 
operation [6]. Compared to native pulmonary leafl ets, explanted autograft leafl ets showed 
a signifi cant increase in thickness. This increase was largely due to increased deposition of 
radially aligned collagen fi bers on the ventricular aspect of the leafl ets [6].
 Semilunar valve leafl ets consist of three distinct layers: the elastin-rich ventricularis, the 
spongiosa composed primarily of glycosaminoglycans and proteoglycans, and the fi brosa 
which is rich in collagen fi bers [7]. Biomechanical properties of a leafl et are determined 
by the properties of each of the three leafl et layers combined [8, 9]. Interestingly, the 
ventricularis appears to contribute more than the fi brosa to the mechanical behavior in 
the radial direction [9]. In native aortic valve leafl ets, both the fi brosa and ventricularis 
are considerably stiffer in the circumferential compared to the radial direction, resulting 
in marked anisotropy [8]. Increased deposition of radially aligned collagen fi bers in the 
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ventricularis may explain the absence of anisotropy in autograft leafl ets demonstrated in 
the present study.
 An increase in leafl et thickness may intuitively be expected to result in an increase 
in leafl et stiffness. However, we calculated stiffness independent of leafl et thickness and 
geometry, to obtain intrinsic material properties. This approach allows the direct study 
of biomechanical remodeling at the tissue level. Native aortic leafl ets were shown to be 
signifi cantly stiffer than both native pulmonary and explanted autograft leafl ets. This fi nding 
may be explained in part by a higher percentage of collagen fi bers in native aortic leafl ets. 
In addition to (relative) collagen quantity, differences in collagen biosynthesis and post-
translational modifi cation have an effect on intrinsic material properties [10]. 
 Changes in intrinsic material properties do not directly refl ect changes in the in vivo 
mechanical behavior of leafl ets. Mechanical behavior is the result of a complex interplay 
between the intrinsic material properties, leafl et thickness and geometry, blood pressure 
and fl ow patterns. The combination of in vivo imaging and computer modelling are 
expected to offer more insights into the mechanical behavior of autograft leafl ets [11].
 Our study provides novel insights into the biomechanical characteristics of autograft 
leafl ets explanted more than a decade after the initial Ross operation. Preservation of 
intrinsic material properties support the current practice of valve-sparing autograft 
root replacement or autograft leafl et repair when reoperation after the Ross operation 
becomes necessary. However, the implications of changes in both leafl et and root geometry 
after the reoperation remain unknown and subject of future study.
Study Limitations
Autograft leafl et stiffness was studied in surgical specimens explanted for a combination of 
autograft root dilatation and valve insuffi ciency. Therefore, this study offers novel insights 
for surgeons who are confronted with patients requiring a reoperation after the Ross 
operation. However, our fi ndings may not be extrapolated to patients in whom autograft 
function is not impaired.
 We compared frozen autograft leafl ets (-80°C) with fresh native aortic and pulmonary 
leafl ets. A pilot study was conducted to study the possible infl uence of freezing on tissue 
material properties, which demonstrated similar elastic moduli in fresh and frozen (-80°C) 
human aortic wall specimens (data not shown). In addition, Schaar et al. demonstrated 
similar material properties for fresh and frozen (-80°C) human coronary, carotid and 
femoral arteries [12]. Although no data is available on the effect of freezing on semilunar 
valves, we feel confi dent our fi ndings refl ect absence of biomechanical remodeling in 
pulmonary autograft leafl ets.
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Conclusions
After more than a decade in the systemic circulation, pulmonary autograft leafl ets retained 
material properties similar to native pulmonary leafl ets. Interestingly, stiffness in explanted 
pulmonary autograft leafl ets was signifi cantly lower than in native aortic leafl ets. In our 
view, these fi ndings do not preclude autograft valve preservation at reoperation after the 
Ross operation.
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Abstract
Progressive autograft root dilatation after a Ross procedure may lead to autograft dissection. 
In this case report, a 47-year-old man underwent autograft explantation 12 years after 
a Ross procedure. Inspection of the explanted autograft revealed a longitudinal intimal 
tear with medial denudation. Autograft material properties were analyzed by equibiaxial 
stretch testing and elastic modulus calculation. Interestingly, response to mechanical 
loading was different comparing dissected and non-dissected autograft sections. A seven-
fold increase in wall stiffness was found in the dissected autograft section. Biomechanical 
characterization of the dissected and non-dissected vessel wall displays the versatility of 
the arterial remodeling response in autografts.
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Young adults have several options when aortic valve replacement is indicated. One option, 
the Ross procedure, offers the prospect of an autologous valve with good hemodynamics 
and freedom from anticoagulation.1 In a randomized controlled trial, the Ross procedure 
has been shown to result in a normal life expectancy.2 A major drawback is progressive 
autograft root dilatation, especially after use of the full root technique. Progressive 
dilatation, often accompanied by aortic valve insuffi ciency, may necessitate reoperation. 
Moreover, focal dissection of the autograft root has been reported.3,4 In this case report 
such a chronic autograft dissection is described with particular focus on autograft material 
properties.
A 47-year-old man with mildly impaired left ventricular function underwent elective 
reoperation on the pulmonary autograft twelve years after a Ross procedure with the 
full root technique. Indication for the initial Ross procedure was progressive aortic root 
dilatation and aortic valve insuffi ciency (AI) in the presence of a bicuspid aortic valve. Serial 
echocardiographic follow-up in the fi rst seven years after the Ross procedure showed a 
gradually progressive diameter increase of the sinotubular junction (STJ) from 30 mm to 
40 mm with trace AI. During the eighth post-operative year, echocardiography revealed a 
sudden increase in STJ diameter to 48 mm with grade I AI. While STJ diameter remained 
stable in subsequent years, AI increased to grade III in the 12th post-operative year. At 
echocardiographic assessment four months prior to reoperation, severe AI and dilatation 
of the pulmonary autograft (STJ 48 mm, distal to STJ 57 mm) was present in the absence 
of cardiac-related symptoms. At reoperation, the pulmonary autograft was replaced with 
a 27 mm St Jude composite mechanical aortic root prosthesis. The early post-operative 
period was complicated by two reinterventions for excess blood loss. After discharge, the 
patient remained in good clinical condition until he died suddenly 1.4 years later, 13.8 years 
after the initial Ross procedure. No autopsy was performed.
Inspection of the explant material revealed a longitudinal intimal tear near the distal 
anastomosis (Figure 1). The tear resulted in medial denudation over an area of roughly 3 
x 1.5 cm. After explantation, tissue was frozen and stored. After thawing, we performed 
biomechanical characterization of the autograft tissue by equibiaxial stretch testing, 
as described previously.5 The elastic modulus, a measure of wall stiffness calculated by 
taking the derivative of the stress-strain curve, was obtained at a fi xed, literature-derived 
stress level.5 We found that the response to mechanical loading was very different in the 
non-dissected compared to the dissected autograft section (Figure 2). Wall stiffness in 
the circumferential and longitudinal direction in the dissected autograft section (4655 
and 4648 kPa, respectively) was increased more than seven-fold compared to the non-
dissected autograft section (633 and 618 kPa, respectively).
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† ‡ 
FIGURE 1 Photo of explanted autograft section
Scale in mm. Symbols indicate locations of sample collection. * = Native aorta, † = Non-dissected 
autograft section, ‡ = Dissected autograft section.
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FIGURE 2 Stress-strain curve of the explanted autograft wall
Long. = Longitudinal, Circ. = Circumferential.
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Comment
In our patient, the dissecting lesion in the pulmonary autograft is thought to have occurred 
several years prior to explantation when STJ diameter suddenly increased from the 
seventh to the eighth post-operative year. The timing, absence of clinical symptoms and 
macroscopic characteristics were similar to previously published cases.3,4
Wall stiffness in the dissected autograft section was considerably higher than in the non-
dissected section. Stiffness values in both sections were in the same order of magnitude 
as observed in freshly tested native aortic roots (906 to 1962 kPa).5 The occurrence 
of dissection is associated with an increase in wall stiffness. However, the nature of our 
analysis does not allow us to determine whether increased wall stiffness was cause or 
consequence of the dissection event. If increased wall stiffness was consequence of the 
dissection, it may have prevented further dilatation at the STJ. At the same time, it may 
have increased the risk of a local rupture. The observations in our case study suggest that 
the pulmonary autograft root may show additional biomechanical remodeling at the site 
of dissection.
14009_AMookhoek_BW.indd   119 20-09-16   10:21
Chapter 10
120
References
1. Stelzer P. The Ross procedure: state of the art 2011. Semin Thorac Cardiovasc Surg. 2011;23:115-23.
2. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L, et al. Long-term outcomes 
after autograft versus homograft aortic root replacement in adults with aortic valve disease: a 
randomised controlled trial. Lancet. 2010;376:524-31.
3. Klieverik LM, Takkenberg JJ, Elbers BC, Oei FB, van Herwerden LA, Bogers AJ. Dissection of a 
dilated autograft root. J Thorac Cardiovasc Surg. 2007;133:817-8.
4. Luciani GB, Favaro A, Viscardi F, Bertolini P, Mazzucco A. Valve-sparing root replacement 
for pulmonary autograft dissection late after the Ross operation. J Thorac Cardiovasc Surg. 
2004;128:753-6.
5. Azadani AN, Chitsaz S, Matthews PB, Jaussaud N, Leung J, Wisneski A, et al. Biomechanical 
comparison of human pulmonary and aortic roots. Eur J Cardiothorac Surg. 2012;41:1111-6.
14009_AMookhoek_BW.indd   120 20-09-16   10:21
Chapter 11
General Discussion
14009_AMookhoek_BW.indd   121 20-09-16   10:21
14009_AMookhoek_BW.indd   122 20-09-16   10:21
Discussion
123
11
Introduction
In this thesis, the aim was to provide a comprehensive overview of the consequences of 
long-term exposure of the native pulmonary root to the systemic circulation after the 
Ross operation. Three important questions were addressed. First, what is the outcome 
after the Ross operation when performed in neonates and infants? Second, is a valve-
sparing reoperation a valuable approach in patients requiring reoperation after the Ross 
operation? Third, does pulmonary autograft remodelling result in an aortic phenotype? In 
this chapter, these questions are discussed in the wider context of aortic valve disease, 
clinical implications of our fi ndings are explored and future perspectives are commented 
on.
Ross Operation in Neonates and Infants
The incidence of early mortality after the Ross operation in neonates is high. In our 
cohort, almost half of the neonates died early after the Ross operation (Chapter 2). This 
disconcerting fi nding may be explained by the large proportion of neonates that were 
critically ill at the time of surgery and those who presented with multiple congenital heart 
defects requiring concomitant surgical intervention. However, several studies reporting 
on neonates with similar patient characteristics have shown lower incidences of early 
mortality [1-5]. Notably, our cohort includes patients from several centres that were 
among the fi rst worldwide to receive a neonatal Ross operation [6]. The learning curve 
from those fi rst operations in each of the included centres may have contributed to the 
relatively high incidence of early mortality in our cohort.
 Coronary button reimplantation is a crucial step in the Ross operation. In neonates 
and infants, size difference between the native aortic and pulmonary root complicates 
assessment of where in the autograft to implant the coronary buttons. In Chapter 2, 
myocardial ischemia is reported in two patients who required a second pump run to 
change coronary button position. Several other cases of coronary fl ow obstruction 
have recently been reported in the literature, some with fatal consequences [1, 3]. Early 
mortality after the Ross operation in neonates and infants appeared, at least in some cases, 
to be associated with myocardial ischemia due to compromised coronary fl ow. Increased 
awareness of this specifi c problem is thought to further reduce early mortality in the near 
future.
 In contrast to perioperative complication and early mortality rates, mid-term follow-up 
shows that the Ross operation offers neonates and infants good autograft valve function 
without the need for early reoperation, despite considerable somatic growth. Moreover, in 
Chapter 3 we have shown a remarkable improvement over time of left ventricular function 
in neonates and infants after the Ross operation. Even in patients with severely impaired 
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preoperative left ventricular function, normal contractility may be restored over time. 
Improved left ventricular function may have contributed to the relatively low estimates 
of late mortality reported in the literature [3]. In our cohort, autograft root diameter 
Z-scores were high upon discharge from hospital after the Ross operation, refl ecting 
the size difference between the native aortic and pulmonary root. However, an increase 
in Z-scores due to autograft root dilatation after fi rst exposure to the pressures of the 
systemic circulation cannot be excluded. Interestingly, Z-scores remained stable in the fi rst 
postoperative decade, supporting the observation of preserved autograft root growth 
potential [7]. Despite these changes in autograft root dimensions, autograft valve function 
in our cohort remained excellent. These results suggest that the Ross operation may 
effectively treat aortic valve disease in neonates and infants. However, follow-up duration 
in our cohort and those published previously is limited [1-5]. In addition, our results 
show a trend towards increased autograft root Z-scores in the second postoperative 
decade. If autograft root dilatation in neonates and infants progresses, reoperations on the 
pulmonary autograft may become necessary and limit autograft durability. Therefore, close 
follow-up is required to monitor both autograft dimensions and valve function.
 High early mortality after the Ross operation has led one centre to advocate an 
alternative approach to surgical treatment of neonates with critical aortic stenosis [8]. They 
focus on postponement of the Ross operation to allow patients to grow and improve their 
clinical condition. However, the techniques that are suggested, such as leafl et repair, do not 
appear feasible in the majority of neonates [8]. In practice, the Ross operation continues 
to be the treatment of choice for aortic valve disease in these young patients. Therefore, 
in principle, every congenital heart surgery unit should offer the Ross operation. However, 
the operation is technically demanding and requires an experienced surgeon. One way to 
balance availability and expertise, is to limit both the number of congenital heart surgery 
units and the number of surgeons in each centre to perform the Ross operation.
Valve-sparing Reoperations after Ross Operation
To prevent the complications associated with mechanical or bioprosthetic valve 
substitutes, valve-sparing techniques were developed to treat patients with native aortic 
valve regurgitation [9-11]. In patients with aortic valve stenosis (or regurgitation), the 
Ross operation is another surgical approach designed to avoid these complications 
[12]. Several advantages of the Ross operation may restore life expectancy of patients 
to the level of the general population [13, 14]. However, some patients may develop 
autograft regurgitation requiring reoperation after the Ross operation. In Chapter 4, our 
experience with valve-sparing reoperations after the Ross operation is presented. Valve-
sparing autograft root replacement and autograft leafl et repair, in patients with autograft 
root dilatation or isolated autograft valve regurgitation respectively, preserved several 
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advantages of the Ross operation. Moreover, early morbidity and mortality associated with 
these reoperations are reassuringly low [15, 16]. 
 In our cohort, high reintervention rates were shown early after the valve-sparing 
reoperation in patients who presented with isolated autograft valve regurgitation at the 
time of the reoperation. Detailed analysis of our cohort led to interesting insights into 
the mechanisms of failure after the Ross operation. Patients who were operated using the 
“root replacement” technique generally presented with autograft root dilatation relatively 
late after the initial Ross operation. A valve-sparing reoperation in these patients may be 
a durable approach as the diseased autograft wall is removed and restoration of normal 
root diameter eliminates autograft valve regurgitation by increasing coaptation surface. 
In contrast, patients who were operated using the “sub-coronary” or “inclusion cylinder” 
technique presented more often with isolated autograft leafl et prolapse relatively early 
after the initial Ross operation. Autograft leafl ets in these patients may be diseased and, 
while leafl et repair may temporarily restore valve patency, the leafl ets remain vulnerable 
to prolapse.
 What causes leafl et prolapse after the Ross operation using the “sub-coronary” or 
“inclusion cylinder” technique? Why does leafl et prolapse not occur when using the “root 
replacement” technique? A case report describing leafl et prolapse after valve-sparing 
autograft root replacement in a patient who received the Ross operation with the “root 
replacement” technique reveals a possible answer (Chapter 5). Prolapse of two leafl ets, 
thin and pliable at the time of the valve-sparing reoperation, occurred in the second 
postoperative year which may suggest an underlying technical complication. The complex 
geometry of the native aortic root may be crucial for valve function. The Ross operation 
using the “sub-coronary” or “inclusion cylinder” technique may change root geometry and 
thereby induce remodelling of autograft leafl ets leading to prolapse. To test this hypothesis, 
one approach is to compare the histological characteristics of explanted autograft leafl ets 
following the three different Ross operation techniques. In addition, biomechanical 
analysis and computer modelling may identify the factors that induce prolapse. These two 
approaches may offer surgeons valuable information for development of novel surgical 
strategies to prevent prolapse.
 The choice of surgical treatment in patients who require a reoperation after the Ross 
operation should not be based solely on reoperation statistics. A patient may for instance 
accept a relatively high chance of an early reoperation when complications of a mechanical 
valve prosthesis can be avoided. Expected quality of life after surgery is important when 
different surgical strategies are possible, especially in young adults. In patients who received 
native aortic valve replacement, results have shown superior quality of life at long-term 
follow-up after implantation of a biological valve substitute compared to a mechanical 
valve substitute [17]. In addition, quality of life in patients who received aortic valve repair 
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or aortic valve replacement with a pulmonary autograft was superior compared to aortic 
valve replacement with a mechanical valve substitute [18]. Future studies will need to 
address quality of life following a reoperation after the Ross operation. 
 The results presented in Chapter 4 should be shared by clinicians with their patients 
and will allow shared decision making by an informed patient and the clinician. However, 
guidelines will continue to be important in this setting. Based on our results, the guidelines 
should include that a valve-sparing reoperation after the Ross operation in patients that 
present with isolated autograft regurgitation should not be considered.
Autograft Remodelling
Pulmonary autograft leafl ets remained viable after transplantation into the systemic 
circulation (Chapter 6). Early after the Ross operation, an increase in the number of 
activated myofi broblasts and the activity of enzymes involved in matrix remodelling 
has been demonstrated in pulmonary autograft leafl ets compared to native aortic and 
pulmonary leafl ets [19]. Interestingly, these and other signs of stress on both the cellular 
and tissue level persist in explanted autografts to a certain degree for more than a decade 
after the Ross operation. The remodelling response, which increases leafl et thickness by 
deposition of collagen, fails to induce tissue homeostasis. This raises concern for the long-
term durability of the autograft valve.
 Remodelling of pulmonary autograft leafl ets does not produce a phenotype similar 
to that of native aortic leafl ets. Progressive autograft root dilatation may have prevented 
leafl et remodelling into an aortic phenotype. Native pulmonary leafl ets have been shown 
to display reduced radial extensibility at systemic pressures, which may reduce coaptation 
surface [20]. In addition, root dilatation also decreases the coaptation surface and may have 
been the driving force for deposition of radially aligned collagen fi bres on the ventricular 
aspect of the leafl ets. However, similar histological changes have been observed in autograft 
leafl ets obtained at heart transplantation or autopsy from patients without autograft 
root dilation [19]. Therefore, histological changes may simply refl ect the limited range of 
remodelling responses available to adult pulmonary valve leafl ets when exposed to the 
high pressure environment of the systemic circulation. Insights from future studies on the 
forces driving the remodelling response after the Ross operation may offer surgeons the 
information necessary to improve surgical technique. In addition, insights into the range 
of remodelling responses of autograft leafl ets and their driving forces may offer scientists 
stepping stones towards development of tissue-engineered valves. One interesting avenue 
of research will be to examine native aortic valve leafl ets explanted from patients with 
aortic root dilatation to determine whether histological changes similar to those observed 
in explanted pulmonary autograft leafl ets can be observed.
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 Interestingly, the remodelling response did not affect leafl et stiffness, despite deposition 
of radially aligned collagen fi bres in the ventricularis (Chapter 9). Biomechanical properties 
of a leafl et are determined by the properties of each of the three leafl et layers combined 
[21]. In native aortic valve leafl ets, both the fi brosa and ventricularis are considerably stiffer 
in the circumferential compared to the radial direction, resulting in marked anisotropy 
[22]. The increase in radially aligned collagen fi bres may explain the lack of anisotropy in 
autograft leafl ets demonstrated in our study. However, based on the increased collagen 
deposition, overall leafl et stiffness was predicted to increase. Future histological and 
biomechanical analyses may offer an explanation for our apparently confl icting fi ndings.
 Wall stiffness of pulmonary autograft roots, explanted for root aneurysm on average 
more than a decade after the Ross operation, was decreased (Chapter 7 and 8). This 
decrease may have contributed to progressive autograft root dilatation. Several surgeons 
performing the Ross operation with the “full root” technique have reported autograft root 
dilatation immediately after removal of the aortic cross-clamp, a fi nding corroborated by 
in vitro studies [23]. The sudden increase in wall stress upon exposure to the high pressure 
environment of the systemic circulation may have resulted in both root dilatation and 
fragmentation (and eventual loss) of elastin fi bres in the media [24]. These hemodynamic 
changes will have resulted in a shift on the stress-strain curve, whereby further dilatation 
was prevented by residual wall stiffness. Over time, increased collagen deposition in the 
ventricularis may have decreased wall stress and thereby contributed to a reduction 
of autograft root dissection and rupture risk. This combination of histological changes, 
decreased elastin and increased collagen, was expected to increase wall stiffness.
 The quantity of extracellular matrix proteins, such as collagen and elastin fi bres, is not 
the only factor determining tissue biomechanical properties. Impaired collagen biosynthesis 
and post-translational modifi cations may also contribute to aneurysm formation, as shown 
in the native aortic root of patients with a bicuspid aortic valve [25]. Future visualisation of 
the microarchitecture of collagen fi bres may demonstrate whether similar changes explain 
the counterintuitive observation of decreased wall stiffness in pulmonary autograft wall 
specimens. A case report of a patient with clinically silent autograft dissection demonstrated 
that the remodelling response may also increase wall stiffness in pulmonary autografts 
(Chapter 10). While the occurrence of dissection was associated with an increase in wall 
stiffness, it was not possible to differentiate between cause and consequence. Dissection 
and subsequent increased wall stress through autograft root dilatation may have initiated 
an increase in wall stiffness to prevent progressive dilatation.
 Given the differences in reoperation rates after a Ross operation with the “full 
root” technique between centres, surgical technique or post-operative management are 
expected to infl uence root remodelling [26]. Therefore, it is important to understand 
the remodelling response underlying a decrease in autograft wall stiffness. One approach 
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may be to study vascular remodelling in patients with pulmonary arterial hypertension. 
Interestingly, several centres have recently reported increased stiffness of the proximal 
pulmonary artery in patients with pulmonary arterial hypertension [27, 28]. Despite 
a more gradual increase in pressure, the remodelling response in an animal model of 
neonatal pulmonary arterial hypertension gave rise to similar histological changes to 
those observed in explanted pulmonary autografts [29]. Interestingly, wall stiffness in these 
animals was increased compared to the native pulmonary root. 
The Debate Revisited
Recent guidelines on management of valvular heart disease do not recommend use of 
the Ross operation in adults [30, 31]. The 2014 American guidelines state that the Ross 
operation should only be considered when performed by an experienced surgeon in 
young adults in whom oral anticoagulation use is not desirable [30]. In the 2012 European 
guidelines, the Ross operation was not even included in the guideline statements [31]. 
Interestingly, both guidelines refer to and criticize the only randomized controlled trial on 
the Ross operation [13].
 In the single centre, single surgeon randomized controlled trial patients were 
randomized to receive the Ross operation or aortic valve replacement using a homograft. 
Long-term survival was similar in patients who received the Ross operation compared 
to an age-matched and sex-matched general population. Despite absence of strict in- and 
exclusion criteria, the cohort consisted primarily of young and relatively healthy patients 
with limited comorbidity. These patient characteristics may explain the excellent survival 
after the Ross operation. Survival in patients who received a homograft was inferior. 
However, use of homografts in the aortic position is rare nowadays with most young 
adults receiving a mechanical valve prosthesis. Performing a randomized controlled trial 
comparing the Ross operation with implantation of a mechanical valve prosthesis in a 
more diverse patient population will prove diffi cult. Improved patient education and 
introduction of shared decision making tools have led to increased patient awareness of 
the risks and benefi ts associated with the different prosthesis types [32]. Therefore, it may 
not be appropriate from an ethical point of view to ask patients, especially young adults, 
to undergo randomisation. In this light, it is even more remarkable that the American 
guidelines disregard the fi ndings from the randomized controlled trial on the basis that 
these have not been replicated in other randomized controlled trials.
  Current guidelines refl ect the scientifi c climate; the majority of the cardiovascular 
community no longer considers the Ross operation when aortic valve replacement in 
adults is discussed [33]. Notably, in adults with congenital heart disease, who are often 
cared for by the same team responsible for paediatric patients, the Ross operation is 
still considered a valuable treatment option. The current climate of ranking surgeons and 
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surgical centres based on early outcome may dissuade cardiothoracic surgeons to learn 
this complex operation [34]. In addition, a cynic might argue that the decline in interest 
may be due to emergence of techniques that are more attractive commercially, such as 
transcatheter aortic valve implantation, or simply more novel, such as valve-sparing aortic 
root replacement. However, there are genuine concerns regarding the Ross operation that 
warrant discussion: the increasing hazard of reoperation on the pulmonary autograft in 
the second postoperative decade, technical complexity and the creation of double valve 
disease.
 In the setting of a single centre single surgeon study, freedom from reoperation on 
the pulmonary autograft after the Ross operation using the “full root” technique was 
almost complete after a decade [13]. However, a large multicentre prospective cohort 
study recently reported substantially higher rates of reoperation [14]. The difference in 
reoperation rates between these two studies may to a certain extent refl ect technical 
complexity. Low-volume centres contributing to registries will have less experience and 
expertise with the Ross operation and the relatively high reoperation rates from these 
centres may refl ect institutional learning curves. This statement is a challenge to the 
community of surgeons with expertise on the Ross operation in adults. Mentorship of 
committed and talented young surgeons may improve long-term outcome after the Ross 
operation and perhaps allow more patients to benefi t from this unique approach to aortic 
valve replacement.
 The challenge now for the proponents of the Ross operation is to shift the debate 
from a focus on the negative (i.e. reoperation rates) to include discussion of the positive. 
Aicher et al. have shown a superior quality of life after the Ross operation compared with 
conventional mechanical valve replacement [18]. The Ross operation may offer a window 
for young adults to lead an active lifestyle and start a family at the cost of a possible 
reintervention later in life. The current guidelines on aortic valve replacement should be 
challenged by demanding a more evidence-based and balanced discussion of the Ross 
operation.
Conclusions
The scientifi c fi ndings presented in this thesis can be summarized in the form of several 
conclusions, which may impact clinical decision making and drive future research.
Ross operation in neonates and infants
1. Coronary reimplantation is a critical step in an otherwise complex operation.
2. High early mortality in neonates is contrasted with remarkable improvement in left 
ventricular function of patients who survived the early postoperative period.
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3. Autograft valve function remains excellent in the fi rst decade despite, or perhaps 
thanks to, increasing autograft root dimensions.
4. Close echocardiographic follow-up of patients is warranted as fi ndings suggest 
autograft root dilatation may occur in the second postoperative decade.
Valve-sparing reoperations after the Ross operation
5. This approach is associated with limited early and late morbidity as well as mortality.
6. Reintervention after valve-sparing reoperation are frequent in patients who presented 
with isolated autograft valve regurgitation (i.e. without autograft root dilatation) at the 
time of reoperation.
Pulmonary autograft root remodelling
7. Autograft leafl ets show architectural changes that suggest changes in the mechanical 
forces acting upon the leafl ets drive the remodelling response.
8. Autograft leafl et stiffness is similar to native pulmonary leafl ets.
9. Wall stiffness in explanted autografts is decreased despite increased collagen deposition.
The Future
Answering the questions raised by the work presented in this thesis may prove challenging. 
In adults, the Ross operation is performed in a select patient population in a limited 
number of centres worldwide. In children, especially in neonates and infants, use of the 
Ross operation is more widespread. However, the relatively low incidence of congenital 
aortic stenosis requiring surgical intervention contributes to the problem of limited patient 
numbers available for scientifi c study. Introduction of a single, prospective global Ross 
registry would increase statistical power of follow-up studies and may act as a stepping 
stone towards formation of a global Ross community. In addition, uniform data reporting 
will result in more reliable data.
 In parallel to strategies designed to increase data availability, ways to increase effi ciency 
of data use should be explored further. This thesis is the result of a multidisciplinary 
approach to addressing questions regarding the Ross operation. Bringing together surgeons, 
cardiologists, epidemiologists, statisticians, pathologists and biomedical engineers greatly 
increases the speed at which the research fi eld moves forward. This approach may also 
allow use of the same dataset or tissue sample for the study of multiple questions. 
 Using the biomechanical data presented in this thesis along with high-resolution CT 
imaging, three dimensional computer models of the autograft root can be constructed. 
Model simulations may predict the behaviour of the autograft root at different blood 
pressures and after different surgical interventions. Results from these simulations could 
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guide surgical decision making and innovation of surgical technique, and generate new 
hypotheses concerning pulmonary autograft remodelling. This avenue of research may 
ultimately lead to a better understanding of both autograft and native aortic root dilatation 
and increase power of existing prediction models designed to identify the optimal timing 
for intervention.
 In this thesis, the use of complex statistical modelling to study the evolution over 
time of several important echocardiographic variables in patients who received the Ross 
operation as neonate or infant is explored. Novel statistical approaches are expected 
to reveal more information than ever before from datasets. However, clinicians should 
proceed with caution and be in the company of an expert when performing complex 
statistics. To ensure quick and correct implementation of these approaches into the clinical 
practice, it is crucial to educate clinicians on how to interpret the data obtained from 
complex statistical approaches. In turn, the ability of clinicians to explain scientifi c results 
to a patient is a prerequisite to allow the informed patient to participate in shared decision 
making.
 The 1960’s represent the pioneering era of aortic valve replacement. In the decades 
following this era, evolution of the techniques and approaches developed in the 1960’s have 
greatly improved life expectancy and quality of life of patients with aortic valve disease. The 
pioneering spirit of the early days of aortic valve surgery appears to have been rekindled 
recently. Novel approaches such as transcatheter aortic valve implantation and valve-
sparing aortic root implantation have revolutionized the fi eld of aortic valve replacement. 
Moreover, results from studies on experimental techniques such as personalised external 
aortic root show promising results. Although these novel approaches may not offer 
patients a valve substitute for life, they may be integrated into a strategy for life with aortic 
valve disease. It can be assumed that the pioneering spirit shown by clinicians and scientists 
will continue to improve the lives of patients with aortic valve disease in the 21st century.
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Summary
Chapter 1, the general introduction, describes the prevalence of aortic valve disease 
and the clinical consequences of aortic valve regurgitation and stenosis. Furthermore, it 
describes the evolution of surgical interventions to replace the aortic valve with a focus on 
the Ross operation. In this operation, the aortic valve is replaced by the pulmonary of the 
same patient, a donor valve replaces the pulmonary valve. Chapter 1 describes the debate 
on use of the Ross operation in adults. After identifying clinically relevant unanswered 
questions, the goals of the research are discussed.
Chapters 2 and 3 describe the experience with the Ross operation in neonates and 
infants with a focus on the post-operative course.
 Chapter 2 describes the combined clinical experience of six centres from The 
Netherlands and Germany with the Ross operation in neonates and infants. The median 
age of the 76 patients was 85 days at the time of the operation. Early mortality, in 13 
patients, occurred relatively more often in neonates and patients with congenital aortic 
arch defects. Function of the pulmonary autograft at the time of last follow-up was 
generally good and a reoperation was necessary in only 1 patient. Although the Ross 
operation in neonates and infants is a high-risk operation, it offers patients a durable aortic 
valve replacement.
 Chapter 3 studies the evolution of echocardiographic variables of patients who 
underwent the Ross operation as neonate or infant in The Netherlands and survived the 
peri-operative period. The median follow-up duration of the 42 patients was 3.2 years. 
The left ventricular function improved signifi cantly over time with an increase of fractional 
shortening of 26% pre-operatively to 34% at the time of last follow-up. Dilatation of the 
pulmonary autograft root was only seen at the level of the sinotubular junction. The 
function of the autograft valve remained unchanged over time. The Ross operation offer 
neonates and infants a vital improvement of left ventricular function. Moreover, growth of 
the autograft root is mainly parallel to the growth of the patient with preservation of valve 
function.
Chapters 4 and 5 describe the experience with valve-sparing reoperations after the Ross 
operation.
 Chapter 4 describes the combined experience of six European centres with valve-
sparing reoperations after the Ross operation in 86 patients. During a median follow-up 
of 4.3 years 4 patients died, one of whom early after the reoperation. A reintervention 
after the valve-sparing reoperation was necessary in 15 patients, mainly due to prolapse 
or retraction of the valve leafl ets. The reintervention hazard was higher in patients with 
isolated or severe autograft regurgitation at the time of the valve-sparing reoperation. Valve 
14009_AMookhoek_BW.indd   137 20-09-16   10:21
Chapter 12
138
function at last follow-up was predominantly good in the patients without reintervention. 
Valve-sparing reoperations after the Ross operation are characterized by a low operative 
risk and acceptable degree of reintervention. In patients with isolated or severe autograft 
regurgitation as indication for the reoperation surgical alternatives should be considered.
 Chapter 5 describes the case of a patient with a reintervention after valve-sparing 
reoperation. Ten years after the Ross operation a 22-year old woman underwent a valve-
sparing autograft root replacement because of severe autograft root dilation and valve 
regurgitation. Two years later she presented with severe valve regurgitation based on 
prolapse of two leafl ets. Histological analysis of the explanted leafl ets showed changes 
which may be associated with prolapse of the leafl ets.
Chapter 6 discusses the histological characteristics of autograft leafl ets and compares 
these with normal aortic and pulmonary valves. In 11 patients, the autograft valve was 
explanted on average 11.2 years after the Ross operation because of autograft root 
dilatation and valve regurgitation. The valve leafl ets of the autograft were signifi cantly thicker 
than the pulmonary valve (137 versus 37 µm). Increase of leafl et thickness was caused by 
deposition of radially aligned collagen fi bres in the ventricularis. Matrix remodelling in 
the autograft valve is, based on the presence of myofi broblasts and the activity of matrix 
metalloproteinases, more than ten years after the Ross operation still an active process.
Chapters 7 to 10 discuss the biomechanical characteristics of the explanted pulmonary 
autograft
 Chapter 7 compares wall stiffness of the autograft with the normal pulmonary root. 
Square vessel wall specimens of 10 patients were stretched using biaxial stretch testing. 
Stiffness was calculated at 8 and 25 mmHg. The autograft wall was signifi cantly less stiff 
than the normal pulmonary root at 8 (134 versus 175 kPa) and 25 mmHg (369 versus 919 
kPa). This fi nding may explain the occurrence of progressive autograft root dilatation.
Chapter 8 compares wall stiffness of the autograft with the normal aorta. Square vessel 
wall specimens of 10 patients were stretched using biaxial stretch testing. Stiffness was 
calculated at 80, 120 and 200 mmHg. The autograft wall was signifi cantly less stiff than the 
normal aortic root at 80 (1527 versus 2993 kPa), 120 (2537 versus 4931 kPa) and 200 
mmHg (4788 versus 9207 kPa). The process of remodelling after the Ross operation did 
not provide the autograft with the biomechanical characteristics of the normal aorta.
Chapter 9 compares the stiffness of the autograft valve with the normal aortic and 
pulmonary valve. Valve leafl ets of seven patients were explanted on average 12 years after 
the Ross operation. Stiffness of the valve leafl ets was determined using biaxial stretch 
testing and compared with normal aortic and pulmonary valves. Although stiffness in 
autograft leafl ets was lower than in normal aortic leafl ets (11273 versus 26866 kPa), there 
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was no difference with normal pulmonary leafl ets (9746 kPa). Despite changes in the 
geometry and histology of the autograft root, no evidence for biomechanical remodelling 
was observed.
 Chapter 10 describes the case of a patient with an incidentally discovered dissection 
of the autograft. A 47-year old man underwent a reoperation 12 years after the Ross 
operation because of autograft root dilatation and valve regurgitation. After the 
explantation, a longitudinal tear in the intima of the autograft was observed. A biaxial 
stretch test showed that wall stiffness at the site of dissection was much higher than in 
the surrounding area. This case illustrates the versatility of the remodelling response in the 
autograft root.
Chapter 11, the general discussion, discusses three prominent questions regarding the 
Ross operation which this thesis has tried to answer. First, what is the outcome of the Ross 
operation in neonates and infants? Second, what is the value of valve-sparing reoperations 
after the Ross operation? Third, does remodelling cause the pulmonary autograft to adopt 
an aortic phenotype? Moreover, Chapter 11 contributes to the debate on the use of the 
Ross operation in adults and discusses the answers to the three questions this thesis has 
produced. The future of research on the Ross operation is seen with confi dence.
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Hoofdstuk 1, de algemene introductie, bespreekt de prevalentie van aortaklepziekten 
en de klinische gevolgen van aortaklepinsuffi ciëntie en stenose. Verder beschrijft het de 
evolutie van chirurgische interventies om de aortaklep te vervangen, met nadruk op de 
Ross operatie. In deze operatie wordt de aortaklep vervangen door de pulmonaalklep van 
dezelfde patiënt, een donorklep vervangt de pulmonaalklep. Hoofdstuk 1 bespreekt het 
debat over gebruik van de Ross operatie in volwassenen. Na inventarisatie van klinisch 
relevante onbeantwoorde vragen worden de doelen van het onderzoek besproken.
Hoofstukken 2 en 3 bespreken de ervaring met de Ross operatie in neonaten en 
zuigelingen met nadruk op het postoperatieve beloop.
 Hoofdstuk 2 beschrijft de verzamelde klinische ervaring van zes centra uit Nederland 
en Duitsland met de Ross operatie in neonaten en zuigelingen. De mediane leeftijd van de 
76 patiënten was 85 dagen ten tijde van de operatie. Vroege sterfte, in 13 patiënten, trad 
relatief vaker op in neonaten en patiënten met congenitale aortaboog defecten. Functie 
van de pulmonale autograft ten tijde van het laatste klinische contact was overwegend 
goed en in slechts 1 patiënt was een reoperatie noodzakelijk. Hoewel de Ross operatie 
in neonaten en zuigelingen een hoog-risico operatie is, biedt het patiënten een duurzame 
aortaklep vervanging.
 Hoofdstuk 3 bestudeert de evolutie van echografi sche variabelen van patiënten 
die als neonaat of zuigeling de Ross operatie in Nederland hebben ondergaan en 
de perioperatieve periode hebben overleefd. De mediane follow-up duur van de 42 
patiënten was 3,2 jaar. De linkerventrikelfunctie verbeterde signifi cant over de tijd met 
een toename van fractionele verkorting van 26% preoperatief tot 34% ten tijde van het 
laatste klinische contact. Dilatatie van de autograftwortel werd alleen gezien ter hoogte 
van de sinotubulaire overgang. De functie van de autograftklep bleef onveranderd over 
de tijd. De Ross operatie biedt neonaten en zuigelingen een cruciale verbetering van de 
linkerventrikelfunctie. Verder is groei van de autograftwortel overwegend parallel aan de 
groei van de patiënt met behoud van klepfunctie.
Hoofdstukken 4 en 5 beschrijven de ervaring met klepsparende reoperaties na de Ross 
operatie.
 Hoofdstuk 4 bespreekt de verzamelde ervaring van zes Europese centra met 
klepsparende reoperaties na de Ross operatie in 86 patiënten. Gedurende een mediane 
follow-up van 4,3 jaar overleden 4 patiënten, waarvan 1 kort na de reoperatie. Een 
reinterventie na de klepsparende reoperatie was noodzakelijk in 15 patiënten, overwegend 
door prolaps of retractie van de klepbladen. De reinterventie hazard was hoger in 
patiënten met geïsoleerde of ernstige autograft insuffi ciëntie ten tijde van de klepsparende 
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reoperatie. Klepfunctie ten tijde van het laatste klinische contact was overwegend goed 
in de patiënten zonder reinterventie. Klepsparende reoperaties na de Ross operatie 
worden gekenmerkt door een laag operatief risico en acceptabele mate van reinterventie. 
In patiënten met geïsoleerde of ernstige autograft insuffi ciëntie als indicatie voor de 
reoperatie moet nagedacht worden over chirurgische alternatieven.
 Hoofdstuk 5 beschrijft de casus van een patiënt met een reinterventie na klepsparende 
reoperatie. Tien jaar na de Ross operatie onderging een 22-jarige vrouw een klepsparende 
autograftwortel vervanging vanwege ernstige autograftwortel dilatatie en klepinsuffi ciëntie. 
Twee jaar later presenteerde zij zich met ernstige klepinsuffi ciëntie op basis van prolaps 
van twee klepbladen. Histologische analyse van de geëxplanteerde klepbladen toonde 
veranderingen die mogelijk geassocieerd zijn met prolaps van de klepbladen.
Hoofdstuk 6 bespreekt de histologische kenmerken van autograftkleppen en vergelijkt 
deze met normale aorta- en pulmonaalkleppen. In 11 patiënten werd de autograftklep 
gemiddeld 11,2 jaar na de Ross operatie geëxplanteerd vanwege autograft worteldilatatie 
en klepinsuffi ciëntie. De klepbladen van de autograft waren signifi cant dikker dan de 
pulmonaalklep (137 versus 37 µm). Toename van klepdikte werd veroorzaakt door depositie 
van radiair georiënteerde collageenvezels in de ventricularis. Matrix remodellering in de 
autograftklep is, gezien de aanwezigheid van myofi broblasten en activiteit van matrix-
metalloproteïnasen, meer dan 10 jaar na de Ross operatie nog steeds een actief proces.
Hoofdstukken 7 tot en met 10 bespreken de biomechanische eigenschappen van de 
geëxplanteerde pulmonale autograft.
 Hoofdstuk 7 vergelijkt de wandstijfheid van de autograft met de normale 
pulmonaalwortel. Vierkante fragmenten vaatwand van 10 patiënten werden middels biaxiale 
strekproeven uitgerekt. De stijfheid werd bij 8 en 25 mmHg berekend. De autograftwand 
was signifi cant minder stijf dan de normale pulmonaalwortel bij 8 (134 versus 175 kPa) 
en 25 mmHg (369 versus 919 kPa). Deze bevinding kan het optreden van progressieve 
autograftwortel dilatatie mogelijk verklaren.
 Hoofdstuk 8 vergelijkt de wandstijfheid van de autograft met de normale aorta. 
Vierkante fragmenten vaatwand van 10 patiënten werden middels biaxiale strekproeven 
uitgerekt. De stijfheid werd bij 80, 120 en 200 mmHg berekend. De autograftwand was 
signifi cant minder stijf dan de normale aortawortel bij 80 (1527 versus 2993 kPa), 120 (2537 
versus 4931 kPa) en 200 mmHg (4788 versus 9207 kPa). Het proces van remodelleren na 
de Ross operatie heeft er niet toe geleid dat de autograft de biomechanische eigenschappen 
van de normale aorta heeft gekregen.
 Hoofdstuk 9 vergelijkt de stijfheid van de autograft klep met de normale aorta- en 
pulmonaalklep. Klepbladen van zeven patiënten werden gemiddeld 12 jaar na de Ross 
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operatie geëxplanteerd. De stijfheid van de klepbladen werd bepaald middels biaxiale 
sterkproeven en vergeleken met normale aorta- pulmonaalkleppen. Hoewel stijfheid in 
autograftklepbladen lager was dan in normale aortaklepbladen (11273 versus 26866 kPa) 
was er geen verschil met normale pulmonaalkleppen (9746 kPa). Ondanks veranderingen 
in de geometrie en histologie van de autograftwortel werd er geen bewijs voor 
biomechanische remodellering gevonden. 
 Hoofdstuk 10 beschrijft de casus van een patiënt met een bij toeval ontdekte 
dissectie van de autograft. Een 47-jarige man onderging een reoperatie 12 jaar na de Ross 
operatie vanwege autograft worteldilatatie en klepinsuffi ciëntie. Er werd na explantatie 
een longitudinale scheur in de intima van de autograft gezien. Een biaxiale strekproef 
toonde aan dat de wandstijfheid ter plaatse van de dissectie veel groter was dan in 
het gebied daaromheen. Deze casus illustreert het vermogen tot remodellering van de 
autograftwortel. 
Hoofdstuk 11, de algemene discussie, bespreekt drie voorname vragen over de Ross 
operatie die dit proefschrift heeft getracht te beantwoorden. Ten eerste, wat is de 
uitkomst van de Ross operatie in neonaten en zuigelingen? Ten tweede, wat is de waarde 
van klepsparende reoperaties na de Ross operatie? Ten derde, zorgt remodellering ervoor 
dat de pulmonale autograft een aortaal fenotype aanneemt? Verder draagt Hoofdstuk 11 
bij aan het debat over het gebruik van de Ross operatie bij volwassenen en bespreekt het 
de antwoorden op de drie vragen die dit proefschrift heeft voortgebracht. De toekomst 
van het onderzoek naar de Ross operatie wordt met optimisme tegemoet gezien.
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8th International Symposium on Biomechanics in   2013  0.6
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Coordination of departmental journal club   2014  0.5
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Dit proefschrift is het resultaat van jarenlang samenwerken met geweldige collega’s en 
onmisbare steun van mijn ouders en goede vrienden. Graag wil ik een aantal mensen in 
het bijzonder bedanken.
Mijn promotor prof. dr. Takkenberg. Beste Hanneke, ongeveer 10 jaar geleden stapte ik 
als tweedejaars student vol zenuwen jouw kamer binnen om hartkleppen op te halen 
voor mijn eerste onderzoeksproject. Zenuwen hebben inmiddels plaatsgemaakt voor diep 
respect. Bedankt voor de vele kansen die je me door de jaren heen hebt geboden en de 
begeleiding tijdens mijn promotietraject en het schrijven van dit proefschrift. Van jou heb 
ik geleerd wat echte passie voor de wetenschap betekent en hoe aanstekelijk dat kan zijn. 
Ik heb in het bijzonder genoten van onze discussies, zowel op jouw kamer als op congres, 
over de wetenschap in al haar facetten en over het onderwijs binnen COEUR.
Mijn promotor prof. dr. Bogers. Beste prof. Bogers, ik wil u hartelijk danken voor 
het vertrouwen dat u mij gegeven heeft door mij als promovendus op de afdeling te 
verwelkomen. Ik heb respect voor uw kritische blik en heb veel van u geleerd over het 
schrijven van wetenschappelijke artikelen. Bedankt ook voor de vrijheid die u mij heeft 
gegeven en de tijd die u heeft genomen om samen oplossingen te zoeken voor problemen 
met enkele complexe projecten.
Mijn copromotor dr. Schoof. Beste Paul, ontzettend bedankt voor een bijzondere 
samenwerking die 10 jaar geleden begon in Leiden. Ik ben dankbaar dat u mij vanaf het 
begin het gevoel heeft gegeven samen onderzoek te doen. Een mooi voorbeeld is de NVT 
waar u mij, naïef gekleed in overhemd met korte mouwen, als tweedejaars student mee 
naar toe nam. Ik heb veel respect voor de rust die u uitstraalt en de manier waarop u 
kliniek en wetenschap combineert. U heeft altijd veel interesse getoond in mijn carrière en 
ik wil u bedanken voor de goede gesprekken, de adviezen en uw steun.
Beste leden van de kleine commissie, prof. dr. Hazekamp, prof. dr. Helbing en prof. dr. Van 
Kemenade, hartelijk dank voor uw bereidheid mijn proefschrift te lezen en te beoordelen. 
Beste prof. dr. Bloemena, prof. dr. Niessen, dr. Wentzel en dr. Witsenburg, hartelijk dank dat 
u plaats wilt nemen in de grote commissie. Ik kijk ernaar uit om met u allen van gedachten 
te wisselen over de inhoud van mijn proefschrift.
Dear dr. Tseng, thank you for the generous invitation to work at your lab on our joint 
project. It was a privilege learning from you and your team and I thank you for the patience 
you showed to someone with no background in biomechanical engineering. I enjoyed the 
weekly lab meetings and cherish my send-off at the Cliff House.
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Graag wil ik alle collega’s bedanken met wie ik het genoegen heb gehad om de afgelopen 
jaren mee samen te werken. Een aantal mensen wil ik in het bijzonder bedanken. Bardia, 
Jonathan en Nelleke, ik heb met plezier samen met jullie gewerkt aan onze systematische 
reviews! Dr. Rebel, bedankt voor het samen opzetten van een complexe studie. Beste dr. 
Bökenkamp, hartelijk dank voor de vele uren samen doorgebracht met het beoordelen 
van echobeelden. Of course, a huge thank you to all my international collaborators who 
have worked hard to make our multicentre efforts a success. Beste Annet, Erna, Liesbeth 
en Usha, bedankt voor jullie hulp en ondersteuning!
Lieve kamergenoten en mede-promovendi Bardia, Elrozy, Gerdien, Jonathan, Mostafa, 
Nelleke, Sahar en Simone, bedankt voor jullie collegialiteit en de vele, te lange lunches in 
de stad. Het is goed om te zien dat een aantal van jullie al gepromoveerd zijn en een aantal 
mij snel zullen volgen!
Dear Andrew, Heidi and Sam, thank you for making me feel at home in the lab. Sam, your 
help and advice the fi rst weeks in the lab was truly invaluable. Dear Andrew and Heidi, I 
enjoyed sharing the lab with you over the summer. I still miss your boxed cheese plates 
whenever I go for a long walk!
Mijn opleiders in het VU medisch centrum prof. dr. Bloemena en prof. dr. Van der Valk en 
mentor prof. dr. De Jong. Beste Elisabeth, Paul en Daphne, dank voor jullie vertrouwen in 
mij. Ik ben trots dat ik onder jullie hoede de opleiding tot patholoog mag volgen. Bedankt 
voor de mogelijkheid die jullie aangereikt hebben om tijdens mijn opleiding twee maanden 
vrij te maken om dit proefschrift te voltooien.
Beste collega’s in het VU medisch centrum, ik ben dankbaar om met zulke geweldige 
collega’s te mogen werken. In het bijzonder wil ik mijn collega-AIOS Anna-Lena, Annefl eure, 
Clifton, David, Emma, Emma, Eriënne, Evita, Evert-Jan, Jolanda, Kimberly, Maartje, Mariëlle, 
Mathilda, Max, Mehrdad, Sara en Shaimaa bedanken. Ik voel me echt thuis op de afdeling 
en dat komt door jullie!
Thank you to Asia, Emelie, Luke and Pierre for discovering San Francisco together, for 
eating and drinking, for hiking, for being great friends! Dear Sophie, thank you for letting 
me live in your house, where I felt at home with you and the cats.
Dear Arianna, do you think I could defend my thesis over Skype? I am still happy we said 
goodbye in a Manhattan hotel and not at a Sicilian airport.
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Graag wil ik mijn vrienden bedanken voor jullie begrip en interesse. In het bijzonder wil 
ik Emma, Justin en Jeroen bedanken voor hun vriendschap en de vele samen gemaakte 
reizen. Oscar, bedankt voor de tijd samen aan de Burgermeester Reigerstraat! En Noortje, 
bedankt voor de gezelligheid op weg naar het Erasmus MC.
Beste Emma en Johan, mijn paranimfen, ik ben erg blij en trots dat jullie naast mij staan op 
deze bijzondere en belangrijke dag. Dank voor jullie steun!
Dearest Violeta, falling in love is such an amazing feeling! 
De laatste woorden zijn voor mijn ouders die mij met veel liefde en toewijding hebben 
opgevoed en mij nog steeds zoveel leren. Lieve ouders, bedankt voor jullie grenzeloze 
steun! Jullie hebben ervoor gezorgd dat ik zelden zorgen heb gekend. Het afgelopen jaar 
hebben jullie je veelvuldig en hardop afgevraagd of ik mijn proefschrift nog af ging maken. 
Het is dan ook mede dankzij jullie dat ik straks vol trots mijn proefschrift in jullie bijzijn 
zal verdedigen.
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A
 Aart Mookhoek was born on October 10th, 1985 in Beverwijk (The Netherlands). After 
graduating from grammar school, he started his academic career at Leiden University (The 
Netherlands) in 2003. Fascinated by the inner workings of the human body, he completed 
a bachelor’s and master’s degree in biomedical sciences. During his time in Leiden, he took 
advantage of the opportunities to study abroad by spending a semester at the Karolinska 
Institute (Sweden) and the National University of Singapore (Singapore).
Exposure to clinical research and inspiring hours spent in the operating room at the 
Leiden University Medical Center (The Netherlands) persuaded him to pursue a career in 
medicine. In 2008, he enrolled in the Selective Utrecht Medical Master, SUMMA in short, 
at the University of Utrecht (The Netherlands), a four year fast-track medical school 
designed to stimulate students to pursue a career as both clinician and scientist. During 
his fi nal year, Aart completed a clinical rotation in adult congenital heart disease at the 
Royal Brompton Hospital (United Kingdom) and performed a research project concerning 
the biomechanical properties of explanted pulmonary autografts at the Department of 
Surgery at the University of California San Francisco (United States) under the supervision 
of Elaine Tseng.
After graduating from medical school in 2012, Aart moved to the Erasmus Medical Center 
(The Netherlands) for the PhD project which resulted in the thesis you are now reading. 
This move was instigated by a wish to fi nish a research project which he started to work 
on while still a bachelor student in Leiden. As of January 2015, Aart is in training to become 
a clinical pathologist at the VU Medical Center (The Netherlands).
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